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Abstract
The 34kDa putative serine protease of M.a.paratuberculosis shows conserved 
features of the HtrA family of bacterial proteases, implicated in the virulence of 
several intracellular pathogens. However its role in virulence of 
M.a.paratuberculosis remained to be determined.
To this end the 34kDa putative serine protease ORF was cloned into a mycobacterial 
shuttle vector under the transcriptional control of the M.tuberculosis hsp60 promoter. 
The expression and subsequent secretion o f the recombinant protein into the 
extracellular milieu by M.smegmatis mc^l55 was shown. M.smegmatis mc^l55 that 
expressed the 34kDa putative serine protease demonstrated enhanced intracellular 
survival in ex-v/vo sheep alveolar macrophages in the 24 hours following 
macrophage ingestion in comparison to M.smegmatis mc^l55 expressing E-GFP and 
wild-type M.smegmatis mc^l55. The presence of the protein had no affect on the 
ability of M.smegmatis mc^l55 to enter macrophages or on the long-term 
intracellular survival.
The upstream region of the ORF in M.a.paratuberculosis was examined for 
transcriptional activity and shown to be capable of expressing the 34kDa putative 
serine protease in M.smegmatis mc^l55. A similar level of increased intracellular 
survival was noted when the 34kDa putative serine protease was expressed from the 
putative upstream promoter as observed when the 34kDa putative serine protease 
was expressed by the hsp60 promoter. A putative IdeR regulatory sequence was 
identified in the upstream region. However, further characterisation o f the upstream 
region failed to demonstrate a role for IdeR or the cellular concentration of iron in 
the regulation of the 34kDa putative serine protease.
Homologues of the 34kDa putative serine protease were observed in the genomes of 
several pathogenic mycobacterial species, including members of the TB complex and 
M.leprae. Significantly, only weak homology noted in the genome of the non- 
pathogenic M.smegmatis. Therefore, the possibility exists that the 34kDa putative 
serine protease represents a conserved feature of mycobacterial pathogenesis.
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CHAPTER 1
INTRODUCTION 
1.1 The Genus Mycobacterium
Mycobacteria belong to the genus Mycobacterium, which is the sole genus in the 
family Mycobacteriaceae, in the order Actinomycelates. The order Actinomycelates 
comprises the genera Corynebacterium, Mycobacterium, Nocardia (the CMN group) 
and Rhodococcus, which are distinguishable on the basis of their ability to synthesise 
mycolic acids (Barksdale and Kim, 1977). The genus includes photochromogens, 
scotochromogens and non-chromogens. All members are aerobic or microaerophillic, 
non-motile and non-spore forming. Mycobacteria posses a complex cell wall that is 
rich in lipids and glycolipids, conferring characteristic acid and alcohol fastness upon 
the bacillus. The phylogeny of the genus has been determined largely on the basis of 
16S rRNA sequences and has been subdivided into fast- or slow- growing species 
(Springer et ah, 1996). The majority of the members of the genus are saprophytic. 
The slow growing mycobacteria have remarkably long generation times (1-14 days) 
and include a wide variety of organisms of medical and veterinary importance, 
including the human pathogens M.tuberculosis and M.leprae responsible for 
tuberculosis and leprosy, respectively. The Mycobacterium tuberculosis complex 
comprises M.tuberculosis together with Mycobacterium africanum, Mycobacterium 
bovis, Mycobacterium canetti and Mycobacterium microti with exceptionally little 
sequence variation observed (Sreevatsan et al, 1997; Musser et a l, 2000; Musser, 
2001). The M.avium complex, another group of closely related slow growing 
mycobacterial species, includes both veterinary and opportunistic human pathogens 
(see sections 1.4 and 1.5).
1.2 The Mycobacterial Cell Envelope
The mycobacterial cell envelope comprises the cytoplasmic membrane and the cell 
wall complex. Electron micrograph studies of ultra thin sections of embedded 
mycobacterial cells demonstrated that the cytoplasmic membrane is asymmetrical 
with the outer electron dense layer appearing thicker than the inner layer (Paul and
Beveridge, 1992; Paul and Beveridge, 1993). The increased thickness has been 
associated with the preferential association of carbohydrates and phosphatidylinositol 
mannosides (PIMs, unique to Actinomycetes), with the outer leaflet (Brennan and 
Nikaido, 1995).
The mycobacterial cell wall is a physically resilient, chemically complex structure of 
exceptionally low permeability which confers characteristic acid and alcohol fastness 
upon the cell, as well as resistance to many commonly used antibiotics and chemical 
disinfectants (Jarlier and Nikaido, 1994). The generally accepted model of the 
mycobacterial cell wall is one of an asymmetric lipid bilayer (Nikaido et a l, 1993; 
Brennan and Nikaido, 1995). In this model, the inner leaflet comprises peptidoglycan 
linked to arabinogalactan polysaccharides, esterified at their distal ends with high 
molecular weight mycolic acids. These long chain mycolic acids (Cgo-Cgo) are 
arranged perpendicular to the cell surface in a tightly packed inner leaflet array.
The outer leaflet comprises a layer of loosely associated solvent-extractable lipid 
compounds such as PIMs, including lipoarabinomannan (LAM). LAM has been 
reported to play a significant role in the immunopathogenesis of M.tuberculosis, 
M.leprae (Barnes et a l, 1992a) (Chatteqee et a l, 1992; Barnes et a l, 1992b)and 
M.a.paratuberculosis (Sugden et al, 1987; Sugden et a l, 1989; McNab et a l, 1991). 
Several classes of free lipids and glycolipids including phenolic glycolipids (PGLs) 
and glycopeptidolipids (GPLs) are associated with the outer cell wall. The GPLs 
form a group of immunogenic cell surface antigens, which have been used to type 
isolates of M.avium, M.intracellulare, and M.scrofulaceum on the basis of serotypic 
identity (Inglis and McFadden, 1999). Other cell wall components include 
phthiocerol dimycocerosates (PDIMs), glycerophospholipids and cell wall associated 
proteins such as the M.leprae bacterioferritin MMP II (Pessolani et a l, 1994) and 
porin proteins (Draper, 1998) embedded in the lipid matrix.
1.3 Mycobacterial Genome Sequencing
In recent years, there have been considerable advances in the application of 
molecular genetic tools to the study of mycobacterial virulence and pathogenicity, 
with the development of plasmid and phage vectors, transposons, reporter molecule
expression, and strategies for the inactivation and mutagenesis of mycobacterial 
genes (reviewed in the introduction to Chapter 3). The publishing of the 
M.tuberculosis H37Rv genome sequence and the continuing genome sequencing 
projects of other mycobacteria represents a significant step in the potential to dissect 
the biology of this important genus. This has proved pivotal in the development of 
new techniques to unravel the transcriptome and proteome of pathogenic 
mycobacteria as well as being the foundation of functional and comparative genomic 
studies of the genus (Behr et ah, 1999; Jungblut et a l, 1999; Brosch et al, 2000a; 
Brosch et a l, 2000b; Mattow et a l, 2001). The completed genomes of other 
members of the TB complex, M.bovis, M.bovis BCG, M.avium, 
M.a.paratuberculosis and M.smegmatis will be of critical importance in our growing 
understanding of the mechanism of pathogenesis of mycobacteria and in highlighting 
important differences between pathogenic strains (Table 1.1).
The first mycobacterial genome to be completed was that of the standard 
M.tuberculosis lab strain, M.tuberculosis H37Rv (Cole et al, 1998). The complete 
M.tuberculosis H37Rv comprises 4,411,529 bp and contains approximately 4,000 
protein-encoding genes and 50 genes coding for stable RNA. Of the predicted open 
reading firames 40% have an attributed function, predominantly associated with core 
metabolism. Limited functional information or sequence similarity has been ascribed 
to a further 44% of the genes with the rest of the genes of unknown function and may 
be unique to mycobacteria. Approximately 51% of the genes of M.tuberculosis have 
arisen fi*om gene duplication events, with a subsequent high degree of sequence 
conservation observed, leading to extensive functional redundancy. M.tuberculosis 
H37Rv is rich in IS elements with 56 copies firom eight different IS families (Gordon 
et a l, 1999a; Gordon et al, 1999b). One of the most remarkable features of the 
M.tuberculosis genome was the discovery that ~9% of the genome encodes two new 
families of glycine-rich proteins, the PE (novel glycine-alanine-rich) and PPE (novel 
glycine-asparagine-rich) proteins (Cole et al, 1998). Functional information about 
these proteins is still very limited and it has been suggested that they could play a 
role in antigenic variation (Ramakrishnan et a l, 2000; Brennan et a l, 2001; Delogu 
and Brennan, 2001; Banu et al, 2002). Another striking feature of the M.tuberculosis 
H37Rv genome is the abundance of genes coding for enzymes involved in fatty acid
metabolism, more than 250 in M.tuberculosis compared to 50 in Eschericha coli, an 
observation that is consistent with the complexity of the lipid content of the 
mycobacterial cell envelope. M.tuberculosis also has the potential to produce over 
100 enzymes involved in p-oxidation of fatty acids.
In contrast to the M.tuberculosis H37Rv genome, the M.leprae genome is smaller in 
size comprising 3,268,203 bp with a lower average G + C content of 57.8% (Cole et 
al, 2001). Only 49.5% of the genome contains protein-coding genes, compared to 
91% in M.tuberculosis H37Rv, a further 27% containing recognisable pseudogenes 
with the remaining 23.5% of the genome apparently non-coding. The genome 
contains 1,604 potentially active genes, of which 1,439 are shared with 
M.tuberculosis H37Rv with 165 containing no M.tuberculosis orthologue. The size 
of the genome compared to the mean genome size of mycobacteria, calculated to be 
-4.4 Mb, indicates that considerable downsizing has occurred and as such the 
M.leprae bacillus has been described as the minimal genome required for pathogenic 
mycobacteria. Comparative proteome analysis has demonstrated that M.leprae 
contains only 391 detectable soluble protein species in comparison to the -1,800 
detectable protein species of M.tuberculosis (Jungblut et al, 1999; Brosch et al, 
2000b). The overall reduction in gene number compared to M.tuberculosis H37Rv 
leads to a limited repertoire of metabolic pathways, particularly those involved in 
catabolism and NADH utilisation (Eiglmeier et a l, 2001). Similarly, the M.leprae 
genome does not contain the mbt operon, encoding the non-ribosomal peptide 
synthases involved in the biosynthesis of the salicyl-capped peptide-polyketide 
scaffold of mycobactins (Morrison, 1995; Cole et al, 2001). Mycobactins represent 
the principle iron scavenging mechanism of mycobacteria in the host cell (Wheeler 
and Ratledge, 1988; Barclay and Ratledge, 1988; De Voss et a l, 2000; Gomes et a l, 
2001), the absence of the enzymes for mycobactin synthesis suggests that M.leprae 
may use other mechanisms to acquire iron in the intracellular environment of the host 
cell (Morrison, 1995).
Several other mycobacterial genomes have now been either completely sequenced or 
are due to be completed soon (Table 1.1). The genomes include other members of the 
M.tuberculosis complex, members of the MAC complex and M.smegmatis, a
saprophytic strain that has been used extensively in developing mycobacterial gene 
expression techniques. Genome comparisons of these genomes may expand our 
understanding of pathogenicity, virulence and host specificity, and evolutionary 
aspects of the genus may be further elucidated. Preliminary information has revealed 
that the genome of M.smegmatis is similar in size (7-8 Mb) to that of the related 
actinomycete Streptomyces coelicolor (Brosch et ah, 2001) 
(http://www.sanger.ac.uk/Projects/S_coelicolor/). This result, coupled to results from 
the analysis of the 16S rRNA genes suggests that slow growing mycobacteria 
represent the most recently evolved branch of the genus. If correct, then the 
possibility exists that loss of genes, rather than horizontal transfer of genetic 
material, may be an important factor in the evolution of the slow growing pathogenic 
mycobacteria. The relative uniformity of the G + C content in the M.tuberculosis 
H37Rv gene has been postulated as confirmatory evidence that little horizontal 
transfer of genetic material has occurred in M.tuberculosis (Brosch et al, 2001).
Members of the MAC complex, like the members of the M.tuberculosis complex 
demonstrate a high level of sequence conservation with strains difficult to 
differentiate (see section 1.4). The sequencing of the genomes of two distinct strains 
of the MAC complex, M.avium (ISPOi negative) and M.a.paratuberculosis (Table 
1,1), and the subsequent genomic comparisons may allow a more complete picture of 
the differences in terms of host specificity and virulence between the two closely 
related species to be determined. Also, it may afford the opportunity for the 
identification of species-specific genomic regions that would form the basis of new 
detection techniques to distinguish between the two strains. A recent preliminary 
report on the comparison of both genomes revealed the presence of 21 ORFs 
apparently unique to the genome of M.a.paratuberculosis (Bannantine et a l, 2002). 
Such differences are based on a comparison of approximately half the completed 
genome of M.a.paratuberculosis, raising the possibility that more genomic 
differences exist between the genomes of these two closely related species.
Mycobacterial Species Database
Mycobacterium smegmatis, 
Mycobacterium avium
http://www.tigr.org/tdb/mdb/mdbinprogress.html/
Mycobacterium avium 
subspecies paratuberculosis
http ://www.cbc.umn.edu/ResearchProj ects/AGAC/ 
Mptb/Mptbhome.html/
Mycobacterium ulcerans, 
Mycobacterium microti, 
Mycobacterium bovis BCG
http://www.pasteur.fr/recherche/unites/Lgmb/
Mycobacterium tuberculosis 
H37Rv **
http://genolist.pasteur.fr/TubercuList/
Mycobacterium tuberculosis 
CDC1551**
http ://www.tigr.org/tigr- 
scripts/CMR2/genomePage3.spl/database=gmt/
Mycobacterium tuberculosis 
strain 210
http://www.tigr.org/cgi-bin/BlastSearch/blast.cgi/
Mycobacterium bovis http ://www. sanger. ac.uk/Proj ects/Mbovis/
Mycobacterium leprae ** http://genolist.pasteur.fr/Leproma/
Table 1.1 Mycobacterial Genome Sequencing Projects. **Indicates a completed 
genome. Adapted from Brosch et al, 2001.
1.4 T h t Mycobacterium avium Complex (MAC)
The MAC comprises a large group of closely related mycobacteria including 
M.intracellulare, M.avium subspecies avium (M.a.avium), M.avium subspecies 
silvaticum (M.a.silvaticum), M.avium subspecies paratuberculosis 
{M.a.paratuberculosis) and M.lepraemurium (Thorel et ah, 1990). M.lepraemurium 
is the causative agent of murine leprosy (Rojas-Espinosa and Lovik, 2001) and 
M.a.silvaticum (originally called the wood pigeon bacillus), containing the specific 
insertion sequences ISPP7 and ISPP2, has been reported to produce a disease 
resembling paratuberculosis in calves and deer (Matthews et al, 1982; Collins et al, 
1983). M.a.avium consist of primarily saprophytic strains, which are widely 
distributed in the environment and also in apparently healthy animals, birds and 
humans. However, a number of M.avium strains are opportunistic pathogens of 
animals and humans, capable of causing infection and disease in debilitated hosts. 
M.avium strains have gained increased importance in recent times due to the 
observed high level of disseminated infection seen in patients with acquired immune 
deficiency syndrome (AIDS) (Hampson et al, 1989; McFadden et a l, 1992).
M.a.paratuberculosis is the causative agent of paratuberculosis or Johne’s disease, a 
chronic enteric disease of animals, principally affecting ruminants (Cocito et al, 
1994). One of the primary distinguishing features of M.a.paratuberculosis is the 
extremely slow growth in culture, generally 16 weeks on primary culture, although 
longer incubation periods have been observed for ovine isolates and those from 
Crohn’s Disease isolates. A second subspecies-specific characteristic is the growth- 
dependency on mycobactin, an iron chelating cell wall component produced by most 
other mycobacteria. The identification and characterisation of a subspecies-specific 
insertion sequence 1S900 has been used extensively to differentiate 
M.a.paratuberculosis from M.a.avium and M.a.silvaticum (Green et a l, 1989; Pavlik 
et a l, 1995; Moreira et a l, 1999; Cousins et a l, 2000; Bull et a l, 2000a; Stevenson 
et a l, 2002). The 1.45kb element was considered unique to M.a.paratuberculosis, 
with approx. 15-20 copies present in the M.a.paratuberculosis genome (Green et al,
1989). The element itself is unusual in lacking inverted repeats or flanking direct 
repeats, showing no target site duplication but still requiring a homologous target site 
sequence for integration.
M.a.paratuberculosis has been shown to possess a very broad host range with cattle 
and sheep isolates of M.a.paratuberculosis reported as well as pigmented strains 
isolated from multibacillary cases of ovine paratuberculosis (see section 1.5) (Cocito 
et al, 1994). Such cases have characteristically yellow or orange intestinal regions 
presumably caused by the presence of large numbers of pigmented organisms present 
(Clarke and Little, 1996). Strains isolated from sheep and goats have been observed 
to be more difficult to culture (Juste et a l, 1991). More recently 
M.a.paratuberculosis has been found in ruminant and non-ruminnat wildlife species 
(see section 1.6.5).
1.5 MAC and M.a,paratuberculosis Strain Differentiation
The development and application of reliable techniques to accurately distinguish 
between members of the MAC has been an ongoing process for the last number of 
years (Stevenson and Sharp, 1997). A set of phenotypic properties based on a large 
number of biochemical tests was shown to be capable of dividing the MAC into three 
distinct subgroups namely, M.a.avium, M.a.silvaticum and M.a.paratuberculosis 
(Thorel et al, 1990). However, such schemes are complex, a more common way of 
differentiating between closely related species is to exploit genomic differences 
between the various strains.
1.5.1 DNA-DNA hybridisation
DNA-DNA hybridisation studies have demonstrated between 72 and 100% 
homology between the various members of the MAC (Hurley et a l, 1989). This 
figure increased to 95-100% when strains of M.intracellulare were ignored 
(McFadden et al, 1987a; Hurley et al, 1989). The results of such studies indicated a 
high level of genetic homogeneity between members of the MAC, rendering many of 
the strains indistinguishable from each other (McFadden et a l, 1990).
1.5.2 rRNA genes
Differences in the 16S rRNA gene have been used successfully to determine the 
phylogenetic relationships of mycobacteria and other bacterial taxa. Unfortunately, 
each of the rRNA genes (16S, 23 S and 5S) as well as their intergenic spacer regions 
are highly conserved in the M.avium complex (Stahl and Urhance, 1990; Rogall et
al, 1990a; Rogall et a l, 1990b; van der Giessen et a l, 1994). Indeed, The 
GenProbe® AccuProbe (GenProbe® Inc., San Diego, California, USA) detection Kit 
is capable of distinguishing between M. avium and M.intracellulare but is unable to 
distinguish between M.avium and M.a.paratuberculosis (Thoresen and Saxegaard, 
1991). Upon sequence analysis a single base pair difference at position 135 in the 
variable region of the 16s rRNA coding sequence exists between M.avium and 
M.a.paratuberculosis (van der Giessen et a l, 1992). A similar level of sequence 
conservation was observed for the 23s rRNA gene, with only 9 mismatches observed 
between M.avium and M.a.paratuberculosis and in the intergenic region 1, where 
only 2 mismatches are observed (van der Giessen et al, 1994).
1.5.3 Molecular typing methods
Molecular typing techniques have been used to study the diversity and strain 
differentiation within the M.avium complex. Restriction fragment length 
polymorphism (RFLP) and field inversion gel electrophoresis have been shown to 
discriminate M.a.paratuberculosis from other M.avium species, with only limited 
differences observed between M.a.paratuberculosis isolates (Whipple et a l, 1987; 
Picken et a l, 1988; Levy-Frebault et al, 1989; Chiodini, 1989a). The ability of 
RFLP to distinguish between M.a.paratuberculosis strains was enhanced by 
hybridising the endonuclease generated genomic DNA fragments with DNA probes, 
resulting in a simplification of the observed banding pattern (McFadden et al, 
1987b). One such fragment contained the 1^900 sequence, which was used to 
successfully discriminate between the two subspecies (McFadden et al, 1987b). 
Other insertion sequence elements in isolation or in combination have also been used 
as probes in RFLP analysis to discriminate between the members of the MAC 
complex including ISP07, IS1245 and IS7377 (Kunze et a l, 1992; Collins et al, 
1997; Ritacco et a l, 1998; Whittington et a l, 1998a; Whittington et a l, 2000; 
Garriga et a l, 2000).
An \S)900 based probe bas been used to distinguish more than 20 different 
M.a.paratuberculosis RFLP types (Pavlik et al, 1995; Pavlik et a l, 1999). The probe 
was based on a short sub-species specific region located in the 5’ region of the 
element. Earlier studies had used ISPOO-RFLP to divide M.a.paratuberculosis strains
into three major groups, the first group comprised primarily New Zealand cattle 
isolates although some sheep and goat isolates were also present (Collins et al,
1990), the second group comprised sheep isolates from New Zealand and the Faeroe 
Islands (de Lisle et al, 1993) and a third group comprising sheep isolates from South 
Africa (de Lisle et a l, 1992), Iceland and Canada (Collins et al, 1990). More 
recently, IS900-RFLP using the endonuclease PvuJl subdivided 42 
M.a.paratuberculosis strains into two major clusters. Cluster I contained slow 
growing sheep isolates (S-strains) with Cluster II containing Cattle and Goat isolates 
(C-strains) (Cousins et al, 2000). In New Zealand and Australia, S-strains are 
predominantly recovered from sheep (Whittington et al, 2000). In Europe, C-strains 
are predominantly isolated from sheep and also from cattle and non-ruminant 
animals. As such, although the terms C and S are used in describing 
M.a.paratuberculosis strains no conclusive evidence of species-specific strains have 
been thus far been described. In general IS900-RFLP has been able to detect limited 
heterogeneity among M.a.paratuberculosis strains with a single IS900-RFLP type 
predominating in many countries.
Probes based on IS1311 have been used to analyse M.a.paratuberculosis isolates, 
with fewer polymorphisms observed than seen with 1^900 probes (Whittington et al, 
1998a). In general however, such techniques are limited by the number of copies of 
the insertion sequence present in each isolate and the genomic distribution of the 
insertion sequence. As such the insertion of insertion elements into the 
M.a.paratuberculosis genome may generate insufficient genomic polymorphism to 
adequately differentiate strains of M.a.paratuberculosis from each other.
As already stated, there are approximately 15-20 1^900 integration sites in the 
M.a.paratuberculosis genome, although there appears to be a degree of strain based 
variability at several sites in terms of the presence of 1^900 at that site or IS900 
mediated re-arrangements of the surrounding loci. These features have formed the 
basis of a multiplex PCR typing technique, reportedly capable of discriminating 10 
different types of M.a.paratuberculosis isolates from different host species e.g., 
cattle, sheep and man (Bull et al, 2000a). Point mutations in IS7577, however, have 
allowed the development of a PCR based detection assay followed by endonuclease
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analysis of the resulting PCR product that allows the differentiation of sheep and 
cattle M.a.paratuberculosis strains (Whittington et al, 1998a). A new 
M.a.paratuberculosis specific insertion element, ISMav2, has been recently 
identified (Strommenger et a l, 2001). The IS element is present in at least three 
copies in the M.a.paratuberculosis genome and demonstrates no significant 
similarity at nucleotide or amino acid level to known mycobacterial IS elements. 
Initial results suggest that the lSMav2 PCR is capable of discriminating 
M.a.paratuberculosis fi*om M.avium.
Field inversion gel electrophoresis (FIGE) using the endonuclease Dral was capable 
of differentiating M.a.paratuberculosis firom M.a.avium and M.a.silvaticum but 
revealed a high level of genetic homogeneity for M.a.paratuberculosis (Arbeit et al, 
1993). Pulsed field gel electrophoresis (PFGE) has been used to demonstrate strain 
differentiation of M.avium strains from AIDS patients and to compare strains of 
M.avium derived from animals and humans (Coffin et a l, 1992; Picardeau and 
Vincent, 1996; Inglis and McFadden, 1999). Such whole genome molecular typing 
techniques may offer greater sensitivity in differentiating M.a.paratuberculosis 
isolates, as they do not rely on the potential polymorphisms generated by the 
presence of insertion elements. A recent comprehensive study conducted at the 
Moredun Research Institute examined 5 pigmented and 88 non-pigmented 
M.a.paratuberculosis strains using multiplex-PFGE (utilising restriction enzymes 
Sna BI and Spe I), ISPOO-RFLP (utilising restriction enzymes Bst Eli and Pvu I) and 
IS7577 polymorphic analysis using PCR (Stevenson et al, 2002). All pigmented 
isolates demonstrated the same multiplex-PFGE. Similarly, all of the pigmented 
strains were designated S (sheep) strains by IS7577-PCR analysis. Finally, multiplex 
PFGE differentiated the panel of mycobacterial strains into two distinct types, type I, 
comprised the pigmented strains with type II comprising all non-pigmented isolates. 
The multiplex-PFGE was found to detect greater heterogeneity than the IS900-RFLP, 
as the PFGE was capable of subdividing an IS900-RFLP type into two multiplex- 
PFGE types. The most common type was observed in cattle, sheep and even wildlife 
arguing that there are no species-specific strains in this panel.
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Randomly amplified polymorphic DNA (RAPD) techniques have been developed for 
M.tuberculosis and M.avium (Matsiota-Bemard et a l, 1997; Kauppinen et a l, 2001; 
Pillai et a l, 2001; Ramasoota et a l, 2001). Application of this technique to 
M.a.paratuberculosis isolates allowed the differentiation of M.a.paratuberculosis 
isolates firom animals and humans, although only limited diversity between the 
isolates was reported (Scheibl and Gerlach, 1997; Francois et a l, 1997).
1.6 Johne’s Disease
1.6.1 Aetiology
Paratuberculosis was first described in 1895 by Johne and Frothingham as a chronic 
enteritis in cattle (Johne and Frothingham, 1895). It was originally thought that the 
disease was an intestinal form of tuberculosis due to the presence of acid fast bacilli 
presumed to be the result of M.avium or M.tuberculosis infection. Bang 
differentiated the disease from tuberculosis in 1906 and the causative organism was 
isolated in 1911 by Twort and Ingram and named Mycobacterium enteriditis 
chronicae pseudotuberculosae bovis johne. Since then the disease has become 
known as paratuberculosis or Johne’s disease and the causative organism has been 
renamed several times and has recently been reclassified as M.a.paratuberculosis 
(Thorel et al, 1990).
1.6.2 Infection
The primary route of paratuberculosis infection appears to be the faecal/oral route, 
probably through the ingestion of contaminated faeces, milk or colostrum (Chiodini 
et a l, 1984; Cocito et al, 1994). Viable M.a.paratuberculosis have also been 
recovered from the reproductive organs of infected animals and intrauterine infection 
of the foetus has been reported (Clarke, 1997a). However, classic paratuberculosis 
lesions have not been identified in infected foetuses. There appears to be an age- 
related resistance to M.a.paratuberculosis infection, with most animals infected at 
the neo-natal stage with fewer animals infected as adults (Cocito et al, 1994; Clarke, 
1997a). Following oral ingestion the organism translocates through the mucosal 
epithelium, probably via the M-cells of the dome epithelium (Peyers patches) of the 
ileum and jejunum. The organism is then phagocytosed by sub-epithelial 
macrophages where the bacilli persist and replicate (Momotani et a l, 1988). Clinical
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symptoms occur in a minority of infected animals after a prolonged incubation 
period. The progressive disappearance of the Peyers patches after birth, although 
patches in the jejunum and ileoceacal valve region persist in adult animals, may be 
sufficient to explain the age-related resistance observed in adult animals (Landsverk 
et al, 1991).
The protracted period of infection prior to the onset of clinical disease allows faecal 
shedding of large number of organisms, contaminating pastures. Clinical symptoms 
in cattle are watery diarrhoea and progressive weight loss, with an absence of 
diarrhoea noted in some sheep and goat cases (Cocito et al, 1994). The sub-clinical 
infection is characterised by weight loss and decreased milk production. The 
appearance of disease associated lesions occur in the jejunal and ileocaecal Peyers 
patches area, with lesions often persisting for long periods of time. As the infection 
progress, lesions will spread to wide areas of the intestine, causing the typical 
granulomatous enteritis.
1.6.3 Pathological features of Johne’s disease
The principal pathological changes centre on the intestine and the related lymphatic 
and lymphoid tissues although in advanced cases, pathology associated with cachexia 
may be present. Where infection with pigmented strains occurs, the mucosal lining 
takes on a pathognomonic bright yellow colour, due to the presence of pigmented 
M.a.paratuberculosis in the lamina propia (Little et al, 1996; Clarke and Little,
1996). There are two type of intestinal pathology seen in Johne’s affected sheep 
(Cocito et al, 1994; Perez et a l, 1996; Perez et a l, 1999). Lesions seen in the 
paucibacillary form (borderline-tuberculoid: 31% of cases) present a marked 
lymphocytic infiltrate with low numbers of acid-fast bacilli and high activated T-cell 
counts, showing a high cell mediated immune (CMI) response and a predominance 
of Th-l-like (IL-2 and IFN-y) cytokines. In the multibacillary form (borderline- 
lepromatous: 69% of cases), lesions are characterised by the presence of macrophage 
infiltration containing numerous acid-fast bacilli and few T-cells, with a greater 
antibody response, no detectable CMI and a predominance of Th-2-like cytokines 
(IL-4 and IL-10) (Begara-McGorum et al, 1997; Burrells et a l, 1998; Begara- 
McGorum et a l, 1998; Burrells et a l, 1999). There are immunological parallels
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between Johne’s disease and another important pathogenic mycobacterial infection, 
leprosy, affecting humans. Both mycobacterioses are chacarterised by a strong early 
CMI response, limiting bacterial proliferation and a terminal anergic stage where 
there is no detectable CMI response but there are elevated serum antibody levels. It is 
thought that animals that succumb to Johne’s disease have mounted an insufficient or 
inappropriate response to clear or contain the infection. To this end, the role of a 
CMI response could be important in determining which type of pathology is 
observed in affected animals.
1.6.4 Prevalence and economic impact
Paratuberculosis is a global disease problem whose prevalence has been reported to 
be increasing in some countries. In the USA the prevalence was determined to be 
1.6% of all cattle and 2.9% of cull cows (Merkal et a l, 1987). Prevalence levels as 
high as between 18% and 30% have been reported among US cattle herds (Chiodini 
and van Kruiningen, 1986). A seroprevalence of 74% and 40% has been reported for 
dairy and beef herds respectively in Missouri (Thome and Hardin, 1997). More 
recently, results fi*om ELISA based serologic testing revealed that 3.4% of cows and 
21.6% of dairy herds were infected with M.a.paratuberculosis in the US (Wells and 
Wagner, 2000), with a herd prevalence of 54% reported in the Michigan area 
(Johnson-Ifeamlundu and Kaneene, 1999). The prevalence of bovine 
paratuberculosis has been estimated to be 15% in the UK. In Europe, using absorbed 
ELISA as the diagnostic tool, the seroprevalence was determined to be 54.7% at the 
herd level and 2.5% at the individual animal level in the Netherlands (Muskens et al, 
2000) and 17.4% level and 1.2% individual animal level in Belgium (Boelaert et al, 
2000). Similarly, a prevalence level of 70% has been estimated for Danish dairy 
herds based on the seriological detection of M.a.paratuberculosis in bulk milk 
samples (Nielsen et al, 2000). Earlier findings using an ELISA method utilising a 
M.a.paratuberculosis specific recombinant protein (a362) indicated a seroprevalence 
of paratuberculosis in the Wallon district of Belgium to be 12% (Vannuffel et a l, 
1994). A seroprevalence of 6.96% has been reported for farms in Austria (Gasteiner 
et a l, 1999).
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The estimated costs to farmers of animals sub-clinically infected with 
M.a.paratuberculosis was estimated to be £209 per infected dairy cow, due to 
decreased milk production (Benedictus et a l, 1987). The cost to the Dairy industry in 
the US has been estimated to exceed $15 billion annually (Stabel, 1998), with the 
estimated costs in the New England area alone to be over $15.4 million per year 
(Chiodini et al, 1984). Indeed, recent work also carried out in the US, has calculated 
that paratuberculosis costs dairy farmers around $100 per cow in moderately infected 
areas rising to $200 per cow in heavily infected areas (Ott et a l, 1999). The same 
study estimated that losses due to reduced productivity amounted to between $200 
and $250 million dollars. Such loses have been associated primarily with poor milk 
production and costs associated with replacing stock. Considerably more research is 
needed in determining the global level of paratuberculosis prevalence before the real 
cost to the agricultural industry can be determined. However, it is likely that the true 
cost of the disease is considerably higher than presently accepted estimates.
1.6.5 Wildlife and non-ruminant infection
During the clinical stage of disease large scale shedding of the organism in faeces is 
observed. Environmental contamination is the major factor in the spread of disease 
not only to other domestic ruminants but also to wild life inhabitants of the pasture. 
The finding that M.a.paratuberculosis can infect non-domestic animals including 
rabbits and other wildlife species, poses serious questions in the overall control of the 
disease, as well as the more general question of the epidemiology of the disease 
(Greig et al, 1997; Greig et al, 1999; Beard et a l, 2001a; Beard et a l, 2001b). 
M.a.paratuberculosis has been isolated from several species of wild animals 
including both ruminant and non-ruminant species (Jorgensen, 1969; Chiodini and 
van Kruiningen, 1983; Buergelt et a/., 2000; Beard et al, 2001b). In the Tayside area 
of Scotland, 67% of wild rabbits surveyed were infected with M.a.paratuberculosis 
and showed histopathological changes that were consistent with those seen in 
ruminants (Greig et al, 1997).
Further investigation across a broader area supported these initial findings and 
confirmed that the Tayside area is indeed a hotspot for M.a.paratuberculosis (Greig
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et al, 1999). A statistical correlation was seen between a past or current 
M.a.paratuberculosis problem and infection of rabbits. Upon investigation the strains 
isolated from rabbits did not appear, based on in vitro growth rates and morphology, 
to be different from cattle strains. PFGE typing failed to detect any difference 
between rabbit and cattle strains on the same farm. The possibility therefore remains 
that the shedding of organisms from infected ruminants, are a source of infection for 
wildlife species, which may then act as a reservoir of infection for the sub-sequent 
re-infection of domestic ruminants.
1.7 Diagnosis of Johne’s Disease
The diagnostic techniques that can be used to detect the disease are influenced by the 
stage of the disease and prevalence in the herd. Attempts to detect sub-clinically 
affected animals are hampered by the long incubation period of the disease 
characterised by the presence of low numbers of bacilli and little or no 
immunological response (Cocito et al, 1994;Clarke et a l, 1996a). Similarly, the 
absence of a humoral response at this stage of disease precludes early serological 
detection of animals infected with M.a.paratuberculosis. In the clinical stage of the 
disease, circulating serum antibodies are detectable in an ELISA assay and the 
bacterium is routinely recovered from the faeces of infected animals, although 
intermittent shedding of the organism has been observed at earlier stages of 
paratuberculosis. The ability of both techniques to detect M.a.paratuberculosis 
increases with disease progression. However there exists considerable variation in 
the responses observed in individual animals, particularly in the pauci-bacillary form 
of the disease in sheep. Exposure to antigenically similar environmental strains of 
mycobacteria has also hampered attempts to develop sensitive and specific 
diagnostic tests for paratuberculosis (Cocito et al, 1994; Valentin-Weigand and 
Goethe, 1999).
1.7.1 Microscopic examination of M,a,paratuberculosis in faeces
The detection of M.a.paratuberculosis in stained (Ziehl-Neelsen-ZN) faecal smears 
depends on the number of organisms present and the degree of bacterial clumping 
that has occurred. The overall sensitivity of the test is considered inadequate because 
faecal shedding of the organisms may be intermittent with insufficient organisms
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present. Similarly, the test is not capable of differentiating M.a.paratuberculosis 
from other environmental mycobacteria that may be passing through the gut 
following ingestion (Clarke, 1997a).
1.7.2 Detection in culture
The ability to culture the organism from the faeces of infected animals is regarded as 
the gold standard for diagnosis of Johne’s disease, but success does vary. In a 
comparison of samples taken from multi- or pauci- bacillary forms of infection in 
sheep, the success of culturing was seen to correlate with the likelihood that 
sufficient numbers of M.a.paratuberculosis were been shed from the intestinal lesion 
(Chiodini et al, 1984). The very slow growth and requirement for exogenous 
mycobactin, while being important characteristic determinants of 
M.a.paratuberculosis, prolong diagnosis. Similarly, slow growth of 
M.a.paratuberculosis necessitates the decontamination of the faecal samples prior to 
culturing to prevent the growth of faster growing bacterial strains (Whipple et al, 
1991). False negatives may occur due to impaired mycobacterial viability as a result 
of such procedures. Confirmation of M.a.paratuberculosis identity has been achieved 
by PCR amplification of the M.a.paratuberculosis specific insertion sequence \S900 
(Vary a/., 1990).
Other more rapid techniques for the detection of M.a.paratuberculosis in culture 
have been investigated. One such technique uses the radiometric based BACTEC 
460 system. Growth of mycobacteria is measured by metabolic conversion of the 
^^C-labelled substrate palmitate to "^^ CO: during growth in liquid medium. The 
release of ^ "^ COa can then be measured sensitively in the gas phase above the culture. 
Using this system it was reported that under the right growth conditions, including 
the presence of egg yolk and Mycobactin J, M.a.paratuberculosis could be cultured 
from sheep intestinal tissues and faecal samples (Cousins et a l, 1995; Whittington et 
al, 1998b; Whittington et al, 1999). Confirmation of the presence of 
M.a.paratuberculosis is still required by the use of down stream methods, such as 
\S900 PCR. The application of such systems should lead to a decrease in the 
diagnostic waiting time compared to more traditional culture methods. This is of
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particular relevance for ovine samples, which are seen as slower growing and harder 
to culture than bovine samples (Whittington et al, 1999).
1.7.3 Nucleic acid based detection of M.a.paratuberculosis
The identification of IS900 in M.a.paratuberculosis and the closely related 
\^901/\S902 in some M.avium strains, has allowed the differentiation of 
M.a.paratuberculosis from other members of the MAC but also has provided an 
important diagnostic tool in the detection of M.a.paratuberculosis in infected 
animals (Sanna et al., 2000; Garrido et al., 2000). The use oflS900  is an attractive 
method of detection as it is a rapid test compared to prolonged culturing methods and 
offered increased specificity. Indeed, IS900 PCR based detection of 
M.a.paratuberculosis in ovine faeces was found to be more sensitive than culturing 
(Collins et a l, 1993). This may be due in part to the difficulties associated with the 
culturing of ovine samples. PCR based detection in bovine samples was found to be 
less sensitive than culturing methods (Collins et al, 1993). In practice a high level of 
sensitivity is rarely attained due to difficulties in sample preparation. Reduced 
sensitivity can result fi*om inefficient template-DNA extraction protocols particularly 
where low numbers of organisms are present in the sample, and the presence of 
inhibitors of PCR in faecal and tissue samples.
Improved sample preparation techniques have been developed, especially for faecal 
samples, improving the sensitivity of such techniques. The application of an IS900 
PCR assay to blood and other tissue specimens fi*om sheep with clinical 
paratuberculosis offered an encouraging alternative to the detection of 
M.a.paratuberculosis in faecal samples (Gwozdz et a l, 2000a). More recently, 
results indicated that such assays lacked the sensitivity and specificity required for 
detection of subclinically infected cattle (Gasteiner et a l, 2000). Techniques have 
also been developed to demonstrate the presence of M.a.paratuberculosis in 
formalin-fixed and paraffin embedded tissue samples using \S900 PCR (Sanna et al, 
2000).
Recently, Cousins et al have reported the isolation of mycobacterial field isolates in 
Australia that were 1^900 PCR positive (Cousins et al, 1999). However, upon
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further examination of the isolated organism using \S900 RFLP, mycobactin 
dependence and 16s rRNA sequencing the isolated organism more closely resembled 
M.scrofulaceum. The authors recommended that restriction endonuclease analysis 
(REA) of IS900 PCR products should be introduced as a routine precaution to 
prevent the assignation of false positive results. Englund et al identified an IS900 
PCR positive strain from cattle that demonstrate microscopic and growth differences 
(loss of mycobactin dépendance in subsequent culture and recovery of colonies in 4 
weeks) to M.a.paratuberculosis (Englund et al., 2002). They report the presence of a 
single 1^900 like element demonstrating demonstrating 94.4% identity at the 
nucleotide level to ISPOO. Subsequent analysis, using 16s rRNA sequences revealed 
that the strain resembled M.cookii. Significantly, they also noted that REA of the 
resulting PCR product, as recommended by Cousins et al, would have reiterated the 
assignation of a false M.a.paratuberculosis identity. Collectively, these findings raise 
fears over the validity of using 1^900 PCR as the sole criteria in determining the 
presence of M.a.paratuberculosis.
Based on these observations other mycobacterial IS elements have been used to 
develop diagnostic PCR techniques for the detection of paratuberculosis. One such 
technique uses REA of IS7577 PCR products (Marsh et a l, 1999). IS7577 is present 
in both M.avium and M.a.paratuberculosis but point mutations exist in the sequences 
of the element from the different M.avium strains, allowing the differentiation of 
M.a.paratuberculosis from M.avium by restriction endonuclease analysis using the 
restriction enzymes Hinfi and Msel. The test was reported to be capable of 
distinguishing between not only M.a.paratuberculosis and M.avium but also between 
ovine and bovine isolates of M.a.paratuberculosis.
In addition to IS elements, species-specific genome sequences have provided the 
bases for the development of diagnostic tests for paratuberculosis. The F57 genomic 
sequence was shown to be specific for M.a.paratuberculosis encoding a 620bp ORF 
with a G + C of 59%, demonstrating no significant homology to any other sequence 
in the EMBL database (Poupart et a l, 1993). Labelled RNA transcripts from the F57 
fragment were shown to hybridise to genomic DNA from all strains of 
M.a.paratuberculosis tested but not to the genomes of other mycobacteria included
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in the study. Coetsier et al developed a duplex PCR based on F57 and a region of up­
stream sequence of the M.a.paratuberculosis immunodominant 34kDa antigen gene 
(Coetsier et a l, 2000). The upstream region of the p34 in M.tuberculosis complex 
strains contains a 79bp deletion compared to the region from M.avium complex 
strains. The authors demonstrated that the duplex PCR is capable of distinguishing 
between M.a.paratuberculosis and M.avium and also members of the M.tuberculosis 
complex (specifically M.tuberculosis H37Rv and M.bovis) in a panel of formalin- 
fixed paraffin embedded tissue specimens from cattle.
A second M.a.paratuberculosis species-specific genomic sequence has been 
identified, characterised and applied to a diagnostic test to discriminate 
M.a.paratuberculosis from other mycobacterial species (Coetsier et al, 2000). The 
423bp sequence encodes a heat shock protein (hsp)-like protein, designated hspXfvas 
recently been demonstrated to be expressed in bovine and murine macrophages 
infected with M.a.paratuberculosis (Bannantine and Stabel, 2000). Initial results 
reported that a 30bp oligonucleotide hspX specific probe in conjunction with a 
second oligonucleotide probe derived from the conserved mycobacterial recA gene 
was capable of detecting mycobacterial genomic DNA and discriminating 
M.a.paratuberculosis from other mycobacteria and even other subspecies of the 
M.avium complex (Coetsier et al, 2000).
More recently, a PCR panel assay using primers for the hspX gene 
{M.a.paratuberculosis specific), the 16s rRNA gene {M.avium complex specific), 
ISP07 {M.a.avium specific), \S1245 {M.avium complex specific) and ISPOO 
{M.a.paratuberculosis specific) has been reported (Ellingson et al., 2000). The 
application of this technique to mycobacterial lysates from 120 strains in 2 
independent laboratories, resulted in 100% and 99.2% detection and differentiation 
of M.a.paratuberculosis from M.avium and other mycobacterial species in Lab 1 and 
Lab 2 (blind test) respectively. The ability to demonstrate similar results in two 
independent laboratories is encouraging, as any standardised detection system must 
demonstrate reproducibility.
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1.7.4 Serological detection of M,a.paratuberculosis infection
Several different tests for the serological detection of paratuberculosis have been 
reported including the complement fixation test (CFT), agarose gel immuno diffusion 
(AGED) and enzyme-linked immunosorbent assay (ELISA) (Cocito et al, 1994). All 
are affected by an overall lack of sensitivity and an inability to detect early stages of 
the disease or paucibacillary forms of the disease in sheep where antibody levels are 
low or absent (Clarke et al., 1996b).
The preferred test for herd analysis is ELISA, based on its sensitivity in comparison 
to other serological tests, ease of use and rapid diagnostic determination of 
M.a.paratuberculosis infection status. However, difficulties in specificity have been 
reported, particularly as a result of the use of crude or partially purified preparation 
of bacterial extracts such as LAM PPD (Dargatz et al, 2001). Such preparations 
contain antigenic reagents that are common to most mycobacteria, resulting in the 
detection of false positives (Nielsen et a l, 2001). The specificity of such tests has 
been increased by absorption of test sera with lysates from environmental 
mycobacteria, such as M.phlei, eliminating cross-reactive mycobacterial antibodies 
(Milner et a l, 1990).
Refinements of ELISA techniques have centred on using M.a.paratuberculosis 
specific recombinant antigens to increase the specificity of the tests. A clone isolated 
from a bacteriophage Ig tl 1 expression library was shown to encode a peptide (a362) 
thought to carry subspecies specific B-cell epitopes corresponding to a 34kDa 
antigen o f M.a.paratuberculosis (de Kesel et al, 1993). A peptide from the carboxyl 
terminus of a362 was used to develop an ELISA based detection system that was 
reportedly capable of discriminating M.a.paratuberculosis from strains of the 
M.avium complex (Vannuffel et al, 1994). More recently, IgGl- and IgG2- 
subisotype specific ELISA protocols have been developed based on the 
M.a.paratuberculosis derived antigens Hsp70 and Hsp65, LAM and Johnin PPD 
(Koets et a l, 2001). The study compared the antibody responses of vaccinated 
animals, asymptomatic animals shedding bacteria and non-shedding animals and 
animals exhibiting clinical symptoms. They report that there is no uniform 
association with increased antibody responses during the progression of the disease
21
to clinical stage of bovine paratuberculosis. Indeed, elevated IgGl and IgG2 
concentrations were only detected in asymptomatic shedding animals. These results 
challenge the standard assumptions that humoral immunity is only seen at later 
stages of the disease and may have important ramifications on the design of future 
serological-based detection techniques.
1.7.5 CMI-based detection of M.a.paratuberculosis infection
Classically, the early stages of M.a.paratuberculosis infection are characterised by a 
strong CMI response with a gradual decrease in cell-mediated immunity during the 
progression of paratuberculosis and a concomitant increase in humoral responses 
(Cocito et al, 1994). Techniques based on measuring cell-mediated immunity offer 
distinct advantages in detecting infected animals at the subclinical stage of the 
disease. Cell mediated immune responses to M.a.paratuberculosis infection have 
been measured in vivo using the intradermal skin test and in vitro using a gamma- 
interferon ELISA assay and a migration inhibitory test. In the intradermal skin test, 
the diameter of the DTH response is measured following inoculation with M.avium 
purified protein derivative (PPD) or Johnin PPD (Gilot and Cocito, 1993). An 
increase in thickness of 2mm is regarded as a positive reaction. Such tests cannot 
discriminate between diseased animals and animals that have been vaccinated, and 
may also detect animals infected with other mycobacterial strains. Techniques have 
been developed to measure IFN-y levels from heparinised blood of infected animals 
stimulated with PPD using an ELISA method (Bilhnan-Jacobe et a l, 1992; Lauzi et 
al, 2000; Gwozdz et a l, 2000b; Stabel and Whitlock, 2001; Whipple et a l, 2001). 
As already mentioned, the crude nature of the both avian and Johnin PPD used as the 
basis of such tests and containing potentially cross reactive antigens results in an 
overall lack of specificity and the occurrence of false positives.
1.8 Crohn’s Disease
Crohn’s disease is a non-specific chronic inflammatory disease of humans most 
commonly affecting the distal ileum and colon but may occur in any part of the 
gastrointestinal tract fi*om the mouth to the anus and perianal area. The most 
common clinical features of the disease are chronic diarrhoea associated with 
abdominal pain, fever, anorexia, weight loss and a right lower quadrant mass or
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fullness. Prolonged constipation has also been noted and may lead to intestinal 
obstruction, necessitating surgical intervention to remove the obstructed ileum. The 
exact aetiology of the disease remains unknown. Numerous infectious agents, viruses 
and immunological factors have all been implicated as potential causes of the disease 
(Thompson, 1994; Sartor, 1997; van Kruiningen et al, 2000; Okabe, 2001). The 
results from several familial studies have also implicated inheritable factors as 
predisposing individuals to the development of Crohn’s Disease, with regions on 
chromosome 12, 14 and 16 implicated in the pathogenesis of both Crohn’s disease 
and ulcerative colitis (Hugot et a l, 1996; Cavanaugh et al, 1998; Brant et a l, 1998; 
Ma et a l, 1999; Frankish, 2001). The pathogenesis of the disease therefore may 
involve an interaction of genetic and environmental factors with the precise 
mechanism responsible for initiating chronic intestinal inflammation remaining 
unclear.
1.8.1 Crohn’s disease and M.a.paratuberculosis
Despite uncertainties surrounding the precise aetiology of the disease, Crohn’s 
disease does exhibit some clinical and pathological similarities to the pauci-bacillary 
form of paratuberculosis in animals (Chiodini, 1989b; Thompson, 1994; McFadden 
and Fidler, 1996; Hermon-Taylor et al, 2000). Several studies have reported 
culturing M.a.paratuberculosis from the inflamed intestine of Crohn’s patients but 
only in up to 5% of infected individuals (McFadden et al, 1987c; Chiodini, 1989b). 
Other mycobacteria have also been isolated from Crohn’s patients including, 
members of the MAC, M.kansasii, M.cheloni, and M.fortuitum (Chiodini, 1989b; 
McFadden and Fidler, 1996). Many of these studies reported the isolation of 
spheroplast forms, some of which appeared to be mycobacteria in subsequent studies. 
M.a.paratuberculosis has been detected in pathological samples from patients with 
Crohn’s disease by 1^900 PCR and also at a lower level, in healthy control 
individuals (Moss et al, 1992; Wall et al, 1993; Dell'Isola et a l, 1994; Rowbotham 
et a l, 1995; Clarkston et al, 1998; Schwartz et a l, 2000). One recent study 
demonstrated the presence of M.a.paratuberculosis in samples of breast milk 
obtained from two mothers with Crohn’s disease, and not from the breast milk of 5 
healthy individuals (Naser et al, 2000a). However, the recent finding of ISPOO-like 
sequences in other mycobacterial species questions the reliance on IS900 PCR as the
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pronciple method of M.a.paratuberculosis in Crohn’s disease patients. There are also 
numerous reports in the literature failing to detect the presence of 
M.a.paratuberculosis in Crohn’s disease samples by \S900 PCR (Dumonceau et al, 
1996; Frank and Cook, 1996; Chiba et al, 1998; van Kruiningen, 1999; Kanazawa et 
al, 1999).
Serological detection of M.a.paratuberculosis in Crohn’s patients based on crude 
M.a.paratuberculosis extracts in ELIS As failed to detect any differences in antibody 
binding between Crohn’s disease patients and control subjects (Thayer, Jr. et al, 
1984; Cho et a l, 1986; McFadden and Houdayer, 1988; Wahnsley et a l, 1996). 
Similarly, no differences were seen in peripheral blood and mucosal CMI responses 
to sonicates of M.a.paratuberculosis, heat killed M.a.paratuberculosis, and 
M.a.paratuberculosis PPD (Seldenrijk et al, 1990; Ibbotson et a l, 1992; Walmsley 
et al, 1996). A recent Japanese study however, reported an increase in IgG binding to 
a crude protoplasmic extract of M.a.paratuberculosis by Crohn’s disease sera 
compared with normal controls (Suenaga et a l, 1999). Several more recent reports 
have focussed on antibody recognition of selected peptides of M.a.paratuberculosis. 
Specific responses have been reported in a proportion of Crohn’s disease patients for 
several M.a.paratuberculosis proteins, including the 38kDa, 24kDa and 18kDa 
proteins (Elsaghier et al, 1992), the p35 and p36 antigens (El Zaatari et a l, 1999) 
and the M.a.paratuberculosis-spocific epitope, a362 (El Zaatari et al, 1999; Naser et 
al, 2000b). However, homologues of these proteins exist in other mycobacterial 
species, and antibody repsonses were also seen in healthy controls and ulcerative 
colitis patients.
Clinical improvement in a limited number of Crohn’s patients has been observed in 
response to treatment with conventional anti-tuberculosis chemotherapy, including 
various combinations of rifampicin, dapsone, isoniazid, streptomycin and ethambutol 
(Hulten et a l, 2000; Colombel et a l, 2001). However, relapse of the disease 
normally occurs and a complete cure is not achieved. The use of drugs such as 
rifabutin and macrolide antibiotics (e.g. clarithromycin) demonstrating increased 
anti-MAC activity have been reported to be more effective in higher numbers of 
Crohn’s patients in open studies, though relapse still occurs (Gui et a l, 1997). A
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large multi-centre, randomised placebo controlled trial of rifabutin, clarithromycin 
and clofazimine treatment in Crohn’s disease is currently being conducted in 
Australia, with results expected in 2003 (Hermon-Taylor and Bull, 2002).
Currently there is insufficient evidence to confirm or deny that M.a.paratuberculosis 
is the causative agent of at least some cases of Crohn’s disease. The detection of 
M.a.paratuberculosis in a greater number of Crohn’s disease patients than in controls 
in several studies suggests that the M.a.paratuberculosis may have a role either as 
the causative agent, as a secondary invader that exacerbates the disease or as a non- 
pathogenic coloniser due to the Teaky’ nature of the damaged mucosa. However, 
other factors may contribute to onset of disease including genetic and other 
susceptibility factors, Wiih M.a.paratuberculosis potentially involved in only a subset 
of Crohn’s disease cases. More work is required to confirm and elucidate the exact 
role that M.a.paratuberculosis plays in Crohn’s disease.
1.9 Identification of genes in M.a.paratuberculosis
To date the main focus of protein and indeed gene identification in 
M.a.paratuberculosis has been to develop more specific and sensitive diagnostic 
tests to aid in the detection of M.a.paratuberculosis in infected animals and to 
facilitate a greater differentiation o f M.a.paratuberculosis fi*om other members of the 
MAC. To this end a number of M.a.paratuberculosis proteins and genome sequences 
have been reported, which have been recently reviewed in (Harris and Barletta, 2001 ; 
Stevenson and Sharp, 1997; Clarke, 1997b). As such this section focuses on several 
of the better charactised examples and also the more recent findings.
Several studies have used SDS polyacrylamide gel electrophoresis often coupled to 
Western blotting to initially identify M.a.paratuberculosis proteins. Such analyses 
have revealed numerous immunoreactive proteins in the 20 to over 90kDa range 
which all belong to a major M.a.paratuberculosis protein antigen complex, A36, 
with similar antigens present in other bacteria (de Kesel et a l, 1992). The most 
extensively characterised of these include an epitope on the carboxyl terminus of a 
34kDa antigen, which has formed the basis of diagnostic tests (see section 1.4) (de 
Kesel et al, 1993; Gilot et al., 1993; Cocito et al, 1994). The use of monoclonal
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antibodies has also been successful in detecting predominately heat shock proteins 
with significant homologies to stress proteins from several other mycobacterial 
studies (Stevenson et a l, 1991). Crossed Immunoelectrophoresis (CIE) was used to 
identify three proteins exhibiting antigenic properties, namely the constitutively 
expressed AhpC (a 45kDa homodimer) and AhpD (19kDa) proteins, and a secreted 
14kDa protein (Olsen et al, 2000a; Olsen et al, 2000b; Olsen et a l, 2001a; Olsen et 
al, 2001b). Both AhpC and AhpD were demonstrated to be capable of illiciting a 
specific IFN-gamma repsonse in goats experimentally infected with 
M.a.paratuberculosis, with antibodies against AhpC also detected in these animals 
(Olsen et al, 2000b). The secreted 14kDa antigen was shown to be capable of 
discriminating M.a.paratuberculosis from M.tuberculosis but not other members of 
the MAC by western immunoblots (Olsen et al, 2001a).
Other approaches to identify potentially sub-species specific M.a.paratuberculosis 
genes have centred on the creation of a M.a.paratuberculosis genomic expression 
library followed by subsequent screening of the library for immunoreactive clones 
using either monoclonal antibodies or rabbit hyper-immune serum. The approach has 
led to the identification of mainly heat shock proteins or stress proteins with 
significant homology to other mycobacterial proteins, such as the 70kDa heat shock 
protein (Stevenson et al, 1991). The production of mAh and anti-sera involves the 
infection of a non-host animal with bacterial lystates or heat killed bacteria. This 
inoculation method however does not accurately reflect the immune response of the 
host animal to infection. This is reflected in the bias towards detection of stress 
proteins and the apparent inability to identify unique mycobacterial immunogenic 
components.
In order to represent better the set of antigens expressed in vivo and to augment the 
identification of potential immunogenic components the library was re-screened with 
sera from a naturally infected sheep. Any clones that are then isolated produce a 
protein that is expressed by the bacteria in vivo and as such may be potentially 
involved in the ovine immune response to M.a.paratuberculosis. This led to the 
identification of a 34kDa antigen with homology to the HtrA family of bacterial 
serine proteases (see section 1.10) (Cameron et al, 1994). A more recent study used
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sera from rabbits infected with live M.a.paratuberculosis to screen a genomic library 
identified two proteins: Cspl and a polyketide sythase (Pks7) (Bannantine and 
Stabel, 2001).
Representative difference analysis (RDA) PCR was successfully used to identify the 
so-called GS element that is present in both M.a.paratuberculosis and also 
M.a.silvaticum but absent in M.a.avium (Tizard et al, 1998). The GS element itself 
is 6.5 Kbp long with a GC content of 9%, markedly lower than most mycobacterial 
genes that have been identified. Sequence data showed that the element itself has 5 
ORF’s with homology to the previously reported ser-2 locus of M.avium encoding 
functions related to extra-cellular polysaccharide synthesis or modification, namely 
the production of a dimethylfueopyranosyl rhamnopyranoside unit at the terminus of 
the glycopeptidolipid (Mills et al, 1994; Bull et a l, 2000b).
An extracellular ferric reductase, which may be unique to M.a.paratuberculosis, has 
recently been characterised (Homuth et al, 1998). The protein was demonstrated to 
be capable of reducing iron complexed in various forms, such as ferritin the main 
storage form of iron in host cells. While the exact role of the protein remains 
unknown, the possibility exists that it might represent an alternative mechanism of 
iron acquisition, rather than the mycobactin-exochelin system of other mycobacteria 
(Dussurget and Smith, 1998; De Voss et a l, 1999). This may be of particular 
importance given the apparent lack of mycobactin activity in M.a.paratuberculosis 
(Thorel, 1984).
Ofher M.a.paratuberculosis gene sequences have been identified, including the hspX 
gene and F57, which has formed the basis of PCR based diagnostic tests for the 
presence of M.a.paratuberculosis (see section 1.6.3). Similarly, several insertion 
elements have been isolated in M.a.paratuberculosis some of which are sub-species 
specific, and have been extensively used in the differentiation of 
M.a.paratuberculosis from other members of the MAC and also in the detection of 
M.a.paratuberculosis in infected animals (see sections 1.4.3 and 1.6.3). More 
recently a secreted manganese superoxide dismutase (SOD) has been described in
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M.a.paratuberculosis with possible implications for protection of the bacilli in the 
intracellular environment of the host macrophage (Liu et a l, 2001).
The interaction between host and M.a.paratuberculosis remains poorly understood, 
with almost nothing known about the bacterial factors that enable the survival of 
M.a.paratuberculosis within macrophages. The M.a.paratuberculosis taxonomic 
database (http ://www.ncbi.nlm.nih.gov/htbin-post/T axonomy/wgetorg?id=l 770)
currently contains over 160 protein sequences and 143 nucleotide sequences (correct 
at time of writing), a significant number of which have been submitted directly to the 
database over the last number of years. This reflects not only the growing application 
of standardised techniques for gene identification developed for M.tuberculosis to 
M.a.paratuberculosis but also the slow release of information from the 
M.a.paratuberculosis genomes and in some cases direct benefits from the 
identification of pathogenesis associated genes in M.tuberculosis. The completion of 
the M.a.paratuberculosis genome sequencing project and the subsequent 
comparative genomics, as well as the application of techniques to examine the 
transcriptome and proteome of M.a.paratuberculosis, may further help unravel some 
of the molecular mechanisms underlying M.a.paratuberculosis infection, persistence 
and virulence in a variety of different species.
1.10 M,a,paratuberculosis 34kDa putative serine protease
Screening a A,gtll M.a.paratuberculosis expression library with serum from a 
naturally infected paratuberculosis sheep led to the identification of two 
immunogenic clones, S4 and 88, containing fragments of the same gene (Cameron et 
al, 1994; Cameron, 1996). Initial hopes that the isolated sequence was unique to 
M.a.paratuberculosis proved pre-mature as the gene was found to be expressed in 
other members of the MAC. The isolated clone coded for a protein with a predicted 
molecular mass of 34kDa, showing no homology to the immunodominant 34kDa 
protein previously identified in M.a.paratuberculosis and M.tuberculosis (Cocito et 
al, 1994). The 88 clone contained the entire coding sequence of the mature protein 
and demonstrated homology to trypsin like serine proteases from both prokaryotes 
and eukaryotes (Fallen and Wren, 1997). An overall similarity was also detected to 
the HtrA family of serine proteases from a number of bacterial species, such as
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Escherichia coli. Salmonella typhimurium. Brucella abortus, Bartonella henselae. 
Yersinia pestis. Yersinia enterocolitica (Baumler et a l, 1994; Roop et a l, 1994; 
Wren et a l, 1995; Anderson et a l, 1996; Williams et a l, 2000). HtrA has been 
implicated in the pathogenesis of several of these pathogenic bacterial species. While 
the overall homology is low there is a higher degree of homology at three sites that 
contain amino acids that are highly conserved in the active site of the well 
characterised E.coli HtrA, namely His, Asp and Ser (Figure 1.1). Other HtrA 
characteristic domains are also retained in the 34kDa putative serine protease, 
namely a N-terminal signal peptide directing export of the protein and a C-terminal 
PDZ protein interaction domain (Figure 1.2 and Section 1.11.1).
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* * *
CAA80638 (9 7 ) VLTtWHVI (1 2 5 ) WGXDRTQDIA (2 1 3 ) GOSGGB
CAC32191 (90) VLTNNHVI (118 ) WGYI'RTQI'VA (206) GDSGGP
CÀB09453 (90) VLTNNHl^I (118 ) WGYI'RTQI'VA (206 ) GDSGGP
CAA17SS2 (192) ILTNNHVI (228) W GAI'PTSDIA (315 ) 'IMSGGA
AAK45259 (174 ) ILTNNHVI (210) WGABPTSDIA (297 ) ‘3NSGGA
CAB3 6690 (177 ) ILTtffiTHW (216) W GAI'PTSDIA (3 0 3 ) '3NSGGA
AAC45270 (279 ) IVTNNHVI (312 ) LVGRI'PKTDLX (399) '3NSGGP
AAK4S518 (265 ) IVTNNHVI (298 ) LVGRBPKTI'LA (3 8 5 ) 'GNSGGP
AAA52916 (270) IVTNNHVI (303 ) LVGRI'PKTDLA (390) ■3NSGGP
A64113 (115) VLTNNHVI (142 ) LVGKDEQSDIÀ (224 ) '3NSGGA
AAC38203 (1 1 2 ) VLTNNHli"! (139 ) LVGKI'ELSRIA (221 ) ■3NSGGA
BAAÜ5608 (126 ) W TNNHW (153) HVGKI'PRSDIA (234) GNSGGA
BAA92745 (126 ) W TNNHW (153) HVGKDPRSBIA (234 ) iINSGGA
S 1 5337 (127) W TNNHW (154) WGKPPRSBIA (235 ) 'GNSGGA
CAA63869 (111) W TNNHW (138) VIGKI'PRTI'IA (219 ) 'GNSGGA
140 0 6 0 (147 ) WTNNHW (174) LIGAI'PRTBLA (2 5 5 ) iGNSGGP
AAA68943 (11) IVTNNHW (39) LIGKI'PKTIiLA (119 ) 'GNSGGA
AAD08063 (79) IVTNNHVI (107 ) LVGTPSESPLA (1 8 7 ) 'GNSGGA
C o n s e n s u s WTNNHVI VG DP SDIA GNSGGA
— CAAB0638
-CAC32191
-CAB09453
.GAA17582
IAAK45259
-CAB36690
.MC4527Ü
1MK4S18
-WW62916
,fl64113 
1/WC38203 
BM05Ô08 
BAA92745 
S15337 
CftA63069 
—  140060
-MA5S943 
 AAD0æ63
Figure 1.1 Alignment of the conserved His, Asp and Ser catalytic triad sites in the 
amino acid sequence of HtrA-like proteins in mycobacteria and other bacterial 
species. Shown in bold is the sequence of the M.a.paratuberculosis 34kDa putative 
serine protease (CAA80638). Stars denote the location of His, Asp and Ser residues, 
respectively. Also shown is a dendogram demonstrating the overall relationship of 
the various HtrA proteins in terms of sequence identity for the total protein sequence. 
Diagram generated using the Vector NTI ALIGN X software package.
CAA80638 (361aa) 34KDa protein [Mycobacterium avium subsp. paratuberculosis\\ CAC32191 
(354aa) probable secreted serine protease [Mycobacterium leprae]’, CAB09453 (355aa) pepA 
[Mycobacterium tuberculosis H37Rv]; CAA17582 (464aa) hypothetical protein Rv0983
[Mycobacterium tuberculosis H37Rv]; AAK45259 (446aa) putative HtrA [Mycobacterium 
tuberculosis CDC1551]; CAB36690 (452 aa) putative serine protease [Mycobacterium leprae]’, 
AAC45270 (542aa) HtrA [Mycobacterium tuberculosis H37Rv]; AAK45518 (528aa) HtrA 
[Mycobacterium tuberculosis CDC1551]; AAA62916 (533aa) HtrA [Mycobacterium leprae]’, A64113 
(466aa) HtrA [Haemophilus influenzae (strain Rd KW20)]; AAC38203 (463aa) HtrA [Haemophilus 
influenzae]’, BAA05608 (474aa) HtrA [Escherichia co//]; BAA92745 (491 aa) HtrA [Shigella sonnei]’, 
S I5337 (475aa) HtrA [Salmonella typhimurium]’, CAA63869 (464aa) HtrA [Yersinia enterocolitica]’, 
140060 (513aa) HtrA [Brucella abortus]’, AAA68943 (368aa) heat shock protein/serine protease 
[Campylobacter jejuni]’, AAD08063 (443aa) HtrA [Helicobacter pylori 26695],
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Trypsin Catalytic Domain 
Signal peptide PDZ
His Asp Ser
34kDa putative Serine Protease
3 6 1  a a
Figure 1.2 Structural features of the 34kDa putative serine protease protein. Shown 
is the location of the N-terminal signal peptide, the central catalytic domain with the 
characteristic triad of His, Asp and Ser residues (Pfam: PF00089 trypsin. Trypsin) 
and the C-terminal PDZ domain (Pfam: PF00595 PDZ, PDZ domain). Figure 
generated using Vector NTI suite. Further information on Pfam entries can be 
accessed at http://www.sanger.ac.uk/Software/Pfam/. See Appendix 4 for protein 
sequence.
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The S8 clone contained the entire open reading frame for the 34kDa putative serine 
protease including the putative Shine-Dalgamo sequence (Cameron et al, 1994). The 
gene could not be expressed as a soluble fusion protein to p-gal even in the presence 
of urea and acetonitrile. However it was possible to generate a partial N-terminal 
fusion that was subsequently used to raise monoclonal antibodies in mice. The gene 
was eventually expressed as free protein by translational coupling in a pUC18 vector 
(Cameron, 1996). However, although detection by western immunoblotting was 
possible, insufficient quantities of the recombinant protein were present for 
purification by anion exchange chromatography or isoelectric focusing (Cameron,
1996). A second approach utilised a T7 promoter based translational coupling 
system, which also resulted in an inability to purify the protein from the periplasm of 
E.coli. It was apparent that the expression of the S8 gene was not detrimental to the 
host E.coli as the host cells retained the plasmid encoded resistance to ampicillin and 
the growth curve, as measured by optical density at ODeoo, was normal. The addition 
of protease inhibitor PMSF to the growth media increased the amount of 
recombinant protein that could be detected in the periplasm. This suggested that 
autoproteolysis of the protein may be occurring and that was at least partially 
responsible for the low levels of protein observed. However it may also be the case 
that PMSF is blocking a host protease from degrading the 34kDa putative serine 
protease (Cameron, 1996).
The presence of the N-terminal signal peptide predicted that the 34kDa putative 
serine protease was exported by M.a.paratuberculosis in vivo. The extracellular fate 
of the protein was consistent with the antigenic nature of the mature peptide, where 
the export of the protein in vivo would facilitate the interaction of the protein with the 
machinery of the host immune response. The secretion of the protein in 
M.a.paratuberculosis was confirmed in culture by demonstrating the presence of the 
protein in cell-free supernatants (Cameron et al, 1994; Cameron, 1996). The 
presence of the protein in the extracellular environment of growing cells was not 
associated with the lysis of the bacilli, as antibodies against the Hsp65, almost 
exclusively associated with the cytosol, failed to detect the proteins in the cell-free 
supernatant. Both the 34kDa putative serine protease and Hsp65 proteins were 
detected in mycobacterial cell lysates. Expression of the 34kDa putative serine
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protease including the leader peptide in E.coli resulted in the transportation of the 
protein into the periplasmic space of E.coli. Therefore, the signal peptide is capable 
of directing the export of the protein both in M.a.paratuberculosis grown in culture 
and also into the periplasmic space of E.coli (Cameron, 1996). Further studies were 
required to determine the potential role that the 34kDa putative serine protease 
played in the virulence of M.a.paratuberculosis.
1.11 The HtrA family of Bacterial Serine Proteases
HtrA, also known as DegP and reportedly identical to the Do protease is a heat 
shock-induced envelope-associated serine protease that was first described in E.coli 
(Fallen and Wren, 1997). The HtrA protein appears to be a highly conserved feature 
of most bacterial species, although not a prerequisite for life as no homologues were 
found in the genomes of Mycoplasma genitalium and Methanococcus janaschii 
(Fallen and Wren, 1997). While it is an interesting protein in terms of its regulation 
and its physiological role what is of particular interest is the finding that several htrA 
mutants in Gram-negative bacteria are attenuated in animal models suggesting a 
possible role for the protein in the pathogenesis of several diverse bacterial species 
(Baumler et al, 1994; Roop et al, 1994; Wren et al, 1995; Anderson et al, 1996; 
Williams et al, 2000).
1.11.1 HtrA structural features
The main structural features of the protein include a central core domain containing 
the catalytic triad of Histidine, Serine and Aspartate residues (Fallen and Wren,
1997). The consensus sequence for the trypsin-like serine proteases catalytic domain 
is GDSGGFK, with a central serine residue required for proteolytic activity of the 
protein at elevated temperatures in E.coli. The N-terminal end of the protein 
determines its sub-cellular localisation by encoding for a signal peptide that is 
cleaved during export into the periplasmic space of E.coli. HtrA is a peripheral 
membrane protein, lying on the periplasmic side of the inner membrane (Lipinska et 
al, 1990; Skorko-Glonek et al, 1997; Kim et a l, 1999) .
The carboxy terminus of the protein is characterised by the presence of one or more 
FDZ domains (Fallen and Wren, 1997), so-called after the three eukaryotic proteins
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(post-synaptic density protein, disc large and zo-1 proteins) in which they were 
initially identified (Ponting, 1997). PDZ domains are thought to mediate protein- 
protein interactions usually by binding to C-terminal tetrapeptides or other PDZ 
domains. Indeed, PDZ domains have been implicated in substrate recognition of 
other bacterial protease, such as the Tsp and ClpX proteases (Levchenko et al,
1997). The E.coli HtrA has been shown to have two PDZ domains in the C-terminus, 
one of which is postulated to be involved in substrate recognition while the second is 
though to be involved in determining the oligomeric structure of the protein (Sassoon 
et al, 1999). Similarly, the PDZ domains of E.coli have been implicated in the in the 
temperature dependant shift from chaperone to protease activity of the native protein, 
with proteolytic activity almost exclusively present at elevated temperatures (Spiess 
et a l, 1999). Consistent with this observation, autodegradation of the protein has 
been observed at 42°C but not at 35°C. However, other bacterial HtrA like proteins 
appear to posses a single PDZ domain at the carboxy terminus, the implications of 
which for protein function and hexameric formation remain to be determined (Pallen 
and Wren, 1997).
1.11.2 HtrA function
The well-characterised E.coli HtrA protein shows an ATP-independent proteolytic 
activity and preferentially cleaves peptide bonds of Val-X or Ile-X, where X can be 
any amino acid (Pallen and Wren, 1997). The proteolytic activity increases with 
rising temperature, with peak activity observed at 55°C. A E.coli HtrA null mutant 
was initially characterised as having two possibly related phenotypes, 
thermosensitivity and decreased degradation of abnormal periplasmic proteins 
(Lipinska et a l, 1988; Lipinska et al, 1989; Lipinska et al, 1990). Indeed the protein 
is essential for E.coli survival above 42°C. The protein is capable of stabilising 
unstable envelope associated proteins but not cytosolic proteins. An E.coli HtrA 
mutant was also shown to have decreased ability to withstand ferrous ion mediated 
oxidative damage compared to wild-type strains but was not more sensitive to the 
oxidative damage mediated by hydrogen peroxide (Skorko-Glonek et a l, 1999). 
There are two paralogues of HtrA in the E.coli genome, HhoA (DegQ) and HhoB 
(DegS). HhoA has been shown to have protease activity and also contains a signal 
peptide that is removed in the mature form of the protein (Bass et a l, 1996).
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Recently, DegS has been implicated in the degradation of the anti-sigma factor 
regulating the cellular concentration of the alternative sigma factor, in E.coli 
(Alba et a l, 2001).
Several bacterial HtrA null mutants, including pathogenic speices, have all been 
shown to be more sensitive to oxidative damage mediated by hydrogen peroxide than 
wild-type bacteria (Johnson et a l, 1991; Yamamoto et a l, 1996; Skorko-Glonek et 
al, 1999; Lowe et a l, 1999; Williams et al, 2000; Jones et a l, 2001). Therefore it has 
been postulated that HtrA participates in the degradation of oxidatively or thermally 
damaged proteins localised in the cellular envelope, especially those connected with 
the membrane. Interestingly it has been shown that a Bacillis subtillus HtrA 
homologue, ykdA, null mutant demonstrated increase resistance to heat and hydrogen 
peroxide compared to wild type cells (Noone et al, 2000; Noone et a l, 2001). This 
suggests that the mutation stimulated an increase in the expression of a gene or genes 
that protect cells against both heat and oxidative stress.
1.11.3 HtrA and pathogenesis
However of particular interest to these studies is that several htrA homologues 
mutants in pathogenic bacterial species show attenuation in animal models and also 
in vitro macrophage models. In Salmonella typhimurium, a HtrA homologue was 
identified in two independent screens of a transposon mutant library, deficient in 
their ability to survive in mice or macrophages (Johnson et al, 1991). Subsequent 
work using a mutant with a defined mutation in the S.typhimurium gene 
demonstrated that the mutant was highly attenuated in mice (Chatfield et a l, 1992). 
However unlike in E.coli the S.typhimurium mutant is not temperature sensitive, but 
does show increased sensitivity to hydrogen peroxide. Mutation of the htrA gene in a 
S.typhi strain already harbouring defined mutations in the aroA and aroC genes 
resulted in a decreased ability to invade epithelial cells in comparison to the mutant 
parent strain but had no affect on the ability of the strain to survive within a human 
monocyte cell line or a murine macrophage cell line (Tacket et a l, 1997). This 
suggests that the native protein may be involved in the colonisation of the epithelium 
and not in the subsequent recruited macrophages. The HtrA mutant strain also 
showed increased susceptibility to oxidative stress. Furthermore, the htrA mutant
35
strain showed decreased survival after intralumenal infection of SCID mice 
implanted with non-transformed human intestinal epithelium. This affect was not 
seen when the animals were infected interperitonealy, again suggesting the mutant 
strain was defective in invading human epithelial cells.
Brucella abortus HtrA mutants were initially recovered at lower levels than wild 
type cells from the spleens of infected mice post infection. By Day 60 however the 
affect was reversed with greater numbers of mutant bacteria recovered from the 
spleens of infected animals (Elzer et ah, 1996a). The Brucella abortus HtrA null 
mutant was also reported to demonstrate decreased resistance to killing by cultured 
macrophages, and the mutant appeared to be attenuated in pregnant goats (Elzer et 
al, 1996b). A Brucella melitensis HtrA mutant was shown to demonstrate reduced 
ability to withstand oxidative stress compared to wild-type and transient attenuation 
in an murine model of infection (Phillips et a l, 1995). The same authors also 
demonstrated that the B.melitensis HtrA mutant also exhibited attenuation in 
pregnant goats (Phillips et a l, 1997). However, more recent work by the same group 
demonstrated that the mutant used in their earlier studies was a double mutant, HtrA 
and cylA. The authors generated a bona fide HtrA B.melitensis that did not show 
attenuation in pregnant goats negating their earlier findings.
A strain of Y.pestis with a defined mutation in a htrA gene was tested for virulence in 
mice. Mice orally inoculated with the mutant strain were capable of clearing the 
bacterial infection whereas mice infected with the wild type strain died within 5 days 
of administration (Williams et al, 2000). A HtrA homologue was also identified 
independently in Y.enterocolitica although it was initially designated gsrA 
(Yamamoto et al, 1996; Yamamoto et a l, 1997). Yamamoto et al reported that 
inactivation of the gene resulted in an inability of the bacterium to grow at elevated 
temperatures and to survive within macrophages following phagocytosis (Yamamoto 
et al, 1997). Loosmore et al report the cloning and sequence analysis of a HtrA 
homologue from two strains of non-encapsulated or non-typeable Haemophilus 
influenzae (NTHI) which are a major cause of otitis media, middle ear infection, in 
young children and respiratory infections in adults (Loosmore et a l, 1998). 
Immunisation with recombinant HtrA or a mutant analogue (with mutations in either
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the conserved Histidine or Serine of the active site) resulted in partial protection 
against live Haemophilus influenzae challenge in both a passive infant rat model of 
bacteremia and also the chinchilla model of otitis. However, a mutation in the 
conserved Serine residue failed to demonstrate protection in the chinchilla model of 
Otitis but was partially protective in the rat model (Cates et a l, 2000).
The exact role of HtrA in the virulence of a number of different bacterial species 
remains unclear. Most researchers have argued that the attenuation of virulence in 
strains harbouring defined mutants in HtrA is due to impaired resistance to oxidative 
damage in the intracellular environment of the host cell. Phagocytic cells, including 
neutrophils, eosinophils and macrophages, are a fundamental part of the host’s 
immune response. One bactericidal mechanism that is activated in these cells in the 
presence of target organisms is the release of superoxide radicals produced by a 
plasma membrane-bound enzyme, NADPH oxidase (Miller and Britigan, 1997). 
Superoxide can undergo spontaneous or catalysed dismutation to form hydrogen 
peroxide or it can be converted to highly reactive oxidants such as OK or HOCl by a 
series of secondary reactions. HtrA may act in vivo to degrade proteins that have 
been damaged by anti-bacterial oxygen radicals preventing their accumulation to 
toxic levels (Pallen and Wren, 1997). Interestingly, a human HtrA homologue has 
been implicated in the degradation of denatured proteins in patients suffering firom 
rheumatoid arthritis, which has been associated with oxygen radical mediated 
damage (Hu et a l, 1998).
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1.12 Proposal
The 34kDa putative serine protease demonstrates homology to the HtrA family of 
serine proteases, implicated in the virulence of several important bacterial 
intracellular pathogens and demonstrates antigenic properties in infected animals. 
The work presented in the this thesis had as its central aim the further 
characterisation of the 34kDa putative serine protease of M.a.paratuberculosis, with 
particular attention to the role that the protein plays in pathogenesis. The subsequent 
chapters describe the development and application of techniques to elucidate further 
the biological function of the 34kDa putative serine protease, specifically in terms of 
its ability to influence the intracellular survival of the saprophytic M.smegmatis 
mc^l55 strain and also the elucidation of the transcriptional activity and regulation of 
the gene.
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CHAPTER 2 
GENERAL MATERIALS AND METHODS 
2.1 Culture of Bacterial Strains
2.1.1 E.coli
E.coli strains (Appendix 2.were maintained in Luria-Bertani (L-B) broth or L-B agar 
(Sambrook et al 1989) (Appendix 3). L-B broth and L-B agar supplemented with the 
appropriate antibiotic was used to select E.coli transformed with plasmid DNA.
2.1.2 Mycobacteria
a) M,a.paratuberculosis
M.a.paratuberculosis strains (Appendix 2.) were routinely propagated in 7H9^ broth 
and on 7H11+ medium (Appendix 3). 7H11-E media supplemented with the 
appropriate antibiotic was used to select M.a.paratuberculosis transformed with 
vector DNA. Cultures were incubated at 37°C for 8-10 weeks.
b) M.smegmatis
M.smegmatis strains (Appendix 2) were propagated in L-B broth, L-B agar, 7H11-S 
medium or 7H9^ broth (Appendix 3). Transformed M.smegmatis strains were 
selected and grown on media supplemented with the appropriate antibiotic. Cultures 
were incubated at 37°C for 2-3 days, liquid cultures were grown with shaking at 200 
rpm at 37°C for 2-3 days.
2.2 Nucleic Acid Preparation and Manipulation
2.2.1 Preparation of plasmid DNA from E.coli host strains
Plasmid DNA was extracted from E.coli host cells using the QIAprep^^ Spin 
Plasmid Kit (Qiagen), in accordance with the manufacturer’s instructions.
39
2.2.2 Restriction enzyme digestion of plasmid DNA
All restriction enzymes were obtained from Promega UK, and used with the supplied 
incubation buffers according to the manufacturer's specifications, unless otherwise 
stated. Where two restriction enzymes were required in concert to digest target DNA, 
an appropriate buffer compatible with the optimal efficiency of both enzymes was 
used.
2.2.3 Agarose Gel Electrophoresis
DNA fragments were resolved in horizontal agarose gels as described by Sambrook 
et al (1989). Gels of 85 x 60 x 6.5mm (mini-gels) and 150 x 125 x 8.0mm (midi-gels) 
were prepared in “Agarose Gel Electrophoresis Apparatus”, Models H2 and H3 
(Amersham Biosciences), respectively. Gels of 0.6%-2.0% (^/y) nucleic acid grade 
“Ultrapure” agarose (Invitrogen life sciences) supplemented with 0.5 p-g/ml 
eithidium bromide were prepared and run in 1 x TBE buffer (0.89 M Tris, 0.89 M 
Boric acid, 0.025 M Na2 EDTA, pH correct at 8.3). Gels from which DNA fragments 
were later recovered, were prepared from nucleic acid grade “Low Melting Point” 
(LMP) agarose (Invitrogen life sciences) (Section 2.3.4). DNA samples were mixed 
with 0.1 volume of gel loading buffer (GLB; 50 mM Na2 EDTA, 0.1% (^/y) 
bromophenol blue, 25% (^/y) Sucrose or Ficoll 400 prior to electrophoresis. The 
duration of electrophoretic separation and the precise current densities were adjusted 
to allow for gel format, agarose concentration and the size of the DNA fragments 
under analysis. Molecular weight markers used were DNA HyperLadder I or DNA 
HyperLadder IV (Bioline UK Ltd.) as per the manufacturer’s instructions. Resolved 
DNA fragments were visualised and photographed using the ImageMaster® YDS 
(Amersham Biosciences) system incorporating the Fuji film Thermal Imaging 
System (FTI-500) or visualised using a short wave ultraviolet transilluminator 
(UVItec Ltd.).
2.2.4 Recovery of DNA fragments from agarose gels
Fragments of interest were excised from 0.6-1.0% LMP-agarose under ultraviolet 
illumination using a clean disposable scalpel. Excess agarose was trimmed away and 
the block was transferred to a pre-weighed 1.5 ml eppendorf tube. The weight of the
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block was determined and the DNA recovered using the Qiagen QIAquick® Gel 
Extraction Kit, as per the manufacturer’s instructions.
2.2.5 Dephosphorylation of plasmid DNA
The dephosphorylation of 5’ phosphates from linear plasmid DNA prior to ligation 
was achieved using Shrimp Alkaline Phosphatase (SAP) (Roche Diagnostics Ltd.) as 
per the manufacturer’s instructions. Briefly, linear plasmid DNA (50-150 ng) was 
added to pre-prepared reaction mixtures ( 1 0  pi final volume) comprising (xl) 
reaction buffer at 0.5 M Tris-HCl, 50 mM MgCb, pH 8.5 (Roche Diagnostics Ltd.) 
and 1 U SAP. The reaction was incubated at 37°C for 10 min (5’ protruding DNA 
ends) or 60 min (blunt DNA ends). The reaction was terminated by the inactivation 
of the SAP by heating for 15 min at 65°C.
2.2.6 Generating “blunt ended” DNA fragments
The filling in of 5’-protruding ends with unlabelled dNTP, generating blunt ends 
suitable for ligation was achieved using DNA polymerase I large (Klenow) fragment 
(Promega UK) as per the manufacturer’s instructions. Briefly, 50-100 ng of digested 
DNA containing 5’-overhangs was added to pre-prepared reaction mixtures 
comprising (x 1) reaction buffer at 50 mM Tris-HCl, pH 7.2, 10 mM MgS0 4 , 0.1 
mM DTT, 40 pM each of dATP, dCTP, dGTP and dTTP, 20 pg/ml acetylated BSA 
and 1 U of Klenow fragment. The reaction was incubated at room temperature for 10 
min. The reaction was terminated by the inactivation of the Klenow fragment by 
heating for 10 min at 75°C.
2.2.7 Ligation of DNA fragments into vector DNA
The insertion of DNA fragments into the desired vectors was achieved using T4 
DNA ligase (Roche Diagnostics Ltd.) as per the manufacturer’s instructions. Briefly, 
insert DNA was added to pre-prepared reaction mixtures (10 pi final volume) 
comprising (x 1) reaction buffer at 660 mM Tris-HCL, 50 mM MgCb, lOmM 
dithioerythriol, 10 mM ATP, pH 7.5 (Roche Diagnostics Ltd.), linear pre-digested 
Vector DNA (50-100 ng) and 3 U T4 DNA ligase (Roche Diagnostics Ltd.). The 
reaction was incubated at either 4°C (sticky end cloning) or at 16°C (blunt end 
cloning) overnight. The reaction was terminated by inactivation of the T4 DNA
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ligase by heating at 65°C for 10 min. The molar ratio (MR) of insert DNA to vector 
DNA was 3:1, unless otherwise stated. The amount of insert DNA used in each 
reaction was determined using the formula:
(Amount of Vector DNA in ng) X (Size of Insert DNA in bp) X 3 (MR)
(Size of Vector DNA in bp) 1
2.2.8 Preparation of vector DNA for electroporation
Plasmid DNA used in electroporation of E.coli and mycobacteria was desalted and 
concentrated using the Microcon Microconcentrator (Amicon-Millipore) system as 
per the manufacturer’s recommendations. The concentration of DNA present in each 
sample was determined using a spectrophotometer at 260nm. The concentration of 
DNA in each sample was determined using the formula;
Concentration of DNA= OD2 6 0  x Dilution factor x 50 mg/ml.
In some cases DNA concentration was ascertained by comparison to the known 
concentration standards of the Hyperladder I or Hyperladder IV (Bioline UK Ltd.), 
molecular weight standards.
2.3 Introduction of Vector DNA into Bacterial Strains
2.3.1 Preparation of electrocompetent cells
a) M.a.paratuberculosis
All M.a.paratuberculosis strains (Appendix 2) were grown to a McFarland 6 in 7H9^ 
broth (Appendix 3), diluted V2 0  in fresh pre-warmed (37°C) 7H9^ broth and 
incubated at 37°C until a McFarland of 4.0-4.5 (4-6 weeks). M.a.paratuberculosis 
cells were harvested by centrifugation at 4,147 x g  for 30 min at 4°C, the supernatant 
discarded and the bacterial pellet washed three times in decreasing volumes of 1 0 % 
(^/y) glycerol, (15, 10 and 5 ml). Mycobacterial cells were re-suspended in 1 ml 10% 
(^/y) sterile glycerol, snap frozen in liquid N2  and stored at -70°C until required.
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b) M.smegmatis
M.smegmatis strains (Appendix 2 ) were grown to an ODeoo 0.5-0.6 in 7H9^ 
(Appendix 3) broth at 37°C with shaking (200 rpm), diluted Vio in fresh pre-warmed 
(37°C) 7H9^ broth and incubated at 37°C with shaking at (200 rpm) until reaching an 
ODôoo 0.5-0.6. M.smegmatis cells were harvested by centrifugation at 4,147 x g  for 
30 min at 4°C, the supernatant discarded and the bacterial pellet washed three times 
in decreasing volumes of 10% (' /^y) glycerol, (15, 10 and 5 ml). Mycobacterial cells 
were re-suspended in 1  ml 1 0 % (^/y) sterile glycerol, snap frozen in liquid N2  and 
stored at -70°C until required.
c) E.coli
A fresh overnight culture of E.coli JM109 cells was diluted Vio in fresh pre-warmed 
(37°C) L-B broth (Appendix 3) and incubated at 37 °C with shaking (200 rpm) until 
an ODeoo of 0 .8 - 1 .0 . The cells were harvested by centrifugation at 4,147 x g at 4°C, 
washed twice in 15% glycerol/272 mM Sucrose (2 x 15 ml washes) and re-suspended 
in 5 ml of 15% glycerol/272 mM Sucrose, dispensed into 500pl aliquots, snap frozen 
in liquid N2  and stored at -70°C. DH5a cells were purchased as high efficiency 
electrocompetent cells from BD Biosciences Clontech UK.
2.3.2 Introduction of vector DNA by electroporation
a) M.a.paratuberculosis 
Method 1
Electroporation of vector DNA into M.a.paratuberculosis strains was carried out in 
accordance with the protocol of Wards et al 1996. Briefly, 200pl of electrocompetent 
M.a.paratuberculosis cells (section 2.2.1a) were mixed with 1 pg of desalted vector 
DNA (section 2.2.8) and equilibrated to 37°C for 10 min, followed by transfer to a 
0.2cm cuvette and electroporated at 2.5 kV, 25pF, 1,000Q in a Gene Puiser® 
apparatus (Bio-Rad Laboratories Ltd.). M.a.paratuberculosis cells were diluted to a 
final volume of 1 ml in 7H9^ broth (Appendix 3), and incubated without selection at 
37°C for 4 hr, followed by selection for positive transformants on 7H1 IE medium 
(Appendix 3) supplemented with the appropriate antibiotic at 37°C for 12 weeks.
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Method 2
A second method of electroporation of vector DNA into M.a.paratuberculosis strains 
was carried out in accordance with the protocol of Dr. Steve Thome, University of 
Surrey (personal communication). Briefly, 200pl of electrocompetent 
M.a.paratuberculosis cells (section 2.3.1a) were mixed with 500 ng of desalted 
Vector DNA (section 2.2.8) and equilibrated to 37°C for 5 min, transferred to a 
0.2cm cuvette (Bio-Rad Laboratories Ltd.) and electroporated at 2.5 kV, 25pF, 
1,000Q in a Gene Puiser® apparatus (Bio-Rad Laboratories Ltd.). 
M.a.paratuberculosis cells were diluted to a final volume of 1 ml in 7H9^^ broth 
(Appendix 3), and incubated without selection at 37°C overnight in a round bottom 
Cryostat tube, followed by selection for positive transformants on 7H10Su medium 
(Appendix 3) supplemented with the appropriate antibiotic at 37°C for 12 weeks.
b) M.smegmatis
Electroporation of vector DNA into M.smegmatis strains was carried out in 
accordance with the protocol of Parish et al 1998. Briefly, 200pl of electrocompetent 
M.smegmatis cells (see section 2.3.1b) were mixed with 1 pg of de-salted vector 
DNA (Section 2.2.8), and incubated on ice for 30 min, transferred to a 0.2cm cuvette 
(Bio-Rad Laboratories Ltd.) and electroporated at 2.5 kV, 25pF, 1,000Q in a Gene 
Puiser® apparatus (Bio-Rad Laboratories Ltd.). Mycobacterial cells were diluted to a 
final volume of 1 ml in 7H9^ broth (Appendix 3) and incubated without antibiotic 
selection for 2 hr at 37°C, followed by selection for positive transformants on 7H11- 
S (Appendix 3) medium supplemented with the appropriate antibiotic at 37°C for 4-5 
days.
c) E.coli
Electroporation of vector DNA into E.coli strains was carried out in accordance with 
the protocol of Parish et al. Briefly, 20 pi of commercial electrocompetent DH5a 
cells (BD Biosciences Clontech UK) or 200pl of electrocompetent E.coli JM109 
(section 2.3.1c) cells were mixed with 1 pg of de-salted plasmid DNA (section 
2.2.8), incubated on ice for 1 hr, and transferred to a chilled 0.2cm gap cuvette (Bio- 
Rad Laboratories Ltd.) and electroporated (2.5 kV, 25pF, 200 Q) in a Gene Puiser®
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apparatus (Bio-Rad Laboratories Ltd.). E.coli cells then were immediately diluted 
with chilled SOC (Appendix 3) broth to a final volume of 1 ml, incubated without 
selection at 37 °C for 1 hr and then plated onto L-B-agar medium (Appendix 3) 
supplemented with the appropriate antibiotic, and incubated overnight at 37°C.
2.3.3 Transformation of high efficiency E.coli JM109 competent cells by heat 
shock
High efficiency competent E.coli JM109 cells were purchased from Promega UK, 
and transformed with vector DNA as per the manufacturer’s instructions. Briefly, 
100 pi of chemically competent E.coli JM109 were mixed with 50 ng of vector DNA 
and incubated on ice for 10 min. The cells were heat shocked for 45-50 sec in a water 
bath at exactly 42°C, the tubes returned to ice for 2 min and 900 pi of ice-cold SOC 
medium (Appendix 3) added to each transformation reaction and incubated at 37°C 
for 1 hr. Positive transformants were selected for on L-B agar medium (Appendix 3) 
supplemented with the appropriate antibiotic at 37°C and grown overnight.
2.4 Sequencing of Plasmid DNA
Cloned DNA fragments were sequenced bi-directionally by the dideoxy chain- 
termination method (Sanger et al 1977). Sequencing of plasmid DNA was preformed 
by Oswell DNA Service, MWG-BIOTECH AG sequencing or at the Functional 
Genomics Unit, MRI, Edinburgh, UK.
2.5 DNA and Protein Database Searching
Database searches were performed using the BLAST (version 2.0) program fi*om the 
National Centre for Biotechnology Information internet site covering the GenBank, 
EMBL, DDBJ and PDB databases, the WU-BLAST (version 2) program from The 
Institute for Genomic Research (TIGR) BLAST search engine for unfinished microbial 
genomes (http://tigrblast.tigr.org/ufing/), the Sanger Centre M. bovis BLAST server 
(http://www.sanger.ac.uk), the tu ber c u list  search engine at the Institute Pasteur 
(http://genolist.pasteur.fi-/TubercuList), Paris, the leprom a  search engine at the 
Institute Pasteur, Paris (http://genolist.pasteur.fr/Leproma/index.htmD and the 
University of Minnesota M.a.paratuberculosis unfinished genome project BLAST 
server http://www.cbc.umn.edU/ResearchProjects/Ptb/#.
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2.6 Preparation of Mycobacterial Cell Lysates
Mycobacterial cells were harvested from culture by centriftigation at 4,147 x g at 4°C 
for 15 min and re-suspended in approximately 400 pi of PBS containing PMSF at 1 
mM final concentration. The cells were transferred to a screw cap eppendorf 
containing 1 ml of washed zirconium silica beads (0.1 mm diameter). Cells were 
disrupted by bead-beating in a RiboLyser (Thermo Hybaid Ltd.). Five bead-beating 
cycles at speed setting 5 of 45 sec were carried out, cooling on ice after each cycle to 
avoid overheating and potential dénaturation of the sample. The lysate was recovered 
from each tube, transferred to a 1.5 ml eppendorf tube and centrifuged at 11,000 x g 
for 1 min. Finally the lysate was transferred to a sterile 1.5 ml eppendorf and stored 
at-20°C.
2.7 DNA Extraction from Mycobacterial Cells
Mycobacterial cells were resuspended in 200 pi of sterile distilled water and added to 
a screw capped microfuge tube containing 1  ml of washed zirconium silica beads 
(0.1 mm). The cells were then beaten on a RiboLyser (Thermo Hybaid Ltd.) at speed 
setting 5 for 3 cycles of 40 sec, cooling on ice between cycles. The supernatant was 
carefully removed. 450 pi of GE (5 M guanidine isothyiocyante, 0.1 M EDTA, pH 
7.0) and 250 pi of ice-cold 7.5 M ammonium acetate (pH 6.3, unadjusted) were 
added to the supernatant and the sample was mixed by inversion and then incubated 
on ice for 20 min. 500 pi of chloroform:octanol (24:1 (%)) was added, mixed by 
inversion and centrifuged at 11,600 x g  for 5 min. The top aqueous layer was 
retained, a further 0.5ml of chloroform:octanol (24:1 (%)) added, mixed and 
centrifuged at 11,600 x g for 10 min. An equal volume of ice-cold isopropanol was 
added to the final aqueous layer, mixed by inversion and centrifuged at 11,600 x g 
for 10 min. The isopropanol was removed, the pellet washed twice in 70% ethanol 
and air-dried. Finally the DNA pellet was re-suspended in 150 pi of sterile distilled 
water and stored at -20°C.
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2.8 Protein concentration and SDS-PAGE
2.8.1 Determination of Protein Concentrations
Soluble protein concentrations were determined using the Bradford Reagent Protein 
Assay (Sigma-Aldrich) as per the manufacturer’s recommendations. Briefly, 
standard protein solutions ranging from 1 pg/ml to 20pg/ml BSA were prepared in 
the same diluent used for the unknown samples. Equal volumes (1ml) of all protein 
samples, including standard solutions and sample diluent, were added to a 15ml 
Falcon tube. One ml of Bradford Reagent was added to each tube and mixed. The 
spectrophotometer was blanked with distilled water, and the absorbance of all 
samples measured at 565nm. The absorbance of the sample diluent control was 
subtracted from the OD5 6 5  readings of the standard solutions and the unknown 
samples. A standard curve was generated by plotting the OD5 6 5  readings for the 
standard solutions against concentration (pg/ml). The protein concentration of the 
unknown samples was determined by comparison to the standard curve. Samples 
whose values exceeded the standard range were diluted and re-tested.
2.8.2 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Polyacrylamide gel electrophoresis of proteins was carried out using the 
discontinuous buffer system of Laemmli (1970). Briefly, ~15pg of protein samples 
were denatured by heating to 100°C for 90 s in V4  volume 4 x Laemmli denaturing 
buffer (LDB) (0.5 M Tris-HCl pH6 .8 , 4% C^ /y) SDS, 1.2 M 2-P-mercaptoethanol, 
40% (^/y) sucrose, 0.1% (f /^y) bromophenol blue). The samples were loaded into the 
wells of an SDS-PAGE gel and separated as follows. Stacking gels of 3% (^/y) 
acrylamide, 0.08% (^/y) bis-acrylamide in 1 x Laemmli stacking gel buffer (LSGB) 
(0.25 M Tris-HCl pH6 .8 , 0.1% (^/y) SDS) were layered over resolving gels of 10% 
(wt/v) acrylamide, 0.26% bis-acrylamide in 1 x Laemmli resolving gel buffer 
(LGRB) (1.49 M Tris-HCl pH 8 .8 , 0.1% C/y) SDS). Mini gels (80 x 70 x 0.7mm) 
were prepared in a Mini Protean™ II Dual Slab Cell (Bio-Rad laboratories) and run 
at 200 V (constant voltage) for 45-50 min in 1 x Laemmli Electrode buffer (LEB) 
(0.025 M Tris-Hcl, 0.192 M glycine, 0.1% (^/y) SDS, pH correct at 8.3). Pre-stained 
protein molecular weight markers spanning size ranges 7.2 -  212.0 kDa [Aprotinin
7.2 kDa, Lysozyme 20.7 kDa, Soybean trypsin inhibitor 28.4 kDa, Carbonic 
anhydrase, 35.0 kDa, Ovalbumin 51.8 kDa, Bovine serum albumin 83.0 kDa, p-gal
47
122.0 kDa and Myosin 212.0 kDa (Bio-Rad laboratories)] were used, as well as 
unstained SDS-PAGE standards spanning the size range 14.4 -  97.4 kDa [Lysozyme
14.4 kDa, Trypsin inhibitor 21.5 kDa, Carbonic anhydrase 31.0 kDa, Ovalbumin
45.0 kDa, Serum albumin 66.2 kDa, and Phosphorylase 97.4kDa (Bio-Rad 
laboratories)].
2,9 Production of 34kDa putative serine protease Monoclonal 
Antibody
2.9.1 Growth and maintenance of Hybridoma cells lines
Hybridoma cell line Mab5.8 (Cameron et al) was recovered from liquid nitrogen 
storage as follows; 7 ml of RPMI-1640 medium (Invitrogen life sciences) 
supplemented as follows; 20% (%) heat-inactivated foetal calf serum (Invitrogen life 
sciences), 2.5 M HEPES (N-[hydroxyethyl]piperazine-N'-[ethanesulphonic acid]), 2 
mM glutamine, 100 U/ml penicillin (Invitrogen life sciences), 100 pg/ml 
streptomycin (Invitrogen life sciences), 20pg/ml ciprofloxacin and 10% (%) OPI, 
referred to as Hybridoma-RPMI (H-RPMI) was added to approximately 1 ml of 
thawed cells, mixed gently and centrifuged at 800 rpm for 5 min at room 
temperature. The cells were re-suspended in 10 ml of H-RPMI and the viability 
tested by 1% Nigrosine staining followed by viability cell counting in a 
Hemocytometer. The cells were diluted (V2 ) and seeded in 24 well plates, and grown 
at 37°C with 5% CO2 . Cells were removed from the bottom of the each well by 
agitation, combined and diluted ( V 2)  in fresh pre-warmed (37°C) H-RPMI medium, 
and seeded into a 25 ml tissue culture flask and grown to confluency at 37°C with 5 
% CO2 . 95% of the supernatant was carefully removed by pipetting and stored, 30 ml 
of fresh pre-warmed (37°C) RPMI-1640 medium (Invitrogen life sciences) 
supplemented as follows; 10% heat-inactivated foetal calf serum (Invitrogen life 
sciences), 2.5 M HEPES, 2 mM glutamine, 100 U/ml penicillin (Invitrogen life 
sciences), 100 pg/ml streptomycin (Invitrogen life sciences) and lOpg/ml 
ciprofloxacin (Invitrogen life sciences) was added to each flask and adherent cells 
removed by agitation. The culture was split into two fresh 25 ml tissue culture flasks, 
and the cells grown to confluency at 37°C with CO2 . This process was repeated until 
sufficient supernatant had been generated. The recovered supernatant was
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centrifuged at 800 rpm for 5 min at room temperature to remove cells and cellular 
debris. Cell free supernatants were stored at -20°C with the addition of 0.05% 
Sodium Azide to prevent growth of contaminates.
2.9.2 Purification of IgG fraction from Hybridoma supernatant
34kDa putative serine protease specific monoclonal antibody was purified from 
hybridoma culture supernatants using a HiTrap Protein A 1 ml affinity column 
(Amersham Biosciences) as per the manufacturer’s instructions. Briefly, the column 
was washed with 10 column volumes of binding buffer (20 mM sodium phosphate, 
pH 7.0) at a flow rate of 1 ml/min using a System Gold HPLC Apparatus (Beckman- 
Coulter). Filter sterilised Hybridoma cell-free culture supernatant (section 2.9.1) was 
added to the column using a syringe fitted to a “luer” adapter at a flow rate of 1  
ml/min. The column was then washed with 5-10 volumes of binding buffer or until 
no material appeared in the effluent. The bound IgG fraction was finally eluted with 
2-5 column volumes of Elution buffer (0.1 M citric acid, pH3-6). The sample was 
eluted into 200 pi of 1 M Tris-HCl pH 9.0 per ml of elutant to neutralise the citric 
acid, preventing degradation of antibody.
2.10 Western Transfer and Immunoblotting
2.10.1 Western Blotting
Proteins resolved in mini gels were transferred onto nitrocellulose membranes by 
electroblotting in Tris/Glycine plot buffer (20 mM Tris, 153 mM glycine, 20% (%) 
methanol, pH 8.0) in a Mini Trans-Blot® Electrophoretic Transfer Cell (Bio-Rad 
laboratories) at 100V/250mA (constant voltage) for 1 hr.
2.10.2 Ponceau S staining of nitrocellulose-bound proteins
Freshly transferred proteins were stained reversibly by incubating the membrane in 
Ponceau-S solution (Sigma-Aldrich) for 5 min. Excess stain was removed by rinsing 
the membrane in distilled water. The positions of the molecular weight markers were 
noted on each membrane and the membrane processed as described in section 2.10.3.
49
2.10.3 Immunoblotting
Membranes were blocked in PBS-Tween solution (1 x PBS, 0.5% (%) Tween 20, 1 
mM EDTA, 0.35 M NaCl, pH 7.2) in the absence of extraneous proteins. The blotted 
proteins were probed by incubation with primary monoclonal antibody for 1  hr at 
room temperature, followed by three 5 min washes in PBS-Tween. Membranes were 
then incubated in secondary antibody (HRP-conjugated anti mouse IgG) (Dako Ltd.) 
diluted V iooo  in PBS-Tween for 1 hr at room temperature. After removing excess 
secondary antibody three 5min washes in PBS-Tween, protein-antibody binding was 
visualised with the addition of a substrate solution [lOOmM Tris pH7.5, 1 mM 
diaminobenzidine (DAB) and 60mM H2 O2 ]. The reaction was stopped by washing 
the membranes thoroughly in running tap water.
2.11 PCR Protocols
2.11.1 Detection oilS900 in M.a.paratuberculosis
Cultured mycobacterial cells were mechanically disrupted by bead beating, as 
described in section 2.6. Lysates were centrifuged at 13,000 x g, for 5 min and the 
supernatants transferred to a fresh tube. 5pi of lysate was added to pre-prepared 
reaction mixtures (50pl final volume) comprising (xl) reaction buffer at 2.5 mM 
MgCl2  (Promega UK), 2.5 mM each of dATP, dCTP, dGTP and dTTP, 10 pMol each 
of the forward (5’-GTT CGG GGC CGT CGC TTA GG-3’ 1S900 positions 22-41) 
and reverse (5’-CCC ACG TGA CCT CGC CTC CA-3’ ISPOO positions 410-391) 
primers and 1 U Taq polymerase (Promega UK). PCR conditions consisted of an 
initial dénaturation of 5 min at 95°C, followed by 40 cycles of 1 min dénaturation at 
96°C, 1 min annealing at 55°C and 1 min extension at 72°C. The final cycle included 
an extension at 72°C for 3 min. Amplification products were analysed by agarose gel 
electrophoresis, and a single band of 389bp confirmed species identity as 
M. a.pamtuberculosis.
2.11.2 Presence of plasmid DNA; aph (kanamycin) PCR
The presence of plasmid DNA in transformed mycobacterial strains was confirmed 
by the amplification of the kanamycin resistance gene located on the plasmid. 
Cultured mycobacterial cells were mechanically disrupted by bead beating, as 
described in section 2.6. Lysates were centrifuged at 13,000 x g, for 5 min and the
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supernatants transferred to a fresh tube. 5 pi of lysate was added to pre-prepared 
reactions mixtures of 50pl (final volume) comprising (xl) reaction buffer at 1.5 mM 
MgClz (Qiagen), 0.2 mM each of dATP, dCTP, dGTP and dTTP, 2% (% ) Glycerol, 
100 pMol Forward (5’-TAT GGA TCC ACT AGT ACT AAA GCC ACG TTG TGT 
CTC-3’) and Reverse (5’-TGA CTG CAG TGA TCA CGT GCG CTG AGG TCT 
GCC TCG TGA A-3’) primers, 2.5 U HotStar Taq (Qiagen). HotStar PCR conditions 
consisted of an initial dénaturation of 15 min at 95°C, followed by 40 cycles of 60 
sec dénaturation at 94°C, 60 sec annealing at 55°C and 60 sec extension at 72°C. The 
final cycle included an extension at 72°C for 3 min. Amplification products were 
analysed by agarose gel electrophoresis, and a single band of approximately 1 . 1  kb 
confirmed the presence of plasmid DNA.
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CHAPTER 3
GENETIC MANIPULATION OF M.smegmatis mc^l55 
AND M.a.paratuberculosis
3.1 Introduction
The development of transformation techniques, permitting the introduction and 
expression of genes in pathogenic and non-pathogenic mycobacteria has proved 
crucial in our growing understanding of this diverse group of important pathogens 
(Hatfull, 1993). Recombinant DNA was first expressed in mycobacteria using shuttle 
phasmid vectors (Snapper et a l, 1988). Since then, shuttle plasmids have been 
constructed, capable of replicating in both E.coli and mycobacteria. Several different 
origins of replication {ori), derived from naturally occurring mycobacterial plasmids, 
have formed the basis of such vectors. The most extensively used mycobacterial 
shuttle plasmids utilise an ori derived from the well-characterised M.fortuitum 
plasmid pALSOOO (Rauzier et a l, 1988; Ranes et a l, 1990; Labidi et a l, 1992; Stolt 
and Stoker, 1996; Stolt and Stoker, 1997; Stolt et a l, 1999). Other mycobacterial 
plasmids, such as the Mycobacterium scrofulaceum pMSC262 (Qin et a l, 1994) 
plasmid, the M.avium plasmid pLR7 (Crawford and Bates, 1984; Beggs et a l, 1995) 
and the M.fortuitum plasmids pJAZ38 (Gavigan et a l, 1997) and pMFl (Bachrach et 
al, 2 0 0 0 ) have been isolated and used to develop additional mycobacterial-E'.co// 
shuttle vectors. Other approaches have centred on utilising mycobacteriophages, such 
as L5, D29 and MS6  as well as the phage derived Streptomyces plasmid pSAM2 as 
the basis of integrative vectors, allowing the stable integration of DNA into 
mycobacterial genomes (Lee et al, 1991; Anes et a l, 1992; Pearson et a l, 1996; 
Hatfull, 1996). The isolation of a high transformation efficient mutant of the fast 
growing saprophytic M.smegmatis strain ATCC607, M.smegmatis mc^l55, has been 
pivotal in the cloning and expression of numerous mycobacterial genes from diverse 
pathogenic species (Snapper et al, 1990).
The use of reporter molecules offers great advantages in screening for novel genes 
with phenotypes that are not readily measured using conventional assays. Such
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reporter systems have been used to measure the relative activity of mycobacterial 
promoters controlling the expression of such genes and to elucidate the 
transcriptional machinery used by mycobacteria both in vitro and in vivo. Several 
reporter molecules have been demonstrated to be functional in mycobacteria 
including the firefly luciferase gene (Jacobs, Jr. et a l, 1993; Riska and Jacobs, Jr., 
1998; Gordon et a l, 1998), which has been used to demonstrate the minimum 
inhibitory concentration (MIC) of numerous antibiotics against M.a.paratuberculosis 
(Williams et a l, 1999). Other reporter molecules have been successfully used in 
mycobacterial studies including chloramphenicol acetyl transferase (CAT) (Das 
Gupta et a l, 1993), the Pseudomanas xylE gene (Curcic et a l, 1994), the Aequorea 
victoria green fluorescent protein (GFP) (Kremer et a l, 1995a; Via et al, 1998), the 
E.coli lacZ gene (Timm et a l, 1994a; Timm et al, 1994b)
The ability to selectively replace genes of interest with inactivated copies allows the 
potential role in virulence of the particular gene to be determined. Allelic exchange 
by homologous recombination (HR) has been demonstrated successfully for a 
number of different mycobacterial species including M.smegmatis, M.bovis BCG, 
M.tuberculosis, M.intracellulare and M.phlei (Husson et a l, 1990; Kalpana et al, 
1991; Marklund et a l, 1995; Mustafa, 1995; Balasubramanian et a l, 1996; Baulard 
et a l, 1996; McFadden, 1996). A number of studies have now applied different 
methodologies, including the use of secondary selection, such as the B.subtilis sacB 
gene and the mycobacterial katG and rpsL genes (Sander et a l, 1995; Pelicic et al, 
1996), for allelic replacement in both pathogenic and non-pathogenic mycobacterial 
species. The HR frequency in M.smegmatis, M.intracellulare and M.tuberculosis 
using non-replicating suicide plasmids was reportedly enhanced by the use of single 
stranded (ss) DNA (alkali denatured double stranded (ds) DNA or single stranded 
phagemid DNA) or UV irradiated ds DNA (Hinds et a l, 1999). Transposon 
mutagenesis of M.smegmatis mc^l55, M.bovis BCG, M.tuberculosis, M.phlei, 
M.avium and M.a.paratuberculosis using a variety of mycobacterial transposons 
including Tn611, Tn5367 and the mini-TnlO has generated mutant libraries 
(McAdam et a l, 1995; Bardarov et a l, 1997; Harris et al, 1999; Cavaignac et al, 
2000; Machowski et a l, 2000). Such libraries then can be screened in vitro or in vivo 
for genes involved in the virulence of mycobacteria.
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The majority of molecular genetic work on M.a.paratuberculosis has centred on 
accurately distinguishing M.a.paratuberculosis from other members of the M.avium 
complex (MAC) and from M.a.paratuberculosis isolates from different host species, 
using such techniques as pulse-field gel electrophoresis (PFGE) and restriction 
fragment length polymorphism (RFLP) (see section 1.4.2). M.a.paratuberculosis has 
been shown to be amenable to genetic manipulation with successful transformation 
of the bacillus reported with both shuttle plasmids and phage vectors by 
electroporation (Foley-Thomas et a l, 1995; Williams et al, 1999). Mutant libraries of 
M.a.paratuberculosis have also been created independently by two groups using the 
mycobacterial transposon Tn5367 (Harris et al, 1999; Cavaignac et a l, 2000). To 
date however, there have been no reports of successful allelic replacement in 
M. a.paratuberculosis.
In order to better elucidate the role that the 34kDa putative serine protease plays in 
the virulence o f M.a.paratuberculosis it was intended to clone the gene and express 
the protein in M.smegmatis mc^l55. Ascertaining the role that the presence of the 
34kDa putative serine protease had on the intracellular survival of M.smegmatis 
mc^l55 would ultimately follow this. In addition, as part of a collaborative project at 
the University of Surrey routine methodologies were being developed for disruption 
of M.a.paratuberculosis genes by HR. Initially, four potential virulence genes were 
targeted for gene knockout, the oxyR and katE genes and those encoding the 34kDa 
putative serine protease and the bacterioferritin protein. The mutant strains could 
then be tested in a macrophage survival assay and in animal models to assess the 
affect of the gene knockout on virulence. The complementation of any mutant 
phenotype by plasmid based expression of the corresponding endogenous gene 
would fulfil Koch’s postulates at the molecular level.
An essential prerequisite of the studies presented in this work was the development 
of techniques, protocols and vectors capable of expressing the 34kDa putative serine 
protease or any gene of interest in both M.smegmatis mc^l55 and 
M.a.paratuberculosis. The most commonly used mycobacterial shuttle vectors 
contain an ori derived from the M.fortuitum plasmid, pAL5000 (designated the “long
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o rr  in these studies, pALSOOO positions 4308 to 1366). A transformation feasibility 
study at the University of Surrey on the genetic manipulation of 
M.a.paratuberculosis had suggested that vectors utilising an alternative pALSOOO 
derived ori (designated the “short ori” in these studies, pALSOOO positions 4308 to 
1100) resulted in increased transformation efficiency in M.a.paratuberculosis. The 
short ori differs fi*om the long ori in that the former contains less pAL5000-derived 
sequence than the latter. Therefore, in creating a set of vectors capable of expressing 
genes of interest in mycobacteria, consideration was given to incorporating this short 
ori. Similarly, it was important to develop adequate controls for these studies. The 
reporter molecule GFP was used for two reasons. Firstly, it offered the potential to 
demonstrate expression of recombinant DNA in M.smegmatis mc^l55 and 
M.a.paratuberculosis. Secondly, it also offered the potential to act as a control 
marker during animal experiments and in vitro survival determination assays. The 
work presented in this chapter set out to create the vectors and techniques required to 
clone the 34kDa putative serine protease and the reporter molecule GFP, or a mutant 
derivative, and the associated expression of the protein in M.smegmatis mc^l55 and 
M. a.paratuberculosis.
55
3.2 Materials and Methods
3.2.1 Amplification of the 34kDa putative serine protease ORF from Genomic 
DNA
The entire 34kDa putative serine protease ORF was amplified by PCR from 
M.aparatuberculosis JD88/107 as follows. M.a.paratuberculosis genomic DNA 
(125ng) (Section 2.7) was added to pre-prepared reaction mixtures (50pl final 
volume) comprising (xl) reaction buffer at 1.5mM MgCl: (Qiagen), 0.2mM each of 
dATP, dCTP, dGTP and dTTP (dNTP mix; Roche Ltd.), 2% C/y) Glycerol, 100 
pMol each of the forward and reverse primers (Forward primer: 5’- 
GGGmCCTCCCGCGACGCAGGAGGGT-3’, nucleotides in bold represent 
positions -25 to -7  of the 34kDa putative serine protease ORF with nucleotides in 
italics representing the Bst Eli restriction enzyme recognition sequence; Reverse 
primer: 5’-GCrCZ4G^TCAGGCCGGCGGCCCCTC-3’, nucleotides in bold 
represent positions 1068 to 1086 of the 34kDa putative serine protease ORF with 
nucleotides in italics representing the Xba I restriction enzyme recognition sequence) 
and 2.5 U HotStar Taq polymerase (Qiagen Ltd.). Hotstart PCR conditions consisted 
of an initial dénaturation of 15 min at 95°C, followed by 35 cycles of 60 sec 
dénaturation at 96°C, 60 sec annealing at 65°C and 90 sec extension at 72°C. The 
final cycle included an extension at 72°C for 8  min.
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3.2.2 Plasmid sequencing primers
Sequencing of plasmid DNA was conducted as described in section 2.4 using the 
following primers:
Primer Sequence
Pr(G)
Pr(al)-1 ’^ACACCAGCGACAGCCGAGCA3’
Pr(al)-2 ^'CCGACAATCCACCGCTGTT 3’
Pr(M) ’^GCGGCCGCGGTACCAGA^'
Source
pALSOOO Positions 4504-4487 
(5’ ORF-1) 
pALSOOO Positions 1056-1074 
(3’0RF-2) 
pMV206/pMV261 
Multiple Cloning Site (MCS)
5’AGTTCTTCTCCTTTACTCAf GFP (Accession number: L20345)
coding sequence positions 2 0 -1 .
3.2.3 Visualisation of GFP expression
Visualisation of fluorescent bacteria was achieved by short wave UV irradiation 
(312nm) of bacterial colonies using a TM 20 transilluminator (GRI). For microscopic 
examination of individual fluorescent bacteria, single colonies of the bacterial strain 
were scraped from solid media, transferred to 250pl PBS and homogenised by 
vortexing. Ten pi of bacterial suspension or liquid culture were placed on a sterile 
glass slide and dried by heating gently over a Bunsen flame. Sample slides were 
fixed by submersion in methanol for 10 minutes and analysed using an Olympus 
BX50 microscope with a wt GFP 605 filter cube (Part No. 39568: Olympus) with an 
excitation spectra of 395 nm (minor excitation peak at 470nm) and emission spectra 
of 509nm, or with a E-GFP filter cube with an excitation spectra of 475nm and 
emission spectra of 509nm.
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3.3 Results
3.3.1 Initial characterisation of plasmid DNA
Several mycobacterial shuttle plasmids and the corresponding vector maps were 
received from members of the mycobacterial group at the University of Surrey in 
E.coli host strains, either DH5a or JMllO, as stab cultures (Appendix 2 Plasmid 
Reference Guide, pUS plasmid series). Initially plasmid DNA was recovered from 
the E.coli host strain as described in section 2.2.1. All vectors were digested to 
completion with the restriction enzyme Hind III (see section 2.2.2) and the 
approximate size determined in comparison to the molecular weight standards. The 
estimated size agreed with the expected sizes as quoted in the vector maps.
3.3.2 Generation of vectors to express GFP in mycobacteria
Initially it was hoped to clone the GFP coding sequence and the upstream promoter 
region from plasmids pUS1878 {hsp60 promoter), pUS1803 (ISkDa promoter) and 
p u s  1883 {mpbVO promoter) into a plasmid utilising the short ori, in this case 
pUS972. The three promoters chosen exhibited a broad range of transcriptional 
activity, from high constitutive expression for hsp60, increased intracellular 
expression observed for the ISkDa promoter and low levels of constitutive 
expression for the mpb70 promoter. If successful, this approach would have 
facilitated further cloning by replacing the GFP coding sequence with the 34kDa 
putative serine protease ORF, ultimately leading to expression of the protein in 
M.smegmatis mc^l55 2û[\à M.a.paratuberculosis.
Originally, the promoter sequences located in plasmids pUS1878, pUS1803 and 
pu s 1883, were to be removed as Xba l-Bcl I fragments and cloned into the Aba I and 
Bel I digested pUS972. However, the restriction enzyme Bel I failed to cut pUS1803, 
pUS1878 and pUS1883 as determined by the presence of multiple undigested bands 
on a 0.8% agarose gel (see section 2.2.3). The restriction enzyme was demonstrated 
to be enzymatically active by the digestion of Ipg of A, DNA (Promega UK Ltd.) 
with 5U of Bel I under the appropriate reaction conditions, resulting in the 
appearance of distinct bands on a 0.8% agarose gel. Also, Xba I failed to digest 
p u s  1878 plasmid DNA as determined by the presence of multiple undigested bands 
on a 0.8% agarose gel. The enzyme was capable of cutting pUS1803 and pUS1883,
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as determined by the presence of a single band of the required molecular size on a 
0 .8 % agarose gel.
An alternative approach was to clone the promoter elements from pUS1803 and 
pUS1883 upstream of the promoter-less GFP coding sequence present in pUS1870. 
It was thought that the mycobacterial ori in pUS1870 was the desired short pALSGGO 
derived ori. Plasmids pUS1883 and pUS18G3 were digested with both Xba I and 
Hind III under buffering conditions compatible with the optimal activity of both 
enzymes (see section 2.2.2) and the resulting fragments resolved on a 1% LMP 
agarose gel. A 389 bp (pUS1883) and a 4G1 bp (pUS18G3) fragment containing the 
required promoter sequences were recovered from a 1% LMP-agarose gel as 
described in section 2.2.4. Plasmid pUS187G was similarly digested with both Xba I 
and Hind III and the linear 4821 bp vector fragment purified from a 1% LMP- 
agarose gel. Both promoter fragments were ligated into the linear pUS187G vector as 
described in section 2.2.7 overnight at 4°C. Five pi of each ligation was used to 
transform electrocompetent E.coli DH5a (see section 2.3.1c and 2.3.2c) and positive 
transformants selected for by growth on LB-agar media containing 5 Gpg/ml 
kanamycin with plasmid DNA recovered from positive transformants, section 2.2.1. 
The presence of the promoter was confirmed by restriction enzyme digestion of the 
resulting plasmid DNA with Xba I and Hind III. The plasmid vectors were 
designated pMRIlGl (containing the mpblO promoter) and pMRIlG2 (containing the 
18kDa promoter). However, further consultation with the University of Surrey 
revealed that the mycobacterial ori present in pUS187G was in fact not the short ori 
but rather the more commonly used long ori present in the plasmids from which the 
promoter fragments had been excised.
3.3.3 Sequencing plasmid DNA
Initial attempts to generate the required plasmids for these studies were hampered 
and confused by an overall lack of sequence information regarding the particular ori 
present in each vector as well as the restriction sites available for successful cloning. 
By sequencing the important constituent parts of the various plasmids it was hoped to 
generate the required sequence data to facilitate the creation of the required plasmid 
constructs.
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In order to determine the exact amount of pALSOOO sequence constituting the ori in 
plasmids pUS1870, pUS1780 and pUS972 were sequenced using primers Pr(al)-1 
and Pr(al)-2 (see section 3.2.2). Dr. Elizabeth Norman had previously demonstrated 
successful transformation of M.a.paratuberculosis with pUS1780 at the University of 
Surrey. The resulting sequences were compared to the published sequence of 
pALSOOO by alignment using the ALIGNX program of the Vector NTI suite (Figures
3.1 and 3.2). Plasmid pUS972 and pUS1780 encompass nucleotide positions 4311 to 
1100 of the pALSOOO sequence (short ori) with pUS1870, encompassing positions 
4308 to 1366 (long ori) (Figure 3.3).
Plasmids pUS1878 (hsp60 promoter), pUS1803 (jnpbVO promoter) and pUS1883 
(18kDa promoter) contained the promoter elements which would be used in further 
studies to ultimately express the 34kDa putative serine protease. As such all three 
plasmids were sequenced with primers Pr(al)-1 and Pr(al)-2 and shown to contain the 
large ori present in pUS1870. The region encompassing the promoter regions in 
these plasmids was sequenced using primers Pr(M) and Pr(G) (see section 3.2.2). As 
the region of interest was approximately 400bp for each plasmid, it was possible to 
generate a Contig of this region, as the generated sequences from both primers were 
the reverse complement of each other (Figure 3.4). Interestingly, and despite the fact 
that the restriction site appears inactive the Xba I site appears to be present in 
plasmid p u s  1878.
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pUS1780:
pALSOOO:4311 agcccaccagctccgtaagttcgggcgctgtgtggctcgtacccgcgcattcaggcggca 4370
M I I I I I I I M M I I I I I I I I M M I M M I I M M I M I I I I I I  I M I I I I I I I I I M
pUSlVSO:166 agcccaccagctccgtaagttcgggcgctgtgtggctcgtacccgagcattcaggcggca 107 
4371 gggggtctaacgggtctaaggcggcgtgtacggccgccacagcggctctcagcggcccgg 443 0
I I I I I I I M I I I I I I M I M M I I I M I I I I I I I I M I M I I I I I I I I I I M I M I I I M
106 gggggtctaacgggtctaaggcggcgtgtacggccgccacagcggctctcagcggcccgg 47 
4431 aaacgtcctcgaaacgacgcatgtgttcctcctggttggtacag 4474
I I I I I I I M I I I I I I M I M M I I I M I I I I I I I I M I I I I I I I
46 aaacgtcctcgaaacgacgcatgtgttcctcctggttggtacag 3
pUS972:
pALSOOO: 4311 agcccaccagctccgtaagttcgggcgctgtgtggctcgtacccgcgcattcaggcggca4370
I I M M I I I M I M I I I I I I M I I I I I I M M I I I I I I I I I M M  I I I I M M M M M
pUS972: 166 agcccaccagctccgtaagttcgggcgctgtgtggctcgtacccgagcattcaggcggca 107 
4371 gggggtctaacgggtctaaggcggcgtgtacggccgccacagcggctctcagcggcccgg 4430
I I I I I M M I I I I I M M I I I I I M I I I I I i l M I I M I M M I I I I I I I I I I I I I I I I I
106 gggggtctaacgggtctaaggcggcgtgtacggccgccacagcggctctcagcggcccgg 47 
4431 aaacgtcctcgaaacgacgcatgtgttcctcctggttggtacagg 447S
M I I I I I I I M M I I M I M I I I I I M M I I I I I I I I M I I I I I I
46 aaacgtcctcgaaacgacgcatgtgttcctcctggttggtacagg 2
pUS1870
pALSOOO: 4308 gtgagcccaccagctccgtaagttcgggcgctgtgtggctcgtacccgcgcattcaggcg4367
M M I I I I I M I I I I I M I I I I I M I I I I I I I I I I M I I I I I I I I I I I I M I I I I I I I M
pUS1870:168 gtgagcccaccagctccgtaagttcgggcgctgtgtggctcgtacccgcgcattcaggcg 109 
4368 gcagggggtctaacgggtctaaggcggcgtgtacggccgccacagcggctctcagcggcc 4427
I I I I I I I I I M I I I I I I I I I M M I I I I I I I I M M I I I I M I I I I I I I I I I M I I I I M
108 gcagggggtctaacgggtctaaggcggcgtgtacggccgccacagcggctctcagcggcc 49 
4428 cggaaacgtcctcgaaacgacgcatgtgttcctcctggttggtacag 4474
I M M I I I I M M I I i l l l l M M M I I I I I I I I I I I M I I I I I I I I
48 cggaaacgtcctcgaaacgacgcatgtgttcctcctggttggtacag 2
Figure 3.1 Alignment of the 5’ end of the ori present in vectors pUS1780, pUS972 
and pus 1870 with pALSOOO. Plasmid DNA was sequenced with primer Pr(al)-1 (see 
section 3.2.2) as described in the text and the sequence compared to pALSOOO by 
BLAST searching. Figure generated from BLAST hit of query sequence and pALSOOO.
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pUS1780:
pALSOOO: 1089 gagcgggtgtcg 1100
M I I I I I I M M
pUS1780: 1 gagcgggtgtcg 12
pUS972:
pALSOOO: 1083 attggggagcgggtgtcg 1100
M M M M M M M M M
pUS972: 4 attggggagcgggtgtcg 21
pUS1870:
pALSOOO: 1084 ttggggagcgggtgtcgcgggggttccgtggggggttccgttgcaacgggtcggacaggt 1143
I I I I I M M I I I M M I I I M M I I I I I M M M I I I I I M M I M M M M I M I I I M
pUS1870: 1 ttggggagcgggtgtcgcgggggttccgtggggggttccgttgcaacgggtcggacaggt 60
1144 aaaagtcctggtagacgctagttttctggtttgggccatgcctgtctcgttgcgtgtttc 1203
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
61 aaaagtcctggtagacgctagttttctggtttgggccatgcctgtctcgttgcgtgtttc 120 
1204 gttgcgcccgttttgaataccagccagacgagacggggttctacgaa-tcttggtcgata 1262
M I I I I I M M I I I I I I I I I I M M I I I I I I I I M M I I I I I I I I I I  M M M I I I I M
121 gttgcgcccgttttgaataccagccagacgagacggggttctacgaattcttggtcgata 180 
1263 ccaagccatttccgctgaatatcggggagctcaccgccagaatcggtggttgtggtgatg 1322 
181 -caagccatttccgctgaatatcggggagctcaccgccagaatcggtggttgtggtgatg 239 
1323 tacgtggcgaactccgttgtagtgcctgtggtggcatccgtggc 1366 
240 tacgtggcgaactccgttgtagtgcctgtggtggcatccgtggc 283
Figure 3.2 Alignment of the 3’ end of the ori present in vectors pUS1780, pUS972 
and pUS1870 with pALSOOO. Plasmid DNA was sequenced with primer Pr(al)-2 (see 
section 3.2.2) as described in the text and the sequence compared to pALSOOO by 
BLAST searching. Figure generated from BLAST hit of query sequence and pALSOOO.
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0 R F 5 ORF 1 0 R F 2 ORF 3
Short oh  Long ori
Fragment of pALSOOO
3200 bp (molecule 4837 bp)
Figure 3.3 pALSOOO derived origins of replications (ori). Fragment of pALSOOO 
sequence showing the location of both origins of replication used in these studies, 
Short ori (pALSOOO positions 4311-1 lOObp) and Long ori (pALSOOO positions 4311- 
1366bp). Also shown are ORF 1 and 2, which constitute the minimum requirements 
for plasmid replication, ORF5 and ORF3. Figure generated using Vector NTI suite, 
using pALSOOO sequence (Accession number: M23557).
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hsp60 Promoter
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X ba  I 
Kpn  I 
N ot I
B st E li
Bam  HI 
P s t l  
Eco  RI 
H indW l 
Kpn  I
GFP
pUS1878 Fragment
Myco Origin
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Kpn  I 
N ot I
18kDa Promoter
B st E li
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H indW l 
Kpn  I
GFP
Myco Origin A%6Zl
Kpn  I 
N ot I
pUS1883 Fragment
mpb70 Promoter
Bam  HI 
P s t l  
E g o  RI 
H ind  III 
Kon  I
GFP
pUS1803 Fragment
Figure 3.4 Vector map of the various promoter elements located in pUS1803, 
pUS1878 and pUS18083 created by Vector NTI based on sequence information 
(Appendix 4) generated by sequencing the plasmids as described in the text. Shown 
is the promoter region in each vector, the location of the down stream GFP coding 
sequence and the location of the mycobacterial ori. Also shown are the various 
restriction enzyme recognition sites used for cloning procedures.
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3.3.4 Plasmid construction
The mycobacterial ori present in pUS972 was confirmed as the short mycobacterial 
ori. As such, pUS972 was selected as the backbone for construction of all future 
plasmids.
a) Transcriptional fusion vectors
In order to express any gene in M.smegmatis or M.a.paratuberculosis plasmids were 
required containing the promoter elements necessary for transcriptional activity. The 
hsp60 (pus 1878) and 18kDa (pUS1883) promoters were cloned into pUS972 
(Figure 3.5 and 3.6). The promoter sequences located in pUS1878 Qisp60 promoter) 
and p u s  1883 {18kDa promoter) were excised fi*om the vector backbone as Kpn I 
fragments (460 bp for pUS1878 and 426 bp from pUS1883) and purified from a 1% 
LMP-agarose gel (see section 2.2.4). Plasmid pUS972 was digested to completion 
with Kpn I and purified from a 1 % LMP-agarose gel. The linear vector was then 
treated with Shrimp Alkaline Phosphotase (SAP) (see section 2.2.5) and gel purified 
as before. The promoter fragments were cloned into the linear pUS972 vector (see 
section 2.2.7) and 5pi of the ligation reaction used to transform electrocompetent 
E.coli JM109 cells (section 2.3.1c and 2.3.2c). Positive E.coli transformants were 
selected by growth on LB-agar media supplemented with 50pg/ml kanamycin. 
Plasmid DNA was recovered as described in section 2.2.2, and digested with the 
restriction enzymes Kpn I and Hind III. Kpn I digestion of the recovered plasmid 
DNA confirmed the presence of both promoter fragments (Figure 3.7).
By using a single restriction site to clone the fragments into pUS972, the orientation 
of the promoter elements in the plasmid backbone was unknown. To determine the 
orientation of the cloned promoter fragments, plasmid DNA was digested to 
completion with the restriction enzyme Hind III. Removal of 6 6 bp from both 
plasmids confirmed that the promoter was in the correct orientation relative to the 
down-stream MCS (Figure 3.7). The resultant plasmids with correctly orientated 
promoter sequences were designated pMRI104 (hsp60 promoter) and pMRI105 
{18kDa promoter).
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EcoRI
oriC
KpnI Phsp60
BamHI
Kan(R)
EcoRI
H nd I
PUS972
3600 bp P(kan) PUS1878 
5244 bp
EcoRI
BamHI
P(kan)EcoRI
Kan(R)
oriM
EcoRI
Sail
Kpn I digestion of both vectors 
(indicated by arrows)
EcoRI Clal
orlC‘
-MCS 
Bell 
Hind III 
SphI 
P stl 
Sail 
Xba I 
BamHI
Kan(R)
P(kan)PMRI104 
4060 bp
P(hsp60)
EcoRI
EcoRI
Sail
Figure 3.5 Construction of pMRI104. Shown are vector maps of pUS1878, pUS972 
and pMRI104. The cloning of the hsp60 promoter into pUS972 was as described in 
the text. Briefly, the hsp60, P(hsp60), promoter was removed from pUS1878 as a 
Kpn I fragment and cloned into pUS972 generating plasmid pMRJ104. The 
orientation of the promoter relative to the downstream MCS was determined by Hind 
III digestion of pMRI104 DNA (Figure 3.7).
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EcoRI RBS RBS EcoRI 
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Kpn I digestion of both vectors 
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Figure 3.6 Construction of pMRI105. Shown are vector maps of pUS1883, pUS972 
and pMRIlOS. The cloning of the 18kDa promoter, P(18kDa), was as described in 
the text. Briefly, the 18kDa promoter was removed from pUS1883 as a Kpn I 
fragment and cloned into pUS972 generating plasmid pMRIlOS. The orientation of 
the promoter relative to the downstream MCS was determined by Hind III digestion 
of pMRIlOS DNA (Figure 3.7).
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Figure 3.7 Agarose gel showing Kpn I digests of plasmids of pUS1878 and pUS972 
as well as Kpn I and Hind III digestion of pMRI104 and pMRI105. Lane 1: Kpn I 
digestion of plasmid pUS1878 results in the removal of the promoter region (460 bp; 
hsp60 promoter); Lane 2 Kpn I digestion of pUS972 resulting in linearlisation of the 
vector (3.6 Kb); Lane 3 and Lane 4: Kpn I digestion of pMRI104 (Lane 3) and 
pMRI105 (Lane 4) resulting in the excision of the cloned promoter region 
(pMRI104: hsp60, 460 bp; pMRI105: ISkDa promoter, 426 bp); Lane 5 and Lane 6 : 
Hind III digestion of pMRI104 (Lane 5) and pMRI106 (Lane 6 ) resulting in the 
excision of 6 6 bp from both pMRI104 and pMRI105. See text for more details. L 
represents the molecular weight markers (Hyperladder I, Bioline Ltd.).
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b) Promoter-less reporter vector
In order to generate a promoter less reporter vector, the E-GFP coding sequence was 
cloned into pUS972. The E-GFP ORF was removed from the plasmid pE-GFP-1 
(Appendix 2) as a single 751bp Bam Yil-Xba I fragment and purified from a 1% 
LMP-agarose gel. Plasmid pUS972 was digested to completion with Bam HI and 
Xba I, and the resulting 3,576bp vector purified from a 1% LMP-agarose gel. The E- 
GFP coding sequence fragment was ligated into pUS972 and 5pi of the ligation 
reaction used to transform electrocompetent E.coli DH5a cells. Positive 
transformants were selected for by growth on LB-agar medium supplemented with 
50pg/ml kanamycin. Plasmid DNA was recovered from positive transformants and 
restriction enzyme digestion of plasmid DNA with Kpn I confirmed an increase in 
size for the resultant plasmid consistent with the incorporation of the E-GFP coding 
sequence. The resultant plasmid construct was designated pMRI103.
c) E-GFP reporter vectors
In order to create plasmid shuttle vectors capable of expressing the reporter molecule 
E-GFP in mycobacteria the hsp60 and 18kDa promoter elements were cloned into 
the promoter-less E-GFP vector, pMRI103 (Figure 3.8). The promoter elements 
contained within pUS1878 and pUS1883 were excised as a Kpn I fragment and the 
resultant fragments (460 bp for pUS1878 and 426 bp for pUS1883) were purified 
from a 1% LMP-agarose gel. pMRI103 DNA was digested to completion with the 
restriction enzyme Kpn I, purified from a 1% agarose gel and treated with SAP. The 
resulting linear dephosphorylated vector was purified from a 1% LMP-agarose gel. 
Both promoter fragments were ligated separately into pMRI103 and 5 pi of each 
ligation reaction used to transform E.coli JM109 cells. Positive transformants were 
selected for by growth on LB-agar supplemented with 50pg/ml kanamycin. The 
orientation of the promoter relative to the downstream E-GFP coding sequence was 
confirmed by restriction mapping using the restriction enzyme Hind III. The excision 
of a 744bp fragment from each plasmid by digestion with Hind III confirmed that the 
promoter was in the correct orientation. E-GFP expression vectors with correctly 
orientated promoter fragments were designated pMRI107 (hsp60 promoter) and 
pMRI108 (18kDa promoter).
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Figure 3.8 Construction of pMRIlOT. Shown are vector maps of pUS1878, pUSlOB 
and pMRI107. The cloning of the hsp60, P(hsp60), promoter into pMRIlOB was as 
described in the text. Briefly, the hsp60 promoter was removed from pUS1878 as a 
Kpn I fragment and cloned into pMRIlOS generating plasmid pMRI107. The 
orientation of the promoter relative to the downstream E-GFP sequence was 
determined by Hind III digestion of pMRIlOB DNA. An identical approach was used 
to clone the 18kDa promoter into pMRIlOS.
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3.3.5 Expression of GFP and E-GFP in M,smegmatis mc^l55
The various plasmid vectors created in section 3.3.4 as well as the plasmids received 
from the University of Surrey capable of expressing GFP (pUS1878, pUS1803 and 
pu s 1883) or E-GFP (pMRI107 and pMRI108) were introduced into 
electrocompetent M.smegmatis mc^l55 (see section 2.3.1b) by electroporation as 
described in section 2.3.2b. Positive transformants were selected by growth on 
7H11S medium supplemented with 30 pg/ml kanamycin. Positive expression of GFP 
in M.smegmatis pUS1878, M.smegmatis pUS1883 and M.smegmatis pUS1803 was 
detected by fluorescent microscopy, using filter cubes specific for GFP detection (see 
section 3.2.3). Unfortunately, no quantification of the level of GFP expression was 
possible using this system. Similarly, positive expression of the E-GFP gene was 
demonstrated in recombinant M.smegmatis mc^l55 strains harbouring plasmids 
pMRI107 and pMRI108 by fluorescent microscopy using filter cubes for E-GFP 
detection (Figure 3.9).
3.3.6 Cloning the 34kDa putative serine protease ORF and expression of the 
protein in M.smegmatis mc^lSS
Previous worked carried out at Moredun Research Institute had sequenced the entire 
34kDa putative serine protease open reading frame and the corresponding upstream 
putative Shine Delgamo sequence present in the S8  clone (see section 1.10).
a) Cloning the 34kDa putative serine protease ORF into a mycobacterial shuttle 
plasmid
PCR primers were designed that would allow the PGR amplification of this entire 
region, with the addition of a 5’ Bst Eli site and a 3’ Xba I site. A double digest of 
pMRI104 (section 3.3.4a: transcriptional fusion vector hsp60 promoter) using both 
enzymes was expected to remove both ribosome-binding sites present in the 
promoter region. By adopting this approach, cloning the 34kDa putative serine 
protease into pMRI104 was expected to generate a transcriptional fusion to the 
hsp60 promoter (Figure 3.10). This would allow the determination of the 
translational activity of the putative RBS located upstream of the 34kDa putative 
serine protease.
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AB
BB
B^H
Figure 3.9 M.smegmatis pMRI107 (A) and M.smegmatis pMRIlOS (B) expressing 
E-GFP under the control of the hsp60 {M.smegmatis pMRI107) and 18kDa 
{M.smegmatis pMRIlOS) promoters. The preparation of cells for visualisation of E- 
GFP expression was as described in the text. Clumps of fluorescent bacteria are 
indicated by asterisks and single fluorescent bacteria indicated by arrows.
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Figure 3.10 The cloning of the 34kDa putative serine protease into the E.coli- 
mycobacterial shuttle vector, pMRI104 was as described in the text. Briefly, the 
entire 34kDa putative serine protease ORF and 25bp of upstream sequence was 
initially cloned into pGEM-T (Figure 3.11) and then excised as a single Xba l-Bst Eli 
fragment and cloned into pMRI104 generating a transcriptional fusion with the hsp60 
promoter. The resulting vector was designated pMRI34.
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The 34kDa putative serine protease open reading frame and 25 bp of sequence 
upstream from the initiation codon was amplified by PCR from M.a.paratuberculosis 
genomic DNA (see section 3.2.1). The l,100bp PCR product was purified from a 1% 
LMP agarose gel and cloned into the pGEM-T vector (Promega UK) as per the 
manufacturer’s recommendations, generating pGEM-34 (Figure 3.11). The insert 
fragment was sequenced using the T7 forward and reverse primers located in the 
pGEM-T vector. Alignment of the generated sequence with the 34kDa putative 
serine protease database entry demonstrated 100% identity. pGEM-34 plasmid DNA 
was digested to completion with Xba 1 and Bst Ell and the resulting 1,117 bp 
fragment was purified from a 1% LMP-agarose gel. pMRI104 plasmid DNA was 
also digested with both Xba I and Bst Ell and the linear 3,930bp plasmid was 
purified from a 1% LMP-agarose gel. The Bst E31-Xba 1 34kDa putative serine 
protease fragment was ligated into pMR1104 and 5 pi of ligation reaction used to 
transform E.coli JM109 cells. Positive transformants were selected for by growth on 
LB-agar containing 50pg/ml kanamycin. Plasmid DNA was isolated from positive 
transformants, and restriction enzyme digestion with Bst Ell and Xba 1 confirmed the 
presence of the correct l,117bp fragment in the vector (Figure 3.12), the vector was 
designated pMRI34 (Figures 3.10). Electrocompetent M.smegmatis mc^l55 (see 
section 2.3.1b) was transformed with pMRI34 by electroporation as described in 
section 2.3.2b, and positive transformants selected by grov/th on 7H11S medium 
supplemented with 30pg/ml kanamycin.
b) Expression of the 34kDa putative serine protease in M.smegmatis mc^lSS
The expression of the 34kDa putative serine protease from the hsp60 promoter in 
M.smegmatis mc^lSS was confirmed by western immunoblotting of M.smegmatis 
pMR134 cell lysates (see section 2.6), probed with a monoclonal antibody raised 
against the C-terminal end of the 34kDa putative serine protease (see section 2.8 and 
2.10). A band of approximately 34kDa was detected in M.smegmatis pMRI34 lysates 
that co-localised with an identical protein band in the M.a.paratuberculosis lysate 
confirming expression of the 34kDa putative serine protease in M.smegmatis mc^l55 
(Figure 3.13). No such band was detected in the control M.smegmatis mc^l55 lysate.
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SD pGEM-34 34R
Figure 3.11 The 34kDa putative serine protease ORF and upstream RBS were 
cloned into pGEM-T and the insert sequenced as described in the text. Shown are the 
important features of the cloned 34kDa putative serine protease sequence, the 34kDa 
putative serine protease ORF complete with the signal peptide and upstream Shine 
Dalgamo sequence (SD). Also shown are the locations of the restriction enzyme 
recognition sites used for further cloning {Bst Eli and Xba I). Fragment map was 
generated from sequence data (Appendix 4) using the Vector NTI suite.
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Figure 3.12 Agarose gel showing Bst EU and A&a I digestion of plasmids pMRI104, 
pGEM-34 and pMRI34. Lane 1: digestion of pMRI104 resulting in presence of a 
3,930 bp DNA band; Lane 2; digestion of pGEM-34 results in the excision of the 
cloned 1,117 bp 34kDa putative serine protease ORF, Lane 3, Lane 4 and Lane 5, 
digestion of pMR134 results in the excision of the cloned 1,117 bp 34kDa putative 
serine protease ORF from the vector backbone (-3,930 bp). L represents the 
molecular weight standards (Hyperladder 1, Bioline Ltd.)
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Figure 3.13 Western blot showing mycobacterial cell lysates probed with anti-
34kDa antigen monoclonal antibody. Lanes 1-9; B.QCovcib\rmi\. M.smegmatis me 155 
expressing the 34kDa antigen, lane 0; control M.smegmatis mc^l55. Lane 10; Wild 
type M.a.paratuberculosis. The lane marked L contains the M.wt markers. Only 
M.smegmatis pMR134 and M.a.paratuberculosis were positive for the presence of 
the 34kDa putative serine protease.
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Earlier work had demonstrated that the signal peptide located at the N-terminus of 
the protein facilitated the secretion of the protein in M.a.paratuberculosis (see 
section 1 .1 0 ). In order to demonstrate if the signal peptide was capable of directing 
the secretion of the recombinant protein in M.smegmatis mc^l55, culture 
supernatants were tested for the presence of the 34kDa putative serine protease. Cell- 
free culture supernatants of M.smegmatis mc^l55 and M.smegmatis pMR134 were 
concentrated down from a initial volume of 2 0  ml to a final volume of 1  ml using 
Microcon Concentrators (molecular weight cut-off; lOkDa) as per the manufacturer’s 
instructions. Western immunoblotting of the concentrated supernatants demonstrated 
the presence of a 34kDa-protein band in the M.smegmatis pMRI34 culture 
supernatant, with no protein detected in control M.smegmatis mc^l55 supernatant 
samples (Figure 3.14). No bands were detected when identical blots containing 
concentrated culture supernatants of M.smegmatis mc^l55 snd M.smegmatis pMRI34 
were probed with a monoclonal antibody against the cellular localised mycobacterial 
Hsp65 antibody, although the protein was detectable in the corresponding cell lysates 
for the same strains (data not shown).
3.3.7 Transformation of M,a.paratuberculosis plasmid DNA
A caveat to the development of expression vectors in M.smegmatis mc^l55, was the 
development of similar procedures to transform M.a.paratuberculosis. The ability to 
express genes in M.a.paratuberculosis was important for two reasons, firstly in 
complementing a null mutant in M.a.paratuberculosis, rescuing any observed 
phenotype. Secondly, the expression of GFP or a mutant derivative in 
M.a.paratuberculosis could be used as a convenient marker in future studies of 
M.a.paratuberculosis infection of cultured macrophages and in animal studies. A 
panel of six different M.a.paratuberculosis strains was chosen for these studies. The 
six different strains represented isolates from a broad host range, (cattle, sheep and 
rabbit) exhibiting different growth rates in culture, with the sheep isolates noted to be 
slower growing than the cattle isolates. It was hoped that the choice of these strains 
representative of the spectrum of M.a.paratuberculosis isolates would lead to the 
identification of a particular strain or strains that were amenable to genetic 
manipulation.
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Figure 3.14 Western blot showing mycobacterial cell lysates and the corresponding 
concentrated culture supernatants probed with anti-34kDa antigen monoclonal 
antibody. Lane 1, M.smegmatis mc^l55 lysate; Lane 2: M.smegmatis pMR1104 
lysates; Lane 3: M.smegmatis pMRI34 lysate; Lane 4: M.smegmatis mc^l55 culture 
supernatant; Lane 5: M.smegmatis pMRI104 culture supernatant; Lane 6 : 
M.smegmatis pMR134 culture supernatant. A unique band at 34kDa is seen in the 
lysate of M.smegmatis pMR134 and also in the concentrated culture supernatant 
(indicated by an arrow).
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Initially the protocol used to transform electrocompetent M.a.paratuberculosis was 
that of Wards and Collins, 1996 (see section 2.3.2a Method 1). Attempts were made 
to transform six M.a.paratuberculosis isolates from different host species, 
demonstrating a wide range of growth rates in culture (Appendix 2). All strains were 
raised directly from low passage number glycerol stocks and prepared for 
transformation as described in section 2.3.1a. In order to confirm previous 
observations regarding the association between the choice of mycobacterial ori and 
transformation efficiency attempts were made to transform M.a.paratuberculosis 
strains with plasmids containing GFP and the long ori of replication, (pUS1803, 
pUS1878, pUS1883 and pUS1780) as described in section 2.3.2a Method 1. Positive 
transformants were selected for by growth on 7H1 IE medium supplemented with 30 
pg/ml kanamycin and incubated at 37°C for up to 16 weeks. Only strains 51/91 and 
R187 transformed with pUS1780 gave positive colonies after 10 weeks in culture. 
However, the overall transformation efficiency was extremely low, 10 CFU/pg DNA 
for 51/91 and 8  CFU/pg DNA for R187. 1^900 PCR confirmed that the resultant 
transformants were M.a.paratuberculosis (see section 2.11.1) and the presence of 
plasmid DNA in each strain confirmed by PCR directed against the kanamycin 
resistance gene (see section 2.11.2). The effect on viability of the electroporation of 
M.a.paratuberculosis strains was determined by comparison of the growth of each 
strain before and after electroporation (in the absence of plasmid DNA) in 7H11E 
media. For each strain, no appreciable difference was detected in the viability of the 
organisms following control electroporation. Similarly, M.a.paratuberculosis strains 
electroporated in the absence of plasmid DNA failed to grow on 7H11E media 
supplemented with 30pg/ml kanamycin. A repeat experiment using the same 
conditions as described above, failed to generate any transformants for any 
M.a.paratuberculosis isolates. The inability to transform M.a.paratuberculosis 
strains 51/91 and R187 in a repeat perhaps underlined the extremely low 
transformation efficiency observed in the initial experiments.
Following preparation of electrocompetent M.a.paratuberculosis the cells were snap 
frozen and stored under liquid nitrogen until required. This was necessitated by the 
different growth rates of the various strains in cultures so that all transformations 
could be conducted on the same day using the same plasmid DNA and
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electroporation conditions. The possibility existed that the freezing of the cells before 
electroporation adversely affected the transformation of these strains. No appreciable 
adverse affect on the overall viability of each culture was noted. In order to address 
this, all M.a.paratuberculosis strains were prepared for electroporation as described 
in section 2.3.1a and immediately transformed with pUS1878, pUS1780 and pUS972 
plasmid DNA without freezing of the prepared mycobacterial cells. No positive 
transformants were observed on selective medium for any strain transformed with 
plasmid DNA following incubation on selective medium for 16 weeks.
A second transformation method was attempted, following consultation with Dr. 
Steve Thome at the University of Surrey (see section 2.3.2a Method 2). The 
possibility remained that the use of the short ori would facilitate the stable 
introduction of plasmid DNA. M.a.paratuberculosis strains 51/91 and R187 were 
transformed with 500 ng of pMR1107, pMR1108, pUS1878 and pUS972 plasmid 
DNA (see section 2.3.2a Method 2). However, no transformant colonies were seen 
following incubation for 8-10 weeks at 37°C on 7HllSu (Appendix 3) media 
supplemented with 30 pg/ml kanamycin following transformation with any plasmid 
DNA.
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3.4 Discussion
The central aim of the work presented in this chapter was to create the shuttle 
plasmid vectors and transformation protocols necessary to express the 34kDa 
putative serine protease or a reporter molecule (wildtype GFP or a mutant 
derivative), in M.smegmatis mc^l55 and M.a.paratuberculosis. Initially an overall 
lack of sequence information relating to the particular ori present in the various 
plasmids as well as an inaccurate restriction enzyme map hampered attempts to 
create the various vectors. As such, several important composite regions of the 
various plasmids were sequenced. Firstly, it was important to determine the exact 
amount of pALSOOO sequence present in the mycobacterial ori as a difference in 
transformation efficiency for M.a.paratuberculosis had been observed using the two 
origins. Both origins of replication contained the complete sequence of ORFl and 
0RF2, which are considered indispensable for plasmid replication in mycobacteria 
(Stolt and Stoker, 1996). The difference between the two ori was in the region down 
stream from 0RF2. The long ori of replication contained 260bp more sequence 
between 0RF2 (719-1078bp) and 0RF3 (1538-2305 bp), than the short ori of 
replication (Figure 3.3). More recent work has postulated a role for the 0RF5 of 
pALSOOO in the faster recovery of M.smegmatis mc^lSS, under kanamycin selection 
(Stolt and Stoker, 1997). However, both the short ori and long ori contain the same 
amount of 0RF5 sequence and do not contain the full coding sequence (4452-4102) 
(Figure 3.3). It remains to be determined if the lack of the 3’ 260bp of sequence has 
any effect on the ability of plasmid DNA to transform M.a.paratuberculosis.
The ultimate choice of the hsp60 promoter to drive expression of the 34kDa putative 
serine protease in M.smegmatis mc^lSS, instead of the ISkDa or mpblO promoters, 
for future in vitro virulence assay determination was based on two factors. Firstly, 
the hsp60 promoter has demonstrated constitutive expression in culture and within 
macrophages (Dellagostin et al, 1995). Secondly, Foley-Thomas et al have 
demonstrated that in terms of luciferase activity, the hsp60 promoter demonstrates 
comparable expression levels in M.smegmatis and M.a.paratuberculosis. The coding 
sequence was cloned as a transcriptional fusion to the hsp60 promoter and the 
resultant vector introduced into M.smegmatis mc^l55. The positive expression of the 
34kDa putative serine protease in M.smegmatis mc^l55 was confirmed by western
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immunoblotting of mycobacterial cell lysates. It was also possible to demonstrate 
that the protein was capable of being secreted by M.smegmatis mc^l55. The native 
protein has been shown to be secreted by M.a.paratuberculosis and as such any 
virulence associated function of the mature protein may be related to the secretion 
and subsequent activity of the protein in the phagosome of infected macrophages.
Published work has demonstrated transformation of M.a.paratuberculosis with 
plasmids pMV262 and a luciferase expressing derivative of pMV262, pYUBlSO 
(Foley-Thomas et al, 1995; Williams et al, 1999). pMV262 contains the long 
pAL5000 derived ori. The authors report that it was possible to transform prototype 
and clinical isolates of M.a.paratuberculosis with a transformation efficiency 
between 1.4 to 7.1 x 10^  cfii/pg DNA depending on the strain. The electroporation 
protocol in these studies used pre-chilled mycobacterial cells (Jacobs, Jr. et al, 1991; 
Parish and Stoker, 1998), which may have been responsible for the low 
transformation efficiency. Ward and Collins reported that pre-warming slow growing 
mycobacterial cells to 37°C improved the transformation efficiency of pathogenic 
strains, including M.avium (Wards and Collins, 1996). The protocol of Wards and 
Collins, 1996 was used in these studies, but it was not possible to transform 
M.a.paratuberculosis strains with plasmids expressing GFP or E-GFP, utilising both 
origins of replication. While it was possible to transform M.a.paratuberculosis 
strains 51/91 and R187 with pUS1780 the efficiency of transformation was very low 
with few colonies recovered on selective medium following incubation. A similar 
plasmid containing the short ori, pUS972 failed to transform any of the strains tested. 
Similarly, extending the recovery time post-electroporation and changing the 
selection media failed to improve the recovery of positive transformants.
There are several potential reasons why it was not possible to transform 
M.a.paratuberculosis. Indigenous plasmids have been reported in M.avium complex 
strains, although as yet no published work has demonstrated the presence of naturally 
occurring plasmids in M.a.paratuberculosis. However, the presence of any such 
plasmids may decrease the efficiency of, or in some cases possibly prevent, 
transformation by a mechanism of incompatibility or competition for replication or 
partition (Crawford and Bates, 1984; Crawford and Bates, 1986; Jucker and
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Falkinham, III, 1990). Mycobacterial plasmids have been demonstrated to have a 
restricted and complex mycobacterial host range. Plasmids harbouring pLR7 and 
pMSC262 based replicons were unable to replicate in M.smegmatis mc^l55, whereas 
pMSC262 was capable of replication in M.smegmatis J15cs (Beggs et al, 1995). 
Similarly, a pALSGGO based plasmid failed to transform a M. avium strain harbouring 
pLR7, whereas a pMSC262 replicon was compatible with the presence of a pALSGGG 
replicon in M.bovis BCG. Therefore, the possibility exists that the inability to 
transform M.a.paratuberculosis with plasmid DNA, may reflect an incompatibility 
between the pALSGGG origin and an endogenous plasmid in the strains used.
Another important consideration is that the complexity and resilience of the 
M.a.paratuberculosis cell wall constitutes a significant barrier to transformation with 
exogenous DNA. Similarly, the propensity of M.a.paratuberculosis to aggregate 
together to form “clumps” both in culture and during the preparation of a 
electrocompetent M.a.paratuberculosis cell suspension may also render the cells 
more resilient to transformation. The particular growth stage at which the 
M.a.paratuberculosis cells are harvested may also affect the transformation 
efficiency. In these studies, the cells were grown to a high density, to late log phase. 
However, in the studies of Foley-Thomas et al the cells were grown to a much lower 
density (ODeoo ~ G.2 ), early log phase. Actively dividing cells may be more 
amenable to transformation than those cells harvested at a later growth stage. In the 
studies of Foley-Thomas et al positive transformants were selected by growth on 
media containing IG pg/ml kanamycin, significantly lower than the concentration 
used in these studies. A higher concentration was deemed advantageous to prevent 
growth of spontaneous kanamycin mutants. The possibility exists that lowering the 
concentration of kanamycin used for selection of transformants without increasing 
the appearance of resistant mutants may allow more efficient recovery of 
M.a.paratuberculosis transformants. Finally, the transient ability to transform two 
strains of M.a.paratuberculosis with pUS178G but not plasmids expressing OFF or 
E-GFP may indicate that the expression of the reporter molecule places a strain on 
the transcriptional machinery of the host mycobacterial cell adversely affecting the 
viability of that cell.
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The long incubation time required for confirmation of positive transformants, up to 
16 weeks, meant that not all the potential barriers to efficient transformation could be 
addressed over the course of the work. Further work is required to determine what 
specific conditions are required to transform M.a.paratuberculosis. The strains used 
in these studies were low passage number strains, to avoid the possible laboratory 
adaptation of the strains by repeated passage in culture over many generations. 
However, the ability to grow the cultures at a faster rate possibly by serial passage, 
coupled to a comprehensive investigation of the different growth stages may 
facilitate greater transformation efficiency. Similarly, the ori used in the construction 
of the plasmid vectors should be re-evaluated to include origins of replication fi*om 
other plasmids to overcome any potential genetic barriers to transformation.
In conclusion, expression vectors have been constructed utilising the short ori. The 
34kDa putative serine protease was cloned as a transcriptional fusion with the hsp60 
promoter and the resultant vector, pMRI34, transformed into M.smegmatis mc^l55. 
It was possible to demonstrate the presence of the recombinant 34kDa putative serine 
protease in M.smegmatis mc^l55. It was also possible to demonstrate that the 34kDa 
putative serine protease is capable of being secreted by M.smegmatis mc^l55. The 
potential effect of expression of the 34kDa putative serine protease on the 
intracellular survival of M.smegmatis mc^l55 could now be determined.
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CHAPTER 4
INFLUENCE OF EXPRESSION OF THE M.a.paratuberculosis 
34kDa PUTATIVE SERINE PROTEASE ON THE 
INTRACELLULAR SURVIVAL OF M.smegmatis mc^lSS
4.1 Introduction
Pathogenic mycobacteria persist in the host by residing in macrophages. Although 
both virulent and avirulent mycobacteria are internalised by macrophages and 
monocytes, only pathogenic mycobacteria survive and replicate intracellularly. 
Mycobacteria enter macrophages primarily by conventional receptor-mediated 
phagocytic pathways, predominantly mediated via type 3 complement receptors 
(Schlesinger and Horwitz, 1991). However the plasma membrane steroid cholesterol 
has also been shown to be required for efficient uptake (Gatfield and Pieters, 2000).
Pathogenic Mycobacterium species alter the normal maturation processes of the 
phagosomes following internalisation by macrophages (Barker et a l, 1997) 
(Clemens and Horwitz, 1995; Clemens and Horwitz, 1996; Clemens, 1996; Deretic 
et a l, 1997). Phagosomes containing live pathogenic mycobacteria exhibit reduced 
acidification, retaining an internal vacuolar pH of 6.2-63 (Clemens, 1996), an 
observation that has been linked to the exclusion or rapid removal of the vacuolar 
proton-ATPase from the mycobacterial containing phagosome (Sturgill-Koszycki et 
al, 1994). This multi-component enzyme complex is primarily responsible for 
acidification of intracellular compartments, including phagosomes (Sturgill-Koszycki 
et al, 1994). This in turn results in altered vacuolar maturation such that phagosome- 
lysosome fiision is blocked with phagosomes containing live bacilli retaining 
markers of early endosomes as well as many plasma membrane proteins (Sturgill- 
Koszycki et a l, 1996; Clemens and Horwitz, 1996; Guerin and de Chastellier, 2000). 
A different situation is found upon internalisation by host macrophages that have 
been exposed to activating cytokines such as interferon-y, in this case the 
macrophage overcomes the block in maturation and delivers the bacterium to an 
acidic, lysosome-like vacuole (Via et a l, 1998). The phagosomes of activated
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macrophages have a lower oxygen tension than those of imstimulated phagocytes. 
Other implicated mechanisms in intracellular mycobacterial survival include 
resistance to killing by reactive oxygen and nitrogen intermediates (ROI and RNI) 
produced by the host cell (Fazal, 1997; Rojas et a l, 1998; Flynn and Chan, 2001; 
Piddington et al, 2001) and modification of the lipid composition of the 
mycobacterial cell membrane, thereby altering its capacity to interact with immune 
or inflammatory cells (Fratti et a l, 2001).
Following M.a.paratuberculosis entry into the mucosa of the host’s gut, via the illeal 
dome M cells, the microbe is taken up by sub-epithelial macrophages in which the 
bacillus persists and multiplies (Clarke, 1997). As such internalisation and survival 
of M.a.paratuberculosis in host macrophages is a vital initial component in the 
establishment of disease in agreement with the other pathogenic Mycobacterium spp. 
Recently Kuehnel et al has characterised the intracellular survival of 
M.a.paratuberculosis in the murine macrophage cell line J774 (Kuehnel et al, 2001). 
The authors demonstrated that phagosomes containing viable M.a.paratuberculosis 
fail to acidify retaining a pH of approximately 6.3 and persist in the phagosome as 
intact single microbes or in groups of multiple microbes for up to 15 days. This is in 
contrast to other pathogenic mycobacteria, which are thought to reside in large 
vacuoles containing several mycobacteria early in the infection and in small vacuoles 
with single organisms after 2-3 days of infection (Xu et al, 1994; Clemens, 1996). It 
remains unclear if this observation is significant in M.a.paratuberculosis survival 
and persistence in macrophages.
The identification and characterisation of the mycobacterial products that promote 
intracellular survival remains a priority as they represent potentially interesting 
targets for novel drugs and vaccines. One method of identifying bacterial genes 
involved in pathogenesis is to express these genes in a non-pathogenic host species 
and determine what affect the presence of the gene has on the intracellular survival 
of the bacterium in host phagocytic cells. Arruda et al identified an M.tuberculosis 
gene responsible for the increased ability of E.coli to invade HeLa cells (Arruda et 
al, 1993). More recently several groups have reported the identification o f M.leprae, 
M.tuberculosis and M.avium genes conferring increased survival in macrophages on
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the saprophytic M.smegmatis (Lagier et al, 1998; Wei et al, 2000; Miller and 
Shinnick, 2000).
The 34kDa antigen demonstrates homology to the HtrA family of bacterial trypsin 
like serine proteases (Cameron et a l, 1994). Disruption of the htrA gene in numerous 
pathogenic bacteria, including Yersinia enterocolitica. Salmonella enterica serovar 
typhiumurium. Brucella abortus and Legionella pneumophila, results in decreased 
rates of survival for the mutant bacteria in cultured macrophages relative to wild-type 
bacterial controls (Baumler et al, 1994; Elzer et a l, 1996; Yamamoto et a l, 1996; 
Pedersen et a l, 2001). The 34kDa antigen may play an analogous role in 
M.a.paratuberculosis survival in the hostile environment of the host macrophage. In 
agreement with this hypothesis, the protein is expressed in vivo by 
M.a.paratuberculosis during the course of infection eliciting a strong antibody 
response in animals presenting with clinical disease (Cameron et al, 1994). If the 
34kDa putative serine protease represents an important virulence determinant of 
M.a.paratuberculosis then expression in a saprophytic host strain, may alter the 
survival of the host microbe in macrophages as has been demonstrated for other 
genes implicated in the survival of pathogenic mycobacterial strains in macrophages. 
The work presented in this chapter attempted to elucidate what affect the expression 
of the 34kDa putative serine protease had on the survival of M.smegmatis in ex-vivo 
ovine alveolar (OA) macrophages. Attempts were also made to demonstrate the 
presence of the protein in macrophages infected with M.smegmatis mc^l55 
expressing the 34kDa putative serine protease.
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4.2 Materials and Methods
4.2.1 Harvesting of OA macrophages from adult ewes
At post mortem the trachea was clamped before removal of the lungs from adult 
ewes to avoid contamination with blood. The lungs were filled with approximately 
1/ of sterile PBS, massaged gently and the lavage fluid recovered by pouring through 
sterile gauze into a sterile centrifuge bottle. Lavage fluids that showed signs of 
discoloration with blood were discarded. Cells were harvested by centrifugation at 
1,200 X g- for 10 min at room temperature and washed three times in Hank’s basic 
salt solution (HBSS- l,3mM CaClz, 5.4mM KCl, 0.5mM KH2 PO4 , 0.8mM MgS0 4 , 
136.9mM NaCl, 0.34mM Na2 HP0 4 , 5.6mM D-glucose, 0.03M phenol red) 
supplemented as follows; 2% (%) FBS, lOU/ml preservative-free heparin (Sigma- 
Aldrich), 4 pg/ml amphotericin B (Sigma-Aldrich), 100 U/ml penicillin (Invitrogen 
life sciences), 100 pg/ml Streptomycin (Invitrogen life sciences) and 50 pg/ml 
gentamicin sulphate (Invitrogen life sciences). Recovered cells were counted using a 
1% C /^y) Nigrosine stain, the cell density adjusted to 1 x 10^  macrophage cells/ml 
and cryopreserved in 1ml vials (Invitrogen life sciences) in a mixture of RPMI 
containing 50% (%) FBS and 10% (^/y) dimethyl sulphoxide (DMSO) (Sigma- 
Aldrich).
4.2.2 Preparation of OA-macrophage for infection with mycobacteria
OA macrophages were resuscitated from liquid nitrogen storage as follows; 7 ml of 
pre-warmed (37°C) RPMI-1640 medium (Life Technologies) supplemented as 
follows; 10% (7v) heat-inactivated foetal calf serum (FCS) (Life Technologies), 
2.5M HEPES (N-[2-Hydroxyethyl]piperazine-N’-[2-ethanesulphonic acid]), 2mM 
glutamine, 8 % (%) sodium bicarbonate and 50pg/ml gentamicin, referred to as OA- 
macrophage complete-RPMI (complete OA-RPMI) medium was added to 1ml of 
freshly thawed OA macrophages, the cells harvested by centrifugation at 800 rpm for 
5 min at room temperature. The OA macrophages were re-suspended in 15ml of 
complete OA-RPMI and cell viability determined using a 1 % (^/y) Nigorsine stain. 
The cell density was adjusted to the required density in complete OA-RPMI medium 
and seeded in 24 well tissue culture plates. The cells were incubated overnight at 
37°C with 5% CO2  to allow adherence of OA macrophages to the bottom of each 
well.
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4.2.3 Preparation of mycobacterial inoculum for OA-macrophage infection
a) M.smegmatis
For infection of macrophages, a fresh culture of each M.smegmatis (ODeoo 0.4-0.5) 
strain was diluted Vio in fresh pre-warmed (37°C) 7H9^ broth (Appendix 3) 
supplemented where appropriate with 30 pg/ml kanamycin and incubated at 37°C 
with shaking at 200 rpm to an ODeoo of 0.4-0.5 (approx. 1 x 10^  mycobacteria/ml). 
The culture was diluted in antibiotic-free complete OA-RPMI to yield a final 
concentration of 1 x 10  ^ mycobacterial cells/ml. Microscopy confirmed that the 
cultures contained many single bacteria. The inoculum was serially diluted in PBS, 
and inoculated onto 7H11-S medium (Appendix 3) supplemented where appropriate 
with 30 pg/ml kanamycin and incubated at 37°C for 3-4 days to determine the 
retrospective viable count.
b) M.a.paratuberculosis
For infection of OA macrophages, M.a.paratuberculosis cells were scraped from the 
surface of 7H11+ medium (Appendix 3) and transferred to 5 ml of PBS and vortexed 
to obtain a cell suspension. The mycobacterial cell suspension was left standing at 
room temperature for 10-15 min, allowing the clumps of bacteria to settle to the 
bottom of the tube. The upper cell suspension was carefully removed, the McFarland 
reading was noted using a Densimat and the cells adjusted to a McFarland 2 in PBS. 
The culture was diluted in antibiotic-free complete OA-RPMI to yield a final 
concentration of approximately 1 x 10^  mycobacterial cells/ml. Microscopy 
confirmed that the cultures contained many single bacteria. The inoculum was 
serially diluted in PBS, and inoculated onto 7 H 1 1 + medium at 37°C for 8-10 weeks 
to determine the retrospective viable count.
4.2.4 Mycobacterial infection of OA macrophages
OA macrophages were seeded in 24 well tissue culture plates as described in section 
4.2.2. Following overnight adherence, OA macrophages were washed twice in sterile 
PBS and antibiotic-free complete medium containing M.a.paratuberculosis (see 
section 4.2.3-2) or M.smegmatis (see section 4.2.3-1) at a concentration of 1 x 10^  
was added to triplicate wells. After incubation for 4 hr (becoming time zero) at 37°C 
and 5% CO2 , macrophage cells were washed three times with PBS to remove
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extracellular particles, and complete OA-RPMI medium (see section 4.2.2) added. At 
0, 24, 48 and 72 hr post infection the media was removed, the macrophages were 
washed twice with sterile PBS and 1 ml of distilled water was added to each well and 
incubated for 30 min at 37°C. The macrophage cell lysate was recovered, serially 
diluted in sterile PBS and plated on 7H11-S medium supplemented where 
appropriate with 30 pg/ml kanamycin for M.smegmatis or 7H11+ medium for 
M.a.paratuberculosis. Mycobacterial cultures were incubated at 37°C for 2-3 days 
{M.smegmatis) or 8-10 weeks {M.a.paratuberculosis) and colonies counted. The 
number of recovered organisms was expressed as CFU/ml of macrophage lysate.
4.2.5 Maintenance of J774A.1 macrophage-like cell line
The preparation, infection and immuno-fluorescence staining procedures of both 
J774A.1 and bovine derived blood mononuclear cells was performed using the 
protocols and facilities of Prof. Peter Valentin-Wiegand and Prof. Gerald Gerlach at 
the Institut fur Mikrobiologie und Tierseuchen, Tierarztliche Hochschule, 
Bischofsholer Damm 15, D30173 Hannover, Germany. Similarly, while the infection 
and fixing of macrophages for immuno-electron microscopy (hnmuno-EM) was 
conducted at the above institute the subsequent embedding, sectioning and analysis 
of infected macrophage cells was performed by Dr. Manfred Rhode at the Beriech 
Mikrobiologie der Gesellschaft fur Biotechnologische Forshung (GBF), 
Braunschweig, Germany.
The mouse macrophage cell line J774A.1 (Ralph et al 1975) was maintained in 
Dulbecco’s modified Eagle medium (DMEM) supplemented as follows: 10% (%) 
heat-inactivated foetal calf serum, 1% (%) glutamine (Sigma-Aldrich), 100 U/ml 
penicillin (Sigma-Aldrich), 100 pg/ml streptomycin (Sigma-Aldrich) (referred to as 
complete J774A.1 medium;) at 37°C and 5% CO2 . For infection experiments, the 
cells were maintained in antibiotic-free complete J774A.1 medium for 48 h and 
grown to confluency or seeded on glass cover-slips and grown to semi-confluency.
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4.2.6 Preparation of mycobacterial inoculum for J774A.1 macrophage infection
a) M.smegmatis
For infection of macrophages with M.smegmatis strains, a fresh culture of each 
M.smegmatis (ODeoo 0.4) strain was diluted Vio in fresh pre-warmed (37°C) media 
supplemented where appropriate with 30 pg/ml kanamycin and incubated at 37°C 
with shaking at 200 rpm to an ODeoo of 0.4-0.6. M.smegmatis strains were diluted to 
an ODgeo of 0 . 1  in antibiotic free complete J774A.1 medium for infection. 
Microscopy confirmed that the cultures contained many single bacteria.
b) M.a.paratuberculosis
For infection of macrophages, M.a.paratuberculosis cells were harvested by 
centrifugation at 1,000 x g  and re-suspended in 5ml of antibiotic free complete 
J774A.1 medium. Homogenisation of the mycobacteria was performed as described 
by Silver et al 1998. Briefly, bacterial suspensions were vortexed in the presence of 
glass beads (3mm diameter) for 5 min and centrifuged for 5 min at 50 x g. 
M.smegmatis strains were diluted to an ODôôo of 0.1 in antibiotic free complete 
J774A.1 RPMI for infection. Microscopy confirmed that the resulting supernatant 
contained many single bacteria.
4.2.7 .Sadight™ LIVE/DEAD® determination of mycobacterial viability
Viability of mycobacterial cultures was determined using the LIVE/DEAD ^acLight 
Bacterial viability assay (L7007; Molecular Probes) as per the manufacturer’s 
instructions. Briefly, 50 pi of the mycobacterial culture suspension to be tested was 
centrifuged at 11,600 x g for 3 min. The supernatant was discarded and the bacterial 
cells re-suspended in 100 pi of colour solution [a 1:1 mix of Solution A (1.67 mM 
SYTO dye and 1.67 mM propidium red in anhydrous DMSO; Molecular Probes) and 
Solution B (1.67 mM SYTO 9 Dye and 18.3 mM propidium iodide in anhydrous 
DMSO; Molecular Probes)]. The cells were left at room temperature for 15 min and 
then centrifuged at 11,600 x g for 3 min. The supernatant was discarded and the 
bacterial pellet was resuspended in 1 0 0  pi distilled water and re-centrifuged at 
11,600 X g  for 3 min. The pellet was then resuspended in a final volume of 25pi 
sterile distilled water. Five pi of labelled mycobacterial suspension was placed on a 
clean microscope slide, covered with a sterile cover-slip and sealed using nail polish.
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Samples were examined microscopically using a Leica DML microscope equipped 
with an N2.1 filter system. For infection of J774A.1 macrophage-like cells, bacterial 
suspensions from M.a.paratuberculosis contained between 70-80% viable bacteria, 
those from M.smegmatis contained ~95%.
4.2.8 Mycobacterial infection of J774A.1 macrophage-like cell line
For the infection of J774A.1 macrophages with M.smegmatis or 
M.a.paratuberculosis, J774A.1 macrophages were seeded as described in section 
4.2.5. After 48 h in culture, the macrophages were washed twice with sterile PBS and 
antibiotic-free complete medium containing M.a.paratuberculosis or M.smegmatis 
(see section 4.2.6) added and incubated for 2 hr at 37°C and 5% CO2 . J774A.1 
macrophages were washed three times with sterile PBS to remove extracellular 
particles, and Dulbecco’s modified Eagle medium (DMEM) supplemented as 
follows: 10% (7v) heat-inactivated FCS, 1% (7v) glutamine and 50 pg/ml gentamicin 
was added.
4.2.9 Preparation of infected J774A.1 macrophage cells for Immuno­
fluorescence microscopy
For the preparation of infected macrophages for immuno-fluorescence microscopy, 
J774A.1 macrophages were seeded onto glass cover-slips in 24 well tissue culture 
plates (Life Technologies) as described in section 4.2.5. The macrophages were 
infected with M.smegmatis and M.a.paratuberculosis as described in section 4.2.8. 
At each experimental time point, residual medium was removed by washing with 
sterile PBS and the macrophages were fixed with a solution of 0.37% (7v) 
formaldehyde in PBS (100 pl/well) for 5 min at room temperature. The macrophages 
were washed twice in sterile PBS and permeabilised in 0.1% (Vy) Triton-X 100 in 
PBS at room temperature for 15 min, followed by a further three washes in PBS. 
Primary antibody, Hybridoma supernatant (section 2.9.1), was added and incubated 
at 37°C in a humidified chamber for 45 min followed by three washes in PBS. 
Secondary antibody, FITC conjugated goat anti-mouse IgG (DAKO Ltd.) diluted 
V iooo  in PBS, was added and incubated at 37°C for 45 min, followed by three washes 
in PBS. Finally, each cover-slip was mounted upside down in Mowiol on a clean 
microscope slide and sealed with nail polish. The slides are then stored at 4°C in the
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dark until analysed. Samples were examined microscopically using a Leica DML 
microscope equipped with an N2.1 filter system.
4.2.10 Preparation of infected J774A.1 macrophage cells for Immuno-electron 
microscopy (Immun-EM)
For the preparation of infected macrophages for immuno-electron microscopy, 
J774A.1 macrophages were seeded in 6 -well tissue culture plates (Life Technologies) 
as described in section 4.2.5, followed by infection with M.smegmatis and 
M.a.paratuberculosis as described in section 4.2.8. At each experimental time point 
residual medium was removed by washing with PBS and macrophage cells were 
carefully removed from the bottom of each well, using a rubber policeman. The 
macrophage cell suspension was transferred to a sterile 1.5 ml eppendorf tube, 
centrifuged at 2,000 x g for 3 min and re-suspended in 500 pi of 10 mM HEPES. The 
macrophage cells were again harvested by centrifugation at 2,000 x g  for 3 min and 
fixed in a solution containing 3 % (7y) glutaraldehyde and 5 % (7y) formaldehyde in 
10 mM HEPES on ice for 1 hr. Macrophage cells were harvested by centrifugation 
and washed in a solution containing 10 mM HEPES and 10 mM Glycine in PBS. 
Finally, macrophage cells were re-suspended in 1 ml of a solution containing 10 mM 
HEPES and 10 mM Glycine in PBS and stored at 4°C prior to preparation for 
sectioning. Samples were dehydrated with a graded series of ethanol solutions (10, 
30, 50, 70, 90, 100%) on ice and infiltrated with the acrylic resin LRWhite (1 part 
ethanol/ 1  part resin over night; 1  part ethanol/ 2  parts resin, 8  h; pure resin for 1  day 
with several changes). Polymerisation of the resin was carried out at 60°C for 24 h. 
Ultrathin sections were cut with a diamond knife and the sections were collected 
using formavar coated grids. Grids were placed onto drops of primary antibody 
(Protein A purified monoclonal antibody; section 2.2.9) and incubated at 4°C 
overnight. After washing the grids with PBS the bound antibodies were visualised by 
floating the grids on drops of a Vioo dilution of the stock solution of 10 nM protein 
A-gold complexes (British Biocell). After several washing steps with PBS containing 
1% (^/y) Tween 20, grids were rinsed in water and air-dried. Counter-staining was 
performed with aqueous uranyl acetate for 5 min. Samples were examined in a Zeiss 
transmission electron microscope EM910 at an acceleration voltage of 80 kV and at 
calibrated magnifications.
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4.2.11 ProteinChip array detection of the 34kDa putative serine protease
Ciphergen Biosystems ProteinChip® System comprises a ProteinChip reader, (a laser 
desorption/ionisation time-of-flight mass spectrometer) and a ProteinChip array to 
analyse peptides and proteins from complex biological samples.
a) ProteinChip® analysis of biological samples
The analysis of biological samples for the presence of the 34kDa putative serine 
protease was achieved using the ProteinChip® system (Ciphergen Biosystems, Inc.) 
as per the manufacturer’s instructions. Briefly, the pre-activated chip (NPl or SAX2) 
was placed in a humidity chamber and the chemical surfaces of the 6  spots on each 
chip pre-equilibrated by the application of 2 pi PBS to each spot. The PBS was 
carefully removed by pipetting and 1  pi of sample (mycobacterial cell lysate; section
2.6 or infected OA-macrophage lysate; section 4.2.4) was added to each spot, and 
incubated for 1 h in the humidity chamber at room temperature or at 4°C overnight. 
Residual spot activity was blocked by the addition of 3 pi of 1 M ethanolamine in 
PBS, pH 8.0 and incubated for 30 min at room temperature in the humidity chamber. 
Unbound protein was removed by washing the chip in 7 ml PBS supplemented with 
0.5% (^/y) Triton X-100 with gentle shaking at room temperature for 15 min. This 
was followed by 3 washes in PBS at room temperature with gentle shaking for 5 min 
and one wash in 15 ml distilled water (HPLC-grade; Amicon-Millipore) and the 
ProteinChip® allowed to air dry. Finally, 0.5 pi saturated Sinapinic Acid Energy 
Absorbing Matrix (EAM) (Ciphergen Biosystems, Inc., P/N 4003-1001) (final 
concentration 25 mg/ml in 99.8% Acetonitrile, 1.0% TEA), referred to as EAM 
solution was added to each spot and allowed to air dry, a further 0.5 pi of EAM was 
added and similarly allowed to air dry. The chip was analysed in a ProteinChip® 
Reader (series PBS II; Ciphergen Biosystems, Inc.), with the data collection 
parameters of the spot protocol adjusted for the molecular weight of the target 
antigen.
b) ProteinChip® antibody-capture analysis of biological samples
The immunological detection of the antigen of interest from crude samples derived 
from in vitro or in vivo experimental models, was achieved using the ProteinChip®
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Antibody Capture Kit (Part Number K100-0005: Ciphergen Biosystems Inc.) as per 
the manufacturer’s instructions. Briefly, 2 pi of each antibody preparation (0.2 
mg/ml Bovine IgG in PBS; Spot A, 0.2 mg/ml goat anti-human TNF-a polyclonal 
antibody in PBS; Spot B, Hybridoma supernatant (see section 2.9.1): Spots C-E, and 
Protein A purified Anti-34kDa putative serine protease monoclonal antibody (see 
section 2.9.2): Spots F-H) were added to the PG20 array (PG20 ProteinChip® Array 
are PS20 protein chip arrays coupled to Protein G; Ciphergen Biosystems, Inc.), 
transferred to a humidity chamber and incubated for 1 h at room temperature, or 
overnight at 4°C. The antibody preparation was carefully removed by pipetting from 
each spot and the array was washed once in 15 ml of a solution containing 0.5% 
Triton X-100 in PBS (referred to as Wash Buffer) for 10 min at room temperature, 
followed by 2 X 5 min washes in PBS. Antibodies were cross-linked to the array for 
30 min at room temperature in a humidity chamber in a solution containing 0.5 mg/ 
ml Bis(sulfosuccinimidyl) (BS3) in PBS, followed by deactivation of the cross 
linking reagent in 0.5 M Ethanolamine in PBS, pH 8.0. The chip array was washed 
once in Wash Buffer for 10 min at room temperature, followed by 2 x 5 min washes 
in PBS with gentle agitation. Diluted TNF-a (100 fM) in PBS was added to spots A 
and B, 2 pi of protein sample of interest (mycobacterial cell lysates: section 2.6 or 
infected OA-macrophage lysate: section 4.2.4) was added to the remaining spots and 
incubated in a humidity chamber for 1 h at room temperature or overnight at 4°C. 
The array was washed once in Wash Buffer for 10 min with agitation at room 
temperature, followed by two 5 min washes in PBS with agitation. The chip was then 
rinsed three times in 1 mM HEPES and allowed to air-dry for 10 min. Finally, 0.5 pi 
of EAM solution was added to each spot on the array and allowed to air dry, a further 
0.5 pi of EAM was added and similarly allowed to air dry. The chip was then 
analysed in a ProteinChip® reader, with the data collection parameters of the spot 
protocol adjusted for the molecular weight of the target antigen.
4.2.12 Statistical analysis
All data generated from the OA-macrophage experiments was analysed by ANOVA, 
regression analysis and Students T-test, performed using the MINITAB"^^ Statistical 
Software package Release 13.1.
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4.3 Results
4.3.1 Ex-v/v<? OA macrophage survival assay
In order to test the hypothesis that expression of the 34kDa putative serine protease 
may alter the virulence of M.smegmatis mc^l55 in phagocytic cells, a OA 
macrophage survival assay was developed. Terminally differentiated OA 
macrophages are present on the outer surface of the alveoli in the lungs of adult 
ewes, where they are easily harvested by lung lavage as described in section 4.2.1.
Initially, Qx-vivo OA macrophages were seeded in 24 well tissue culture well plates 
at a concentration of 10^  macrophages/well (see section 4.2,2). The macrophages 
were infected with M.smegmatis mc^l55 control untransformed cells and 
M.smegmatis mc^l55 harbouring the plasmid pMRI34 {M.smegmatis pMRI34 see 
section 3.3.6) using a multiplicity of infection (MOI) of 1:1 (section 4.2.3 and section 
4.2.4).
The calculated colony forming (CPU) units recovered at each time point decreased 
appreciably over the course of the experiment for each group, demonstrating that the 
Q X -vivo  OA macrophages were capable of killing substantial numbers of ingested 
mycobacteria over 48 hours in culture (Figure 4.1). The mean bacterial counts 
recovered at 24 hours post infection appeared greater for M.smegmatis pMRI34 than 
for the wild type control, although this was not statistically significant. Suggesting 
that the presence of the 34kDa putative serine protease in M.smegmatis mc^l55, 
while not completely preventing bacterial killing by the host macrophage did 
enhance bacterial survival over the first 24 hours of infection compared to 
untransformed control M.smegmatis mc^l55 (Figure 4.1). The increase in survival of 
M.smegmatis mc^l55 based on the expression of the 34kDa putative serine protease 
also was evident in a repeat experiment. However while these results were 
encouraging they were confounded by high levels of variation seen in both 
experiments between triplicate wells for each of the two strains of M.smegmatis. 
Similarly, the low numbers of organisms recovered at 48 hours post infection 
prevented any firm conclusions being made regarding the long-term affect of the 
34kDa putative serine protease on M.smegmatis survival.
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Figure 4.1 Initial experiment comparing the survival of M.smegmatis pMRI34 
(Blue) versus M.smegmatis mc^l55 (Wine) control cells in OA macrophages 
(derived from Animal A, 643G). Macrophages were seeded at a cell density o f 10  ^
cells/well and infected with either M.smegmatis pMR134 or M.smegmatis mc^l 55 
using a MOI of 1:1 (section 4.2.4). Mean values for triplicate wells are presented 
plus and minus the standard deviation.
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4.3.2 Optimisation of the ex-v/vo OA macrophage survival assay 
While the exact source of the variation was not known, several constituent 
components of the system were systematically investigated as potential sources of 
variation. Originally, 10^  macrophages were added to each well and allowed to 
adhere overnight, non-adherent cells were removed by washing as described in 
section 4.2.2. Following overnight incubation the ovine macrophages appeared as a 
densely packed monolayer. By 24 hours post infection a substantial proportion of the 
macrophages in each well were no longer viable, characterised by the loss of the 
adherent phenotype and the presence of cellular debris in the culture media, with a 
greater loss of cells observed at 48 hours. OA macrophage loss also was seen for the 
control uninfected macrophages suggesting that the observed macrophage death was 
not a result of cytotoxicity due to the presence of ingested M.smegmatis but may 
have been a function of the OA macrophage cell density prior to infection.
In an attempt to address the question of macrophage cell density affecting the long­
term viability of the macrophage cells in culture, the seeding density was lowered to 
10^  macrophages per well and the macrophages allowed to adhere overnight (section
4.2.3). Immediately prior to infection the adherent macrophage population for each 
well presented as a sub-confluent monolayer of macrophage cells with less crowding 
observed by microscopic examination of cultures. OA macrophage where then 
infected with M.smegmatis pMRI34 and M.smegmatis mc^l55 control cells with an 
MOI of 1:1 (section 4.2.4). At each experimental time point, the macrophage cultures 
were microscopically examined using a light microscope, no significant loss of 
macrophage viability was observed for experimental or control macrophage cultures. 
The recovered CFU counts for each well retained a level of variation but this 
variation was substantially lower than observed previously (Figure 4.2). No 
significant difference was observed at time 0 between the M.smegmatis pMRI34 and 
control cells (p-value = 0.463). At 24 hours post infection, a statistically significant 
increase in the number of recovered M.smegmatis pMRI34 compared to 
M.smegmatis controls is observed (p-value = 0.0124: Figure 4.2), supporting the 
earlier results (section 4.3.1) that the presence of the 34kDa putative serine protease 
increases the survival of M.smegmatis over the first 24 hours of infection. The 
number of recovered organisms at 48 hours, where no M.smegmatis control cells
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Figure 4.2 Comparison of M.smegmatis pMRI34 (Blue) and M.smegmatis me 155 
(Wine) survival in sheep ovine macrophages. OA macrophages derived from animal 
643G (Animal A) were seeded at a cell density o f 10  ^macrophages/well and infected 
with either M.smegmatis pMRI34 or M.smegmatis mc^l55 using a MOI of 1:1 
(section 4.2.4). Mean values for triplicate wells are presented plus and minus the 
standard deviation.
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were recovered, prevented any meaningful determination of the longer-term affect of 
the 34kDa putative serine protease on M.smegmatis.
A MOI of 1:1 in the earlier experiments resulted in low bacterial counts at 24 and 
particularly 48 hours, due to the high level of bactericide observed over the 
experimental time course. An increase in the MOI was examined, namely 10:1 and 
50:1, over 24 hours of infection to determine if an increase in the MOI resulted in 
increased bacterial counts at all time points. Infection with an MOI of 50:1 resulted 
in macrophage cytotoxicity as few adherent cells remained after 24 hours for both 
M.smegmatis mc^l55 and M.smegmatis pMRI34. Control uninfected macrophages 
remained viable over the same time period. No significant loss of macrophage 
viability was observed over the same time course when a MOI of 10 was used. The 
calculated CFU counts for each strain using a MOI of 10 at 0 and 24 hours post 
infection demonstrated a similar trend to the results seen with an MOI of 1:1. No 
statistically significant differences were observed at 0 hours post infection for both a 
MOI of 10 and 1 between M.smegmatis pMRI34 and M.smegmatis mc^l55. A 
significant difference in recovered CFU counts was observed between the 
recombinant M.smegmatis pMRI34 and M.smegmatis mc^l55 strains at 24 hours (p- 
value = 0.028) using a MOI of 10 (p-value = 0.028) and 1 (p-value = 0.012) (Figure
4.3 and Figure 4.4).
Another important consideration in the optimisation of the OA macrophage survival 
assay was variation in experimental results dependant on the animal from which the 
OA macrophages were harvested. In an attempt to address whether or not the source 
of OA macrophages affected the observed trends, identical experiments comparing 
different MOI as described above were conducted in OA macrophages derived from 
a second source (Animal B; 1148G). A MOI of 50:1 resulted in a substantial loss of 
macrophage cell viability for both M.smegmatis pMRI34 and M.smegmatis mc^l55. 
Greater numbers of both M.smegmatis pMRI34 and M.smegmatis were recovered 
from the OA macrophages derived from Animal B at all time points using both a 
MOI of 1:1 and 10:1 than observed with OA macrophages derived from Animal A 
(Figure 4.5 and 4.6). This did not appear to affect the overall trend of decreased 
mortality for M.smegmatis pMRI34, a significant difference in recovered CFU
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Figure 4.3 Comparison of M.smegmatis pMRI34 (Blue) and M.smegmatis me 155 
(Wine) survival in OA macrophages. OA macrophages derived from animal 643G 
(Animal A) were seeded at a cell density of 10  ^ macrophages/well and infected with 
either M.smegmatis pMRI34 or M.smegmatis mc^l55 using a MOI of 1:1 (section
4.2.4). Mean values for triplicate wells are presented plus and minus the standard 
deviation.
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Figure 4.4 Comparison of M.smegmatis pMRI34 (Blue) and M.smegmatis me 155 
(Wine) survival in OA macrophages. OA macrophages derived from animal 643G 
(Animal A) were seeded at a cell density of 10^  macrophages/well and infected with 
either M.smegmatis pMR134 or M.smegmatis mc^l55 using a MOI of 10:1 (section
4.2.4). Mean values for triplicate wells are presented plus and minus the standard 
deviation.
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Figure 4.5 Comparison of M.smegmatis pMRI34 (Blue) and M.smegmatis me 155 
(Wine) survival in OA macrophages. OA macrophages derived from animal 1148G 
(Animal B1 were seeded at a cell density of 10^  macrophages/well and infected with 
either M.smegmatis pMRI34 or M.smegmatis mc^l55 using a MOI of 1:1 (section
4.2.4). Mean values for triplicate wells are presented plus and minus the standard 
deviation.
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Figure 4.6 Comparison of M.smegmatis pMRI34 (Blue) and M.smegmatis me 155 
(Wine) survival in OA macrophages. OA macrophages derived from animal 1148G 
(Animal B) were seeded at a cell density of 10^  macrophages/well and infected with 
either M.smegmatis pMRI34 or M.smegmatis mc^l55 using a MOI of 10:1 (section
4.2.4). Mean values for triplicate wells are presented plus and minus the standard 
deviation.
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counts was observed between M.smegmatis pMRI34 and wild-type M.smegmatis 
mc^l55 strains at 24 hours post infection using a MOI of 10 (p-value = 0.007) and 1 
(p-value = 0.023). No statistical differences were observed between the two strains at 
0 hours post infection.
M.smegmatis pMRI34 recovered from macrophages were grown on 7H11S media 
supplemented with and without kanamycin with no difference in the calculated CFU 
observed, suggesting that kanamycin is not required for plasmid stability in vitro. 
The antibiotic Gentamicin (final concentration 50pg/ml) was included in the post 
infection media to prevent growth of bacteria prematurely released from 
macrophages during the course of infection. It remained possible that any increase in 
survival observed for M.smegmatis pMRI34 was as a result of increased resistance to 
gentamicin. M.smegmatis pMRI34 and M.smegmatis control cells were grown in 
complete OA-RPMI culture media supplemented with 50, 5 or 0.5pg/ml gentamicin. 
In comparison to wild type M.smegmatis, M.smegmatis pMRI34 exhibited no 
increased resistance to gentamicin at any of the concentrations tested.
4.3.3 Survival of M.smegmatis pMRI34 in ex-vivo OA macrophages
Having established a more robust OA macrophage survival assay the effect of the 
34kDa putative serine protease on M.smegmatis mc^l55 could be more accurately 
determined. It was considered that wild-type M.smegmatis mc^l55 was not a 
sufficiently representative control for M.smegmatis pMRI34. The increased survival 
for M.smegmatis pMRI34 might be due to the expression of a non-endogenous gene 
in M.smegmatis, irrespective of what that gene encoded, and would not represent an 
affect of the presence of the 34kDa putative serine protease. Similarly the 
electroporation and subsequent antibiotic selection of recombinant M.smegmatis 
mc^l55 may have altered the microbe sufficiently to account for any observed 
intracellular increase in survival. Experiments were conducted comparing infection 
of OA macrophages between wild type M.smegmatis mc^l55, M.smegmatis pMRI34 
and M.smegmatis pMRI107. M.smegmatis pMRI107 harbours a similar plasmid to 
that in M.smegmatis pMRI34, except that pMRI107 expresses a mutant form of the 
Aequorea victoria GFP protein, namely E-GFP, under the transcriptional and 
translational control of the hsp60 promoter (Appendix 2 and section 3.3.4c).
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OA macrophages (10  ^macrophages/well) derived from Animal A were infected with 
untransformed M.smegmatis mc^l55, M.smegmatis pMRI34 and M.smegmatis 
pMRIlO? with an MOI of 10 (section 4.2.4). The experiment was repeated at total of 
three times on different days with the results presented as the mean values for the 
triplicate wells in triplicate experiments. A consistent reduction in the recovered 
CFU for all strains was observed over the course of infection, particularly at the later 
time points, with few bacteria recovered for all strains. In order to facilitate a greater 
comparison between the various strains over time, the calculated CFU, which 
followed a normal distribution, were normalised using a logarithmic transformation. 
It can be seen from the interaction plot (Figure 4.7) that the calculated mean counts 
for M.smegmatis mc^l55 and M.smegmatis pMRI107 are higher at time 0 than 
M.smegmatis pMRI34 but have become lower by 24 hours and remain so until the 
end of the experiment. From 24 hours onwards the relationship between the 
calculated counts (expressed on a logarithmic scale) and time is approximately linear 
(Figure 4.7). A regression analysis (see section 4.2.12) confirmed that the estimated 
slope of each linear relationship was similar after 24 hours for both M.smegmatis 
pMRI34 and M.smegmatis pMR107:
M.smegmatis (pMRI34) = (-0.05995) +/- 0.007091 
M.smegmatis (pMRI107) = (-0.05369) +/- 0.006275 
(p-value = 0.258764; see section 4.2.12)
In this case the slope of the line represents the rate at which the internalised 
mycobacteria are being killed over the experimental time period examined, reflected 
in the magnitude and negativity of the returned value in each case. The rate of 
mortality was slightly different for M.smegmatis mc^l55, although the low numbers 
of organisms recovered at 72 hours post infection may have led to an overall skew in 
the mortality rate for that strain. The main difference in the behaviour of the three 
strains appeared to be during the first 24 hours post infection (Figure 4.7). The data 
for the first 24 hours of the infection was re-analysed, in an attempt to determine the 
exact nature of the observed trend. Regression analysis again was utilised to estimate
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Figure 4.7 Comparison of M.smegmatis pMRI34 (Purple), M.smegmatis pMRI107 
(Yellow) and M.smegmatis mc^l55 (Pink) survival in OA macrophages. OA 
macrophages (10  ^ cells/well) were infected with M.smegmatis pMR134, 
M.smegmatis pMRI107 or M.smegmatis mc^l55 as described in section 4.2.4. 
Surviving bacteria were recovered at 0, 24, 48 and 72 hr post infection. The mean 
values for triplicate experiments are presented plus and minus the standard deviation.
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the slope of the linear relationship between the mean counts for the total data set of 
three experiments (on a logarithmic scale) and time for each group;
Sample Estimated slope Standard error
M.smegmatis pMRI34 -0.059 0.0076
M.smegmatis pMRIlO? -0.097 0.0077
M. smegmatis mc  ^155 -0.096 0.0099
A statistically significant difference between M.smegmatis pMRI34 and both 
M.smegmatis pMRIlO? (p-value = 0.0043) and M.smegmatis mc^l55 (p-value = 
0.0013) was seen in the rate of mortality over the first 24 hours of infection. No 
difference was seen between M.smegmatis mc^l55 and M.smegmatis pMRIlO? (p- 
value = 0.4604). An approximately 1.6 reduction in the mortality rate was observed 
for M.smegmatis pMRI34 over both M.smegmatis mc^l55 and M.smegmatis 
pMRIlO? controls for the first 24 hours post infection.
Analysis of variance (ANOVA) on the total data for the mean counts for three 
experiments (on a logarithmic scale) revealed a significant level of variation across 
experiments for each strain. To demonstrate whether or not the observed trend was 
consistent each experiment was analysed separately. A regression analysis was used 
to estimate the rate of mortality for each strain in each experiment. The results are 
presented in Table 4.1 (a) and (b), as can be seen in Table 4 (b) a statistically 
significant difference in the rate of mortality is maintained between M.smegmatis 
pMRI34 and both M.smegmatis pMRIlO? and M.smegmatis mc^l55 for each 
experiment. No significant difference was seen between the control groups in each 
experiment. Therefore, the experimental variation may be explained as a 
consequence of different CPU counts for each experiment, with each experiment 
retaining the observed trend of increased survival for M.smegmatis pMRI34.
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Strain Experiment number Estimated slopes Standard Error
M.smegmatis pMRI34 Experiment 1 -0.047 0.011
M.smegmatis pMRIlO? Experiment 1 -0.095 0.012
M. smegmatis mc  ^155 Experiment 1 -0.082 0.013
M.smegmatis pMRI34 Experiment 2 -0.077 0.013
M.smegmatis pMRIlO? Experiment 2 -0.118 0.014
M. smegmatis mc  ^155 Experiment 2 -0.126 0.021
M.smegmatis pMRI34 Experiment 3 -0.042 0.008
M.smegmatis pMRIlO? Experiment 3 -0.079 0.010
M.smegmatis me? 155 Experiment 3 -0.080 0.008
Table 4.1(a) Rate of mortality for M.smegmatis pMRI34, M.smegmatis mc^l55 and 
M.smegmatis pMRIlO? over the first 24 hours in OA macrophages. Regression 
analysis (section 4.2.12) was used to calculate the slope of the linear relationship 
between recovered CFU (logarithmic scale) and time over the first 24 hours of 
infection for each strain in each experiment.
1 1 0
Two way statistical comparisons Experiment T-value P-value
M.smegmatis A!M.smegmatis mc^l55 Experiment 1 3.003 0.0149
M.smegmatis A!M.smegmatis pMRI107 Experiment 1 2.082 0.0459
M.smegmatisme? 155!M.smegmatis pMRIl07 Experiment 1 0.715 0.2530
M.smegmatis A!M.smegmatis mc^l55 Experiment 2 2.245 0.0373
M.smegmatis A!M.smegmatis pMRI107 Experiment 2 2.025 0.0493
M.smegmatis me? 155!M.smegmatis pMRI107 Experiment 2 0.332 0.3764
M.smegmatis A!M.smegmatis mc^l55 Experiment 3 2.871 0.0174
M.smegmatis A!M.smegmatis pMRI107 Experiment 3 3.378 0.0098
M.smegmatis me?\55!M.smegmatis pMRI107 Experiment 3 0.074 0.4717
Table 4.1(b) Two-way statistical comparison of the difference in mortality rate 
(slope) over 24 hours between the different strains in three experiments. Regression 
analysis (section 4.2.12) was used to calculate the slope of the linear relationship 
between recovered CFU (logarithmic scale) and time over the first 24 hours of 
infection for each strain in each experiment (Table 4.1b).
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The decreased rate of mortality observed for M.smegmatis pMRI34 is reflected 
further in an observed increase in the percentage surviving bacilli after 24 hours of 
infection, calculated on the same data as previously analysed. A significant 
difference in the percentage of bacteria surviving after at 24 hours between 
M.smegmatis pMRI34 and M.smegmatis mc^l55 (p-value=0.035) and M.smegmatis 
pMRIlO? (p-value=0.042) was observed, with no difference observed between the 
two control groups after 24 hours (p-value = 0.11) (Figure 4.8). A greater percentage 
of M.smegmatis pMRI34 appeared to be surviving at 48 and 72 hours post infection 
in comparison to controls, although no statistically significant differences were 
observed between any of the groups at these time points.
4.3.4 Survival of M.smegmatis pMRIus34-I iu ex-v/vo OA macrophages
Another important consideration in the interpretation of the results was the use of the 
promoter driving the expression of the 34kDa putative serine protease in 
M.smegmatis. The hsp60 promoter has been demonstrated to exhibit high levels of 
constitutive expression both in culture and in vitro within cultured macrophages 
(Dellagostin et a/., 1995). There was a possibility that the observed increase in 
survival may have been the result of over-expression of the gene from the hsp60 
promoter on a multi-copy number plasmid and not a property of the expressed 
protein itself. Chapter 5 describes the identification of a functional promoter in the 
upstream region of the 34kDa putative serine protease that is capable of expressing 
the gene from a mycobacterial shuttle plasmid (pMRIus341) in M.smegmatis mc^l55 
{M.smegmatis pMRIus341 see section 5.3.4).
In order to test whether or not the choice of promoter used to express the 34kDa 
putative serine protease in M.smegmatis exerted an important influence on the 
observed increase in survival for M.smegmatis pMRI34, the survival of M.smegmatis 
pMRI34 was compared to M.smegmatis pMRIus34 I in OA macrophages. OA 
macrophages were infected with M.smegmatis pMRI34, M.smegmatis pMRIus34 I 
and the control strain M.smegmatis pMRI104 (section 3.3.4a) containing an empty 
plasmid construct as described in section 4.2.1 - 4.2.4. The percentage bacteria 
surviving at each time point was calculated based on the mean CFU counts for two 
independent experiments as a function of the total count calculated at time 0.
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Figure 4.8 Survival of M.smegmatis pMRI34 (Blue), M.smegmatis mc^l55 (Wine) 
and M.smegmatis pMRI107 (Yellow) in OA macrophages. OA macrophages (10  ^
macrophages/well) were infected with M.smegmatis pMRI34, M.smegmatis 
pMRI107 and M.smegmatis mc^l55 as described in section 4.2.4. Percent survival at 
a given time was calculated by dividing the number of CFU recovered at that time by 
the number of CFU recovered at time zero and multiplying by 100. Error bars 
represent the standard error of the means for three replicate cultures.
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Concordant with earlier findings, a statistically significant difference in percentage 
survival at 24 hours was observed between M.smegmatis pMRI34 and M.smegmatis 
pMRI104 (p-value = 0.012). A similar increase in percentage survival was observed 
fox  M.smegmatis pMRIus34 I o y g x  M.smegmatis pMRI104 (p-value = 0.027) (Figure
4.9). However, no difference was observed between M.smegmatis pMRI34 and 
M.smegmatis pMRIus34 I (p-value = 0.22) at 24 hours. At 48 and 72 hours post 
infection, no significant difference in the percentage-survival for any of the strains is 
observed (Figure 4.9). Therefore the increase in survival observed in for 
M.smegmatis pMRI34 in section 4.3.3 appears to be independent of the promoter 
used to drive expression as a similar increase in intracellular survival is seen for 
M.smegmatis pMRIus34 I, expressing the 34kDa putative serine protease from the 
endogenous upstream promoter.
4.3.5 Demonstration of the presence of the 34kDa putative serine protease in 
infected ex-v/vo OA macrophages
a) Immuno-fluorescent microscopy and Immuno-Electron microscopy 
(Immuno-EM)
The results of the macrophage survival studies suggested that the presence of the 
34kDa putative serine protease increased the survival of M.smegmatis in OA 
macrophages, as such it was important to confirm the presence of the potentially 
secreted 34kDa putative serine protease in infected macrophages. In an attempt to 
demonstrate this, immuno-fiuorescence staining was performed on J774A.1 
macrophages infected with M.smegmatis pMRI34, M.smegmatis pMRI104 and 
M.a.paratuberculosis (see section 4.2.5 - 4.2.8), and samples prepared for Immuno­
fluorescence microscopy as described in section 4.2.9. In two separate experiments 
fluorescent microscopy revealed no specific staining for the 34kDa putative serine 
protease above background levels using the hybridoma supernatant (see section
2.2.9) as the primary antibody, in macrophages infected with M.smegmatis pMRI34 
at all experimental time points. The relative abundance of the protein in the infected 
macrophage samples was unknown and as a result any weak specific staining for the 
34kDa putative serine protease may have been masked by the high level of
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Figure 4.9 Survival of M.smegmatis in OA macrophages expressing the 34kDa 
putative serine protease under the transcriptional control of the hsp60 promoter or a 
promoter located in the upstream region of the 34kDa putative serine protease in 
M.a.paratuberculosis compared to M.smegmatis pMRI104 plasmid control. Ovine 
macrophages were infected with M.smegmatis pMRIus34 I (Blue), M.smegmatis 
pMRI34 (Wine) and M.smegmatis pMRI104 (Yellow) as described in section 4.2.4. 
Percentage survival at a given time was calculated by dividing the number of CFU 
recovered at that time by the number of CFU recovered at time zero and multiplying 
by 100. Error bars represent the standard error of the mean for two replicate 
experiments.
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background staining observed for all samples, including uninfected controls. In an 
attempt to address this, the MOI was increased to 25:1, resulting in an increased 
number of ingested mycobacteria (as viewed by microscopic analysis of infected 
macrophages) and potentially the level of protein available for detection in infected 
macrophages. However, no specific staining was observed using an increased MOI 
for macrophages infected with M.smegmatis pMRI34 compared to controls. The 
level of antibody present in the hybridoma supernatant may have been too weak to 
detect the protein. Therefore the experiment was repeated and the J774A.1 
macrophage samples were probed with the Protein A purified 34kDa putative serine 
protease specific monoclonal antibody (see section 2.2.9), with again no specific 
staining observed. Throughout all experiments no 34kDa putative serine protease 
antibody staining was observed for the J774A.1 macrophages containing 
M. a.paratuberculosis.
In a final attempt to demonstrate the presence of the 34kDa putative serine protease 
in situ, immuno-EM analysis was conducted on infected J774A.1 macrophages. 
J774A.1 macrophages were prepared and infected as described in sections 4.2.5 to 
4.2.8, and samples were prepared for Immuno-EM at 0, 24 and 48 hr post infection 
as described in section 4.2.10. Figure 4.10 and Figure 4.11 show the presence of 
ingested M.smegmatis pMRI34 at 24 and 48 hr post infection. However, despite the 
presence of intact M.smegmatis pMRI34 at both time points, immuno-EM analysis 
using the purified 34kDa putative serine protease specific monoclonal antibody as 
the primary antibody, failed to demonstrate the presence of the 34kDa putative serine 
protease in J774A.1 macrophages infected with M.smegmatis pMRI34 or 
M. a.paratuberculosis.
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VFigure 4.10 Intracellular localisation of M.smegmatis pMRI34 in J774 macrophages 
J774A.1 were infected with M.smegmatis pMRI34 and transmission electron 
microscope (TEM) pictures taken after 24 hr. Degraded material is indicated by stars, 
bacteria are indicated by arrows. Bar = 2 pm.
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Figure 4.11 Intracellular localisation of M.smegmatis pMRI34 in J774 macrophages 
J774A.1 were infected with M.smegmatis pMRI34 and a TEM picture taken after 48 
hr. Degraded material is indicated by stars, bacteria are indicated by arrows. Bar = 2 
pm.
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b) ProteinChip analysis of biological samples
Results presented above had failed to demonstrate the presence of the 34kDa putative 
serine protease in infected macrophages. Ciphergen Biosystems Inc. ProteinChip® 
technology allows the constitutive protein components of an in vitro or in vivo 
sample to be determined. Initially, mycobacterial lysates of M.smegmatis pMRI34, 
M.smegmatis pMRIus34 I and M.smegmatis pMRI104 (see section 2.2.7) were 
prepared and analysed on a ProteinChip® reader (Ciphergen Biosystems, Inc.) as 
described in section 4.2.11-1. As can be seen in Figure 4.12, no unique protein was 
detected at the appropriate molecular weight for M.smegmatis pMRI34 or 
M.smegmatis pMRIus34 I lysates in comparison to control M.smegmatis pMRI104 
lysates. This was in spite of the fact that the 34kDa putative serine protease was 
detected by western immunoblotting, (see section 2.2.10) in both M.smegmatis 
pMRI34 and M.smegmatis pMRIus34 I lysate samples. Similar results were observed 
when macrophage lysates prepared at 0 hours post infection from OA macrophages 
infected with M.smegmatis pMRI34, M.smegmatis pMRIus34 I or M.smegmatis 
pMRI104 (see section 4.2.4) were tested for the presence of a specific 34kDa protein 
signature. The results presented in Figure 4.12 show the data range 20^0  kDa, no 
unique proteins were detected in M.smegmatis pMRI34 samples over the molecular 
weight range examined, namely 15-100 kDa.
The possibility existed that the amount of 34kDa putative serine protease present in 
all these samples was insufficient to allow detection above background protein levels 
in the samples tested. In order to address this, a ProteinChip® Antibody Capture Kit 
was used to analyse not only infected macrophage lysates but also mycobacterial 
lysates for the presence of the 34kDa putative serine protease as described in section 
4.2.11. The primary antibody used was both hybridoma supernatant and also the 
purified 34kDa putative serine protease specific monoclonal antibody. The same set 
of samples was analysed with each primary antibody, namely OA-macrophage 
lysates infected with M.smegmatis pMRI34, M.smegmatis pMRIus34-I or 
M.smegmatis pMRI104 (see section 4.2.4) and mycobacterial lysates prepared from 
M.smegmatis pMRI34, M.smegmatis pMRIus34-I and M.smegmatis pMRI104, (see 
section 2.2.4). Upon analysis using the ProteinChip® reader, no unique protein was 
detected at the appropriate molecular weight for either macrophage lysates infected
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with M.smegmatis pMRI34 over M.smegmatis pMRI104 samples or mycobacterial 
lysates derived from the same strains (Figure 4.13).
Finally, macrophage lysates prepared from OA-macrophage infected with 
M.smegmatis pMRI34, M.smegmatis pMRIus34-I and M.smegmatis pMRI104 (see 
section 4.2.4) were analysed for the presence of the 34kDa putative serine protease at 
0 and 24 hours post infection using Western immunoblotting (see section 2.2.10). No 
34kDa putative serine protease specific band was detected in any of the samples at 
any time points (results not shown). The positive control sample, M.smegmatis 
pMRI34 lysate, was positive for the presence of the 34kDa putative serine protease 
on the same blot with M.smegmatis pMRI104 lysate negative. This remained the case 
even when the approximately 1ml of macrophage lysate was concentrated to lOOpl 
using a 10,000 molecular weight cut off spin column (Amicon-Millipore) as per the 
manufacturer’s instructions.
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Figure 4.12 ProteinChip” analysis of the mycobacterial cell lysates prepared from 
cultures of M.smegmatis pMRI34, M.smegmatis pMRIus34-I, M.smegmatis 
pMRI104, as described in section 4.2.11-1. Presented is the range of proteins 
detected following excitation for the range 20,000 to 40,000 kDa. MYO represents 
the control protein sample, namely purified myoglobin
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Figure 4.13 ProteinChip® Antibody capture analysis of OA-macrophage lysates, 
prepared at time 0, infected with M.smegmatis pMRI34, M.smegmatis pMRIus34-l 
or M.smegmatis pMRI104, as described in section 4.2.11-2. Presented is the range of 
proteins detected following excitation for the range 20,000 to 40,000 kDa.
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4.4 Discussion
The primary stage in infection of the host by mycobacteria, including 
M.a.paratuberculosis, consists of infection, persistence and replication of the 
microbe in the hostile environment of the host macrophage. To achieve this 
pathogenic Mycobacterium species have the ability to withstand the bactericidal 
mechanisms of the host by altering the normal processing of the phagosomes where 
they reside and replicate. The 34kDa putative serine protease is expressed in vivo by 
M.a.paratuberculosis and demonstrates homology to the HtrA family of bacterial 
serine proteases (Cameron et al, 1994). Several intracellular pathogenic bacterial 
strains harbouring defined mutations in the htrA gene have been shown to exhibit 
decreased survival in macrophage models (Baumler et al, 1994; Elzer et al, 1996; 
Yamamoto et al, 1996; Pedersen et al, 2001). As such the work in this chapter 
attempted to answer the question of what affect expression of the 34kDa putative 
serine protease would have on the intracellular survival of the M.smegmatis mc^l55 
in host macrophages.
To achieve this a reliable and robust macrophage survival assay was required. OA- 
macrophages were chosen as these cells represented a good in vitro approximation to 
the environment encountered by M.a.paratuberculosis during the course of natural 
infection. It was noted that such in vitro systems possibly do not reflect the dynamic 
process of natural infection where the recruitment and interaction with other cells of 
the host immune response may alter the environment within the macrophage. It was 
thought that the use of ex-vivo OA macrophages would represent as accurate a model 
as possible in determining the intracellular fate of recombinant and wild-type 
M.smegmatis mc^l55. The macrophages also represent a uniform population, as only 
terminally differentiated macrophages will be present on the outside of the alveoli, 
where they can be easily harvested by lavage.
The optimisation of the OA-macrophage assay served to reduce the overall variation 
observed in the initial experiments both within and between repeat experiments. 
Several parameters were analysed as potential sources of variation. Firstly, the 
plating density of the macrophages prior to adherence appeared to have an affect on 
the number of surviving macrophages at later time points post infection. As cell
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morbidity also was observed in uninfected macrophage controls, the loss of 
macrophage viability was attributed to the density of the resulting macrophage 
monolayer following overnight adherence. While a low level of macrophage death in 
culture was expected over the course of the infection, such a substantial loss of 
potentially infected macrophages suggested that the counts taken at later time points 
were not an accurate reflection of the number of bacteria present after ingestion of 
the mycobacteria had taken place. A reduction in the plating density of the 
macrophages appeared to abrogate this affect, resulting in substantially less 
macrophage morbidity in culture over the experimental time course. A MOI of 10 
mycobacteria was adopted as it resulted in higher recovered counts at later time 
points, in comparison to a MOI of 1. This facilitated a more accurate count of the 
number of bacteria surviving at later time points post infection. However, the 
recovered CFU at 72 hours post infection were consistently very low for all 
mycobacterial strains.
Immediately following infection the number of bacteria recovered from the OA 
macrophages was consistently lower for M.smegmatis pMRI34 than for M.smegmatis 
pMRIlO? and M.smegmatis mc^l55. The greater number of bacilli present following 
ingestion may have led to increased macrophage activation resulting in a 
corresponding increase in the ability of the macrophage to kill the internalised 
mycobacteria. Under this hypothesis the decrease in mortality rate observed for 
M.smegmatis pMRI34 is a result not of expression of the 34kDa putative serine 
protease in M.smegmatis, but rather an increase in the number of both control 
M.smegmatis strains being killed over the same time period due to an increase in the 
activation of the macrophages. However on average the calculated counts for 
M.smegmatis pMRIlO? are higher than M.smegmatis mc^l55 at 0 hours post 
infection, with no difference in the mortality rate observed between these groups. 
Similarly, a closer examination of the individual experiments revealed that a similar 
level of variation existed between the recovered CFU counts for the control groups at 
0 hours post infection. For example, in experiment three the calculated counts for 
M.smegmatis mc^l55 were similar to those for M.smegmatis pMRI34 (Figure 4.14) 
at time 0, with higher calculated counts for M.smegmatis pMRIlOT. The rate of 
mortality was significantly different between M.smegmatis pMRI34 and both
124
M.smegmatis mc^l55 and M.smegmatis pMRIlO? in this experiment, Table 4.1 (a) 
and (b). No difference in mortality rate was observed for the controls, despite the 
differences between the calculated CFU counts at time 0. This argues that the 
observed affect of the presence of the 34kDa antigen is not due to the lower counts 
observed for M.smegmatis pMRI34 at time 0.
While numerous attempts were made to demonstrate the presence of the 34kDa 
putative serine protease in M.smegmatis pMRI34 infected macrophages all proved 
ultimately unsuccessful. The monoclonal antibody used for all these experiments was 
raised against the C-terminal portion of the protein and as such the specific epitope 
recognised by the monoclonal antibody may be masked or inaccessible in the native 
form of the protein. This may explain why no specific staining was seen in the 
immuno-fiuorescence, immuno-EM experiments, and also in ProteinChip® antibody 
capture. The failure to detect the native protein in macrophages infected with 
M.a.paratuberculosis supports the idea that the monoclonal antibody does not detect 
the protein in its native state. ProteinChip® analysis of mycobacterial lysates and 
infected OA-macrophage lysates also failed to demonstrate the presence of a specific 
protein of the appropriate size. The number of different proteins observed at 
approximately 30-36 kDa in all mycobacterial samples may have “masked” the 
presence of the 34kDa putative serine protease in those samples expressing the 
protein. E.coli HtrA has been shown to form a multimeric structure, the possibility 
therefore existed that in the native state the 34kDa putative serine protease existed in 
a similar multimeric form. However an examination of the broader molecular weight 
parameters selected in the ProteinChip® reader, failed to identify any unique protein 
in samples expressing the 34kDa putative serine protease. The monoclonal antibody 
remains a reliable indicator of the presence of the protein in western blots conducted 
under denaturing conditions. However large quantities of protein are required for 
detection, such as those present in the mycobacterial lysates. The protein was not 
detected on a blot of a V io o  dilution of an M.smegmatis pMRI34 lysate. As the 34kDa 
putative serine protease undergoes auto-degradation, insufficient amounts of protein 
may be present in the macrophage lysates to be detected by this method. The use of a 
polyclonal antibody against the native 34kDa putative serine protease may prove 
more successful in detecting the protein in macrophages.
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Figure 4.14 Comparison of M.smegmatis pMRI34 (Blue), M.smegmatis pMRIlOT 
(Purple) and M.smegmatis mc^l55 (Yellow) survival in OA macrophages 
(Experiment No. 3). OA macrophages (10^ macrophages/well) were infected with 
M.smegmatis pMRI34, M.smegmatis pMRIlO? or M.smegmatis mc^l55 as described 
in seetions 4.2.4. The mean values for triplicate wells (presented on a logarithmic 
scale) are presented plus and minus the standard deviation.
126
M.smegmatis pMRI34 demonstrated an approximate 1.6-fold increase in survival in 
comparison to controls during the first 24 hours of infection. While the macrophages 
retained the ability to kill the ingested microbe, a significant decrease in the rate of 
mortality was seen for M.smegmatis pMRI34 over the first 24 hours of infection. The 
expression of the GFP protein in M.smegmatis mc^l55 had no affect on the ability of 
the microbe to survive suggesting that the expression of a non-endogenous gene 
alone does not alter the survival of M.smegmatis mc^l55 in macrophages. Expression 
of the 34kDa putative serine protease appeared to have no affect on the long-term 
survival of M.smegmatis mc^l55 as there was no significant difference in the rate of 
mortality from 24 hours onwards between the different strains. This argues that the 
protective function of the 34kDa putative serine protease is active during the initial 
stages following ingestion of M.smegmatis. A similar level of increased survival was 
also observed when the 34kDa putative serine protease was expressed firom the 
putative endogenous promoter in M.smegmatis mc^l55, demonstrating that the gene 
is transcriptionaly active in vitro. However, it remains unknown whether or not the 
34kDa putative serine protease promoter undergoes specific up-regulation in the 
macrophage and whether the identified promoter region is active in 
M.a.paratuberculosis. The use of the 34kDa putative serine protease promoter does 
demonstrate that the observed affect on M.smegmatis survival appears to be 
independent of the promoter used to drive expression.
The proposed function of HtrA-like proteins in several bacterial species is the 
degradation of mis-folded or damaged proteins following stress conditions, such as 
heat shock and oxidative stress in E.coli (Lipinska et a l, 1990; Fallen and Wren, 
1997; Skorko-Glonek et al, 1999) and oxidative stress in S.typhimurium and 
Y.enterocolitica (Johnson et a l, 1991; Williams et a l, 2000). While the exact role 
that HtrA plays in the virulence of pathogenic mycobacteria remains unknown, it is 
thought that its function is to prevent the aggregation of damaged proteins in the 
periplasm of the cell caused by the actions of the bactericidal mechanisms of the host 
macrophage following ingestion of the microbes (Fallen and Wren, 1997). 
Macrophages have been demonstrated to undergo an oxidative burst following 
ingestion of mycobacteria (van Furth, 1990; Rastogi, 1990; Eisenstein et a l, 1994; 
Gordon et a l, 1995), followed by the acidification of the phagosome (Schaible et a l.
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1998). The possibility therefore exists that the 34kDa putative serine protease confers 
on M.smegmatis an increased ability to withstand the early bactericidal mechanisms 
of the host cell, such as protecting the microbe from the affects of reactive oxygen 
intermediates (ROI) or the acidification of the phagosome. However the results 
would also suggest that the presence of the gene does not alter the maturation of the 
phagosome as the presence of the gene has no affect on the survival of M.smegmatis 
after 24 hours. Other mechanisms of the host cell, such as the phago-lysosome fusion 
may be responsible for killing the ingested mycobacteria, with the presence of the 
34kDa putative serine protease having no affect on this maturation process.
In E.coli there are two HtrA paralogues, one of which DegQ is thought to be 
housekeeping gene (Bass et a l, 1996), with a similar function to DegP (HtrA) itself, 
responsible for the degradation of abnormal proteins. The other paralogue, DegS, has 
recently been demonstrated to regulate the activity of the alternative E.coli sigma 
factor, (Alba et a l, 2001). Miller et al demonstrated that expression of a HtrA 
homologue, annotated as HtrA in the TUBERCULIST web site, failed to increase the 
survival of M.smegmatis in macrophages (Miller and Shinnick, 2000). In these 
studies expression of another mycobacterial HtrA homologue the 
M.a.paratuberculosis 34kDa putative serine protease does increase the survival of 
M.smegmatis in macrophages. The possibility that the 34kDa putative serine protease 
is acting as a potential regulator of an alternative sigma factor, possibly regulating 
stress response genes required for intracellular survival is intriquing and merits 
further investigation.
Similar studies using M.smegmatis recombinants and/or mutants have implicated 
numerous M. tuberculosis, M. leprae and M.avium genes in intracellular survival. Wei 
et al demonstrated that M.smegmatis expressing the M.tuberculosis eis (enhanced 
intracellular survival) gene of unknown function on a multicopy number plasmid 
exhibited a 2.4 and 5.3 fold increase in survival over controls M.smegmatis cells at 
24 and 48 hours post infection (Wei et a l, 2000). The 42kDa Eis protein has been 
shown to be cell wall associated and is also released into the extracellular media. 
Miller et al used a co-infection assay to demonstrate enhanced survival for 
M.smegmatis mc^l55 expressing the M.tuberculosis genes Rv2962c and Rv2958c
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(probable glucuronsyl transferases), Rv2220 (glutamine synthetase Al, a secreted 
gene in M.tuberculosis), Rv0365 and Rv2235 (hypothetical proteins of unknown 
function) (Miller and Shinnick, 2000). Wieles et al demonstrated that expression of 
the M.leprae thioredoxin-thioredoxin reductase (Tr-Trx) gene enhanced the 
intracellular survival of M.smegmatis in human mononuclear monocytes (Wieles et 
al, 1997). By screening insertional mutants of M.smegmatis, Lagier et al isolated 8 
mutants with impaired ability to survive in human peripheral blood monocyte- 
derived macrophages and identified the M.tuberculosis gene corresponding to the 
mutated M.smegmatis gene for five of them (Lagier et a l, 1998). The genes 
included: Rv3052c (probable nrdl) which is postulated to be involved in 
deoxynucleotide production under stressed conditions; RvOlOl which is a 
nonribosomal peptide synthetase that displays a strong homology with a 
Pseudomonas nonribosomal peptide required for the synthesis of the pyoveridine, a 
siderophore involved in iron uptake; Rv3420c which displays homology with the S18 
ribosomal protein acetyltransferase which behaves as a heat shock protein in 
Chlamydia trachomatis', and Rv0497 and Rv3604c which are hypothetical conserved 
membrane proteins of unknown function. Expression of the M.avium pH inducible 
early secreted mig gene has also been demonstrated to confer an increased resistance 
to intracellular killing 2 days after infection (Plum et a l, 1997).
It has been noted by several of the above authors that the expression of genes derived 
from pathogenic strains confers only a limited enhancement in survival on 
M.smegmatis in macrophages (Lagier et al, 1998; Wei et al, 2000; Miller and 
Shinnick, 2000). This is consistent with the observations presented in this chapter, 
with a limited enhancement seen for the presence of the 34kDa putative serine 
protease. Several of the identified genes are either secreted or stress response genes. 
Again this is consistent with the observations presented here. The initial resistance to 
killing by macrophages following ingestion represents a subset of the overall 
pathway leading to mycobacterial persistence and replication in macrophages. Taken 
collectively the results fi*om these and other studies reaffirm the idea that pathogenic 
mycobacterial species require numerous different gene products co-ordinately 
regulated to survive and persist in the changing environment of the host cell. As such 
single genes would not be expected to greatly increase the virulence of a non-
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pathogenic mycobacterial strain. However they may offer sufficient protection in 
M.smegmatis mc^l55 to be measured, as is the case in these and other studies.
The interaction of the host and pathogen is a dynamic process and probably requires 
numerous mycobacterial gene products to maintain parity with the host bactericidal 
mechanisms and ultimately survive. A consistent trend of increased survival for 
M.smegmatis mc^l55 expressing the 34kDa putative serine protease was observed 
over wild type and recombinant controls during the initial stages post phagocytosis. 
Further experiments, primarily examining intermediate time points between 0 and 24 
hours post infection may facilitate a greater understanding of the precise extent of 
this survival. Similarly, definitive evidence for a virulence associated role for the 
34kDa putative serine protease would only be ascertained by the generation of a 
knock-out mutant oî M.a.paratuberculosis and the determination of the intracellular 
survival of the mutant strain compared to wild type.
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CHAPTER 5
IDENTIFICATION AND CHARACTERISATION OF PUTATIVE 
PROMOTER ELEMENTS IN THE UPSTREAM REGION OF 
THE M,a.paratuberculosis 34\iD^ PUTATIVE SERINE PROTEASE 
ORE
5.1 Introduction
Pathogenic mycobacteria such as M.a.paratuberculosis express proteins in vivo that 
permit the persistence and multiplication of the organism within the host resulting 
ultimately in the appearance of clinical disease. As such intracellular persistence 
depends on the co-ordinated regulation of gene expression. The primary level of gene 
regulation is through the modulation of the transcriptional activity from the promoter 
of the particular gene in question.
A number of mycobacterial promoters have been identified, o f which several have 
been studied in detail (Sirakova et a l, 1989; Das Gupta et a l,  1993; Curcic et a l,  
1994; Timm et a l, 1994a; Dellagostin et a l, 1995; Kremer et a l,  1995b; Mulder et 
a l,  1997; Bannantine et a l, 1997; DasGupta et a l, 1998; Mulder et a l,  1999; Verma 
et a l, 1999; Barker et a l, 1999; Juarez et a l,  2001; Mehrotra and Bishai, 2001). 
These include the promoters for the 16S rRNA genes of M.smegmatis (Ji et a l,  
1994), M.tuberculosis (Kempsell et a l, 1992) and M /qprae (Sela and Clark-Curtiss,
1991); the bla gene of M.fortuitum (Timm et a l,  1994b); the ask^ gene o f 
M.smegmatis (Narayanan et a l, 2000); the hsp60 gene of M.bovis BCG (Dellagostin 
et al, 1995); the ISkDa and 28kDa M.leprae genes (Dellagostin et al, 1995); the 
cpn60 gene of M.tuberculosis’, the 85A antigen of M.tuberculosis (Kremer et al, 
1995b); the P a n  promoter from the 1^900 element of M.a.paratuberculosis (Gormley 
et a l, 1997); the three promoters responsible for transcribing the repressor-like gp71 
protein of mycobacteriophage L5 (Nesbit et a l,  1995); the M.tuberculosis katG  gene 
(Master et a l,  2001) and the M.marinum G13 promoter (Barker et al, 1999). Other 
studies have used transcriptional fusions of mycobacterial sequences to different 
reporter molecules to identify promoter activity and to detect promoters specifically
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regulated in vivo or as result of environmental stress (Curcic et al, 1994; Gordon et 
a l, 1994; Barker et a l, 1998; Carroll et a l,  2000).
There are currently too few mycobacterial promoter sequences that have been 
transcriptionally mapped, available to create a true picture of what constitutes a 
consensus mycobacterial promoter. There appears to be a high degree of sequence 
diversity in both the -35 and -10  hexameric sequences with no true homology 
emerging (Bashyam gf a l, 1996; Mulder et al, 1997; Bashyam and Tyagi, 1998). A 
number of mycobacterial promoters have been shown to resemble the typical 
prokaryotic E.coli a^^-like promoter consensus sequences and were demonstrated to 
be transcriptionally functional in E.coli (Thomas et a l,  1992; Barietta et a l,  1992; 
Barker et al, 1999). In these cases, mycobacterial promoters demonstrate greater 
like consensus at the -10  hexamer with more diversity seen in the consensus -35 
region, where no strongly conserved consensus emerges. In addition 
M.a.paratuberculosis promoters have been demonstrated showing greater homology 
to the a^^-like -35 hexamer with limited consensus homology observed for the -10  
hexameric region (Bannantine et al, 1997). Several mycobacterial promoters have 
also been identified that show limited or weak homology to the E.coli consensus 
promoter (Das Gupta et al, 1993). It is difficult to create any form of a consensus 
sequence among the various mycobacterial promoters that have been so far 
characterised as many belong to specifically regulated genes and thus may not 
contribute towards the elucidation of constitutive gene expression in mycobacteria. 
Similarly most in vivo or stress regulated genes do not appear to function in E.coli 
and show differences in expression levels between mycobacterial species (Gordon et 
al, 1994; Barker et al, 1998). However as with the consensus sequence itself there 
appears to be a degree of variability in all these factors.
Mycobacterial promoters lacking homology to the E.coli a^^-like promoter 
consensus exhibit weak or no expression in E.coli (Das Gupta et al, 1993). As such 
M.smegmatis offers clear advantages to the use of an E.coli system that is unable to 
recognise many mycobacterial expression sequences (Jain et a l, 1997; DasGupta et 
al, 1998). M.smegmatis has been extensively used to study the transcriptional activity 
of mycobacterial promoters. Several different systems have been used to identify
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mycobacterial promoters whose expression is up-regulated by environmental stimuli 
such as those encountered inside phagocytic host cells. These include 
chloramphenicol acetyltransferase (CAT)-based vectors (Das Gupta et al, 1993), 
lacZ vectors (Barietta et al, 1992; Timm et al, 1994a and 1994b) and GFP vector 
systems (Dhandayuthapani et a l,  1995; Kremer et a l,  1995a; Via et a l,  1998; 
Barker et al, 1998; Luo et a l,  2000; Cowley and Av-Gay, 2001) coupled to 
fluorescent activated cell sorting (FACS) with and without the counter selective 
properties of the B.subtilus SacB protein (Triccas et a l, 1999; Triccas et a l,  2001).
Mycobacterial promoters have been shown to have similar levels of expression in 
different mycobacterial species, namely between M.bovis BCG, M.tuberculosis and 
M.smegmatis (Bashyam et al, 1996; Bashyam and Tyagi, 1998). This suggests that 
the basic transcriptional machinery o f these mycobacterial species share determinants 
of transcriptional specificity in common. The authors do point out that this may only 
be true for constitutive promoters and may not be true for genes that are specifically 
regulated. In contrast some mycobacterial promoters exhibit different activities in 
different mycobacterial host species. This may reflect a general differential 
requirement for gene products by different mycobacterial species, reflected in the 
differences in promoter recognition and expression patterns between species.
Sigma factors (g ) combine with the basic RNA polymerase core enzyme to direct 
transcription, the unique affinity o f different sigma factor for the particular promoter 
consensus sequence is an essential component in many gene regulation systems. The 
M.tuberculosis genome contains genes encoding 13 putative a  factors belonging to 
the major G^^-like class of sigma factors (Doukhan et a l, 1995; Fernandes et a l,  
1999; Michele et a l, 1999; Manganelli et a l,  1999; Hu and Coates, 2001). sigA is 
presumed to encode the major a  factor in mycobacteria, as it was demonstrated to be 
essential m M.smegmatis (Gomez et a l,  1998). Manganelli et al identified three heat 
shock responsive sigma factor genes, .yzgB, .y/g-H and fzgE, of which sigB  and sigY  
also respond to detergent stress (Manganelli et al, 1999). sigE and sigR  also have 
been shown to be up-regulated in M.tuberculosis infected macrophages (Jensen-Cain 
and Quinn, 2001). In M.tuberculosis 10 of the 13 putative sigma factors are 
considered to be members of the extra cytoplasmic factor (ECF) family o f alternative
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sigma factors, thought to be involved in regulating bacterial interactions with the 
extracellular environment, adaptation to stress and, in some cases, bacterial virulence 
(Manganelli et al, 1999). Raman et al demonstrated that SigH regulates the stress- 
inducible expression of sigE and sigB (Raman et a l,  2001). In a recent paper 
Manganelli et al identified several genes that are induced in a a^-dependant manner 
after SDS surface stress (Manganelli et a l, 2001). The genes identified encode 
proteins belonging to different protein classes, including transcriptional regulators 
{sigB), enzymes involved in fatty acid degradation and classical heat shock proteins.
Mycobacterial promoters have been identified showing specific regulation in 
response to environmental stress conditions, regulated by specific proteins other than 
sigma factors. Oxidative stress response in pathogenic mycobacteria is thought to 
play an important role in the survival and persistence of mycobacteria at various 
stages of infection. OxyR is a major positive regulator of the oxidative stress 
response in many bacteria. OxyR is present in most mycobacterial species and has 
been shown in M.marinum to regulate the expression of ahpC (an alkyl 
hydroperoxide reductase homologue) but not that o f katG (a catalase peroxidase) in 
response to hydrogen peroxide (Pagan-Ramos et a l, 1998). In M.smegmatis and 
M.tuherculosis, katG has been demonstrated to be co-transcribed with and regulated 
by fu r  A, which encodes a repressor similar to the ferric uptake regulatory protein 
(Fur) in many bacteria (Pym et a l, 2001). Fur acts as an iron-responsive repressor 
and appears to be a central component in a complex network involving iron 
metabolism, response to oxidative stress, acid tolerance response, sugar metabolism 
and toxin synthesis (Pagan-Ramos et al, 1998; Pym et al, 2001; Milano et a l,  2001). 
A second iron responsive transcriptional regulator has been identified in 
mycobacterial species. The iron-dependent regulatory protein, IdeR, is a functional 
homologue of the Corynebacterium diphtheriae DtxR protein (Schmitt et a l, 1995). 
DtxR is an iron dependant repressor controlling siderophore biosynthesis and 
transcription of the tox gene (Boyd et a l, 1990; Schmitt and Holmes, 1991a; Schmitt 
and Holmes, 1991b; Tao et a l, 1994). When activated by Fe^^ DtxR, and IdeR, bind 
to operator sequences known as “Iron boxes”, repressing transcription o f iron 
regulated genes. An IdeR isogenic mutant strain of M.smegmatis mc^l55 was unable 
to repress the synthesis of exochelin and mycobactin (Dussurget et a l, 1998). The
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mutant strain also exhibited greater sensitivity to hydrogen peroxide and had 
decreased catalase/peroxidase and superoxide dismutase activities (Dussurget et ah, 
1996). Further work expanded the exact role that IdeR plays in mycobacterial gene 
regulation by demonstrating that expression of the exochelin biosynthesis gene fxbA  
(encoding a putative formyltransferase) is negatively regulated by iron only in the 
presence of IdeR (Dussurget et a l,  1999). Several such iron boxes have been 
identified upstream of mycobacterial genes and shown to bind IdeR in the presence 
of divalent metals in gel retardation experiments (Manabe et a l,  1999). More 
recently, Gold et al identified “Iron box” homologues in the upstream regions o f a 
further 40 M.tuberculosis ORFs, whose gene products are involved in diverse 
functions including iron acquisition or storage and amino acid biosynthesis, as well 
as genes with no known role in iron metabolism or demonstrating no significant 
homologies to any known proteins in databases (Gold et a l, 2001). The authors 
demonstrated that 5 of these genes namely: mbtA, mbtB, mbtl (involved in 
siderophore biosynthesis), rv3402c (demonstrating homology to an aminotransferase, 
a dehydratase and an enzyme involved in perosamine/O-antigen biosynthesis), and 
bfd (demonstrating homology to Bfd from E.coli) are IdeR and iron repressed, with 
mbtB, mbtl and rv3402c being up-regulated in THP-1 macrophages. A sixth ORF, 
bfrA (a bacterioferritin sub-unit involved in iron storage), is controlled by three 
promoters, two of which are IdeR and iron repressed, whereas the third promoter is 
activated by IdeR and high iron conditions. The diversity o f products of genes 
regulated by iron as well as the findings that pathogenic mycobacteria encounter an 
iron-limited environment during intracellular growth, suggest that the regulation of 
gene expression by iron may play an important role in the survival o f mycobacteria 
in the host macrophage.
Several mycobacterial genes have been identified that undergo up-regulation in 
response to environmental stress or during intracellular growth. As such these genes 
may be required at specific stages during infection to ensure intracellular survival. 
Results presented in Chapter 4 demonstrated that expression of the 34kDa putative 
serine protease in M.smegmatis mc^l55 conferred a statistically significant increase 
in the ability o ïM.smegmatis mc^l55 to survive in ovine alveolar (OA) macrophages 
over the first 24 hours of infection. It was also known from previous work that the
135
34kDa putative serine protease gene is expressed during a natural infection as 
indicated by the presence of host antibodies against the 34kDa putative serine 
protease (Cameron et a l, 1994). It was thought that a more detailed understanding of 
the transcriptional activity of the 34kDa putative serine protease would provide 
important information on the role the gene plays in the virulence of 
M.aparatuberculosis. Therefore, the work presented in this chapter, attempted to 
identify the promoter responsible for expression of the 34kDa putative serine 
protease and characterise what environmental stimuli were responsible for gene 
expression.
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5.2 Materials and Methods
5.2.1 Amplification of the upstream region of the 34kDa putative serine protease 
from M.a.paratuberculosis genomic DNA
a) Using HotStar Taq DNA polymerase
Three hundred and sixteen bp of 34kDa putative serine protease upstream sequence 
including the start and first 3 codons of the 34kDa putative serine protease ORF was 
amplified by PCR from M.a.paratuberculosis JD88/107 as follows. 
M.a.paratuberculosis genomic DNA (125 ng) (section 2.7) was added to pre­
prepared reaction mixtures (50pi final volume) comprising (x 1 ) reaction buffer at 
1.5mM MgClz (Qiagen), 0.2 mM each of dATP, dCTP, dGTP and dTTP (dNTP mix; 
Roche Ltd.), 2% ('^/y) Glycerol, 100 pMol each of the forward and reverse primers 
(forward primer: 5’-CGG GGC CTT GCG CGA GGG CG-3% positions -316 to -  
303; reverse primer: 5’- GCG ATT TGC TCA TCC GTC ACC CT-3% positions -12  
to +12) and 2.5 U HotStar Taq polymerase (Qiagen). HotStar PCR conditions 
consisted of an initial dénaturation of 15 min at 95°C, followed by 35 cycles o f 60 
sec dénaturation at 94°C, 60 sec annealing at 60°C and 60 sec extension at 72°C. The 
final cycle included an extension at 72°C for 8  min. The 316 bp amplification 
product was excised from a 1% LMP agarose gel (section 2.2,4) and cloned into the 
pGEM®-T vector (Promega UK) as per the manufacturer’s instructions. Competent 
E.coli JM109 cells were transformed as described in section 2.3.3. plasmid DNA was 
recovered from positive transformants as described in section 2 .2 .1 .
b) Using ACCUZYME DNA polymerase
Three hundred and sixteen bp of 34kDa putative serine protease upstream sequence 
including the start and first 3 codons of the 34kDa putative serine protease ORF was 
re-amplified by PCR from plasmid pGEMusP (5.2.1-1) as follows. pGEMusP 
plasmid DNA (50ng) was added to pre-prepared reaction mixtures (50pl final 
volume) comprising (xl) reaction buffer at 2.0 mM MgS0 4  (Bioline, Ltd.), 0.2mM 
each of dATP, dCTP, dGTP and dTTP (dNTP mix; Roche Ltd.), 2% C"Vy) Glycerol, 
100 pMol each of the forward and reverse primers (forward primer: 5’-CGG GGC 
CTT GCG CGA GGG CG-3’, positions -316 to -303; reverse primer: 5’- GCG ATT 
TGC TCA TCC GTC ACC CT-3’, positions -12  to +12; position o f primer
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recognition sites are described in relation to start codon of 34kDa putative serine 
protease) and 2.5 U ACCUZYME DNA polymerase (Bioline, Ltd.). ACCUZYME 
PCR conditions consisted of an initial dénaturation o f 5 min at 95°C, followed by 35 
cycles of 60 sec dénaturation at 94°C, 60 sec annealing at 60°C and 60 sec extension 
at 72°C. The final cycle included an extension at 72°C for 8  min.
5.2.2 Amplification of the 34kDa putative serine protease ORF and upstream 
region from M.a.pamtuberculosis genomic DNA
The entire 34kDa putative serine protease ORF and 333 bp of upstream sequence 
was amplified by PCR from M.a.paratuberculosis JD88/107 as follows. 
M.a.paratuberculosis genomic DNA (125ng) (section 2.7) was added to pre-prepared 
reaction mixtures (50pi final volume) comprising (xl) reaction buffer at 1.5mM 
MgCL (Qiagen), 0.2mM each of dATP, dCTP, dGTP and dTTP (PCR nucleotide 
mix; Roche, Ltd.), 2% (^/Q Glycerol, 100 pMol each of the forward and reverse 
primers (forward primer: 5’-GCC GTG TAG ACC ACG TCC GG-3’, positions -333 
to -314 upstream of the 34kDa putative serine protease start codon; reverse primer 
5’-G C r CTA GAG CTC AGG CCG GCG GCC CCT CCG-3% underlined sequence 
represents positions 1,110 to 1,091 of the 34kDa putative serine protease ORF, 
sequence in italics represents m X b a  I restriction enzyme recognition site) and 2.5 U 
HotStar Taq polymerase (Qiagen UK Ltd.). HotStar PCR conditions consisted of an 
initial dénaturation of 15 min at 95°C, followed by 35 cycles o f 60 s dénaturation at 
94°C, 60 s annealing at 65°C and 90 s extension at 72°C. The final cycle included an 
extension at 72°C for 8  min. The 1,419 bp amplification product was excised from a 
LMP agarose gel (see section 2.2.4) and cloned into the pGEM®-T vector (Promgea 
UK Ltd.) as per the manufacturer’s instructions. Competent E.coli JM109 cells were 
transformed as described in section 2.3.3.
5.2.3 Measuring P-gal expression using the X-gal substrate
To demonstrate expression of P-gal in M.smegmatis from a mycobacterial promoter, 
M.smegmatis strains were inoculated onto L-B agar plates supplemented as follows; 
20pg/ml streptomycin and 80pg/ml X-gal substrate. The cultures were then 
incubated at 37°C until the appearance of colonies, the appearance of blue colonies 
confirmed expression of p-gal activity in those recombinant strains.
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5.2.4 Induction of p-gal expression from a mycobacterial promoter 
a) By iron starvation
p-Gal assays were performed as described in (Dussurget et a l, 1999). Briefly, a fresh 
culture of each M.smegmatis strain was diluted Vio in fresh pre-warmed (37°C) L-B 
broth supplemented as follows; 1% (^Vy) Tween 80 and 20pg/ml streptomycin, and 
incubated at 37°C with shaking (200 rpm) until an ODgoo of 0.4-0.6. 10 ml of 
mycobacterial culture was added to two 50ml falcon tubes. The Iron chelator 
Dipyridyl (DP) was added to one falcon tube to a final concentration of 200pM, the 
same volume of water was added to the duplicate culture. The cultures were 
incubated at 37°C with shaking (200 rpm) for a further 4 hours, the ODeoo noted for 
each strain, centrifuged at 4,147 x g  for 10 min, the supernatant discarded and the 
mycobacterial cell pellet frozen on dry ice and stored at -70°C until processed.
5.2.5 Measuring P"Gal expression using ONPG substrate
The mycobacterial cell pellet prepared as described in 5.2.4 or 5.2.5 was re­
suspended in SOOpl of Z-buffer (lOOmM Sodium Phosphate and ImM Magnesium 
Sulphate, pH 7.0) supplemented with ImM P-mercaptoethanol. Mycobacterial 
lysates were prepared by bead beating as previously described (see section 2.7). The 
supernatant was removed and transferred to a 1.5ml Eppendorf tube centrifuged at 
11,000 X g  for 10 min at 4°C. The total protein content of the Lysates was measured 
using the Bradford Reagent (Sigma-Aldrich Ltd.) with BSA as the standard as per 
the manufacturer’s recommendations. The lysates were then adjusted, diluting if 
required, to give roughly equal concentration of proteins in all lysates. 2 0 0 pl of 
adjusted lysate was added to a 1.5ml Eppendorf tube and equilibrated at 37°C for five 
min, followed by the addition of 200pl of a 0.4% o-nitrophenyl-p-D- 
galactopyranoside (ONPG) in Z-buffer substrate solution. The reaction was allowed 
to proceed until the reaction mixture appeared yellow. The reaction was stopped by 
the addition o f 400pl of STOP solution (IM  Na2 C0 ]). The colorimetric change was
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then measured for each sample in a spectrophotometer set to read at 420nm, using Z- 
buffer as a blank, p-gal activity in Miller units was calculated by the formula;
( O D 4 2 0  X 1000)/(^ X  V X  O D ô o o )  
where t is the incubation time in minutes and v is the volume of culture used.
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5.3 Results
5.3.1 Determination of the upstream region of the 34kDa putative serine protease 
ORF in M,avium and M.a.paratuberculosis
A BLAST search of the unfinished TIGR M.avium genome sequence project 
(http://tigrblast.tigr.org/ufmg/) using the entire 34kDa putative serine protease 
sequence as the query sequence revealed the presence on M. avium cosmid 4 of a 
100% identical region. This was expected, given earlier work demonstrating the 
presence of the 34kDa-putative serine protease sequence in M. avium by Southern 
blot hybridisation. The sequence of the M. avium cosmid 4 was recovered from the 
TIGR database and the location o f the 34kDa putative serine protease on the cosmid 
was determined by alignment using the ALIGN X program of the Vector NTI suite 
(InforMax Inc.). To confirm that the corresponding upstream sequence was identical 
in M.aparatuberculosis, the upstream region of the 34kDa putative serine protease 
was amplified by PCR using primer sequences directed against the upstream region 
of the gene in M.avium as described in section 5.2.1a. The 316 bp insert fragment in 
the resulting plasmid, designated pGEM34P was sequenced using the T7 forward 
and reverse primers whose target sequences are located 5’ (T7 forward primer) and 
3’ (T7 Reverse primer) of the cloned insert in pGEM-T. Upon sequence analysis, 
using the ALIGN X program in the Vector NTI suite, the cloned M.a.paratuberculosis 
upstream sequence was identical to the M.avium cosmid sequence.
5.3.2 In silica identification of promoter elements in the upstream region of the 
34kDa putative serine protease
In order to determine whether or not a recognisable promoter element was present in 
the upstream sequence region of the 34kDa putative serine protease in 
M.a.paratuberculosis, the sequence was analysed by computer-based homology 
searching for the presence of a mycobacterial promoter consensus. A broad 
consensus mycobacterial promoter sequence was compiled by aligning the - 1 0  and -  
35 hexameric regions of known mycobacterial promoters (Figure 5.1) using the 
ALIGN X program (Vector NTI suite, InforMax Inc.). This generated the consensus 
sequence MPI. Thomas et al has also proposed a M.a.paratuberculosis promoter 
consensus sequence based on compiling several promoter sequences identified in
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-35 - 1 0
M.a.paratuberculosis PAN gCGACA pÀ C A C ^
M.a.paratuberculosis Consensus P g m c g t CGGCCS
M.bovis BCG mpbJO CCSATC CATgAG
M.fortuitum pblaF TTCAAA E a c g c t
M.leprae 16s rRNA TTGAC r ATTAAT
M.leprae 18kDa TTGCAT CTATAT
M. leprae 28kDa [TGiGTCA TACCAT
Mmarinum G13 TTGCTG TAGAAA
M.smegmatis ask CCCACG Z^CGCTG
M.tuberculosis hsp60 TTGCAC T A A G ^
M.tuberculosis 85kDaA ^TGACT CGCCTG
M.tuberculosis cpn60 '^GCT^A CATCAG
M.tuberculosis I6SrRNA jTTGACT ÎTAGACT
E.coli [TTGACA [TATAAT
MPI consensus TTGACM
Figure 5.1 Generation o f MPI promoter consensus. Alignment o f several known 
mycobacterial promoters to generate consensus -35  and -10  hexameric sequences. 
The promoters were aligned using the ALIG N X  program of the Vector NTI suite. 
Nucleotides depicted in blue with shading represent identity to the MPI consensus. 
M.aparatuberculosis PA N  (Gormley et al, 1997); M.aparatuherculosis Consensus 
(Thomas et al, 1992); M.bovis BCG mpbJO (Matsumoto et a l, 1995); M.fortuitum 
pblaF (Timm et al, 1994b); M. leprae 16s rRNA (Sela and Clark-Curtiss, 1991); 
M.leprae ISkDa, M.leprae 28kDa (Dellagostin et al, 1995); Mmarinum G13 (Barker 
et al, 1999); M.smegmatis askJ3 (Narayanan et al, 2000); M.tuberculosis hsp60 
(Dellagostin et al, 1995); M.tuberculosis 85kDa A (Kremer et al, 1995b); 
M.tuberculosis cpn60; M.tuberculosis 16S rRNA (Kempsell et al, 1992).
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their studies of the transcriptional machinery of M.a.paratuberculosis (Thomas et al,
1992). As this differed significantly from the consensus sequence generated above it 
was included in the computer analysis. Both MPI and the M.a.paratuberculosis 
promoter consensus sequences were aligned to the M.a.paratuberculosis upstream 
sequence of the 34kDa putative serine protease. This analysis failed to reveal any 
significant identity to either promoter consensus.
A mycobacterial promoter prediction program (Triccas et al, 2001) 
(http://www.centenary.usyd.edu.au/research/promoter.html) was also used to 
analysis the upstream region of the 34kDa putative serine protease. The search 
program utilises the consensus sequence of Mulder et al (-35: TTGACG; -10, 
TATAAT) (Mulder et al, 1999). Using this program it was possible to identify two 
potential promoter regions in the upstream region (Figure 5.2), sharing a common -  
35 sequence with two predicted -10  regions (Figure 5.2). Promoter A demonstrated 
58% identity to the target sequence, with promoter B demonstrating 67% identity. 
Given the low level of identity observed for both potential promotes, experimental 
evidence was required to demonstrate the presence of a functional promoter element 
in the sequence upstream of the 34kDa putative serine protease in 
M.a.paratuberculosis
5.3.3 Promoter identification in the upstream region of the p40 gene of 1S901^ 
M. avium
The upstream region of the p40 gene, previously identified in IS901 positive 
(ISPOf^) M. avium, was analysed using the same methodology as described in 
section 5.3.2. The gene encodes a 40kDa protein that is present in IS901^ M. avium 
but absent from IS901' strains (Burrells et a l, 1995; Inglis et a l ,  2001). The gene 
sequence has been shown to be present in 26 mycobacterial species investigated but 
the protein product is only detected in 1^901^ M. avium (Inglis et a l,  2001). The 
promoter consensus sequence generated in section 5.3.2 (MPI) (Figure 5.1) was 
aligned with p40  upstream sequence from 1S901^ M.avium, TS>901' M.avium, 
M.a.paratuberculosis, M.bovis, M.leprae, M.smegmatis and M.tuberculosis 
highlighting a potential promoter element.
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cggcagcaaa
ggctgagaac
ctacctgcat
tgtgccgcca
tttggtgttt
cggATGagca
cggcggtaag
ctggcacaùg
tacggttat&
ggatcctcag
accgcgacgc
aatcgc
cctatgagcc
ccgtgcatag
fcacacaaaat
gccgggacag
aggagggtga
-35 -10
P r o A a t g c c g — 17(bp)—t a c g g t —7 7(bp)—AT G 
ProB a t g c c g —23 (bp)—t a  t a  t a —68(bp)—AT G
Start matches
7
8
Figure 5.2 Analysis o f the upstream region o f the 34kDa putative serine protease 
using the Mycobacterial Promoter Prediction program. The program identified two 
potential promoters; promoter A (ProA) and promoter B (ProB). Shown are the 
location o f both putative -1 0  regions, the putative -35  region and the distance fi'om 
the end of either putative -10  hexamer to the start codon (ATG) o f the 34kDa 
putative serine protease ORF. The number o f matches to the consensus site are 
shown for each putative promoter.
144
A putative promoter (PI) was located 7 base pairs from the start codon (GTG) of the 
ORF (Figure 5.3). This region also contained an extended -10  motif (the TGN 
motif), that has been linked to an increased transcriptional activity o f several 
mycobacterial promoters. The observed distance between the -35 and -10  regions is 
within the expected range (between 9 and 24 base pairs) seen for mycobacterial 
promoters. Upon sequence analysis, the first base o f the putative -10  hexamer is a T 
in both M.smegmatis and IS90Ü M.avium, the same position contains a C in all other 
species (Inglis et al, 2001). However more recent data, involving re-sequencing the 
upstream region of the gene in M.a.paratuberculosis has confirmed the presence of a 
T at that position.
5.3.4 Cloning the 34kDa putative serine protease ORF and upstream region into 
a mycobacterial shuttle vector
If a promoter element was located in the upstream region of the 34kDa putative 
serine protease then the possibility existed that it would be capable o f driving 
expression of the 34kDa putative serine protease in M.smegmatis mc^l55. To 
demonstrate this, the entire open reading frame and upstream sequence was cloned 
into an appropriate mycobacterial shuttle vector and introduced into M.smegmatis 
mc^l55. Expression of the 34kDa putative serine protease from a promoter located 
upstream of the gene could then be determined using western immunoblotting (see 
section 2.10) probing with the 34kDa putative serine protease specific monoclonal 
antibody.
a) PCR amplification of the entire 34kDa putative serine protease ORF and 
upstream region
PCR primers were designed that would allow the amplification of the 34kDa putative 
serine protease ORF and 346 bp of upstream region from M.a.paratuberculosis 
genomic DNA. The reverse primer contains the recognition site for the Xba I 
restriction enzyme at its 5’ end, generating a fragment containing a 3’ Xba I site. A 
1,419 bp product was amplified by PCR (see section 5.2.2), purified from a 1% LMP 
agarose gel (see section 2.2.4) and ligated into the pGEM-T vector system as per the
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- 4 0 - 3 0 -20
M.avium {1S901+) 
M.avium {1S901-)  
M. a . p t h  
M. t u b e r c u l o s i s  
M .b o v i s  
M. l e p r a e  
M. smegmatis  
C o n s e n s u s  - 1 0  
C o n s e n s u s  - 3 5
GATTGÂqCCT CGATTCTACA GCCTGCgAGq 
GA^TGACGCT CGATTYCACA GCCTGCcKgC 
GA^TGACjCCT CGATTCCACA GCCTACCAGC 
TA&TGACCCC CTGTCCGATA GCCTGCCAGC 
TATTGAgCCC CTGTCCGATA GCCTGCCAGA 
GA&TGÀTCCC G . GATCGACA ATCTGCCpGQ 
G G C ^ c g c C  G . . . CGGAGG CGTGAApAGC
..................................................................gAGg
. . (TTGACAl..................................................................
10 -1
ÂrjGTGGCGTT 
ATGTGGCGTT 
ATjGTGGCGTT 
AT|GTGGCGTT 
ATGTGGCGTT 
ATGTGGCGTT 
ATGTGAAGCC 
^ .............
+1 +10
GTGACCAGTG
GTGACCAGTG
GTGACCAGTG
GTGGCTAGCG
GTGGCTAGCG
GTGACTGCTA
GTGACTGCAC
Figure 5.3 Alignment o f sequences upstream o f the p40 gene homologues in 1^901^ 
M.avium, 1^901' M.avium, M.avium subsp. paratuberculosis {M.a.ptb), M.bovis, 
M.leprae, M.smegmatis and M. tuberculosis. Numbering (-40 - +10) refers to the 
IS901^ M.avium sequence. The first lObp o f the p40 ORFs are shown underlined 
beginning +1 at the GTG translational start codon. Consensus -1 0  and -35  regions 
mark the position o f a putative promoter. A TGN m otif immediately precedes the -  
10 region in all species except M.avium subsp. paratuberculosis. In the case o f 
M.smegmatis, a single nucleotide (A) separates the TGN m otif and the start o f the -  
10 hexamer. Figure and legend taken from Inglis et al, 2001, with permission.
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manufacturer’s instructions, with a vectorhnsert ratio of 3:1 (Promega UK). 
Competent E.coli JM109 cells were transformed with 5ul of the ligation mix on L-B 
agar medium supplemented with 50pg/ml (see section 2.3.3) and plasmid DNA 
recovered as described in section 2.2.1. Plasmid DNA was digested to completion 
with the restriction enzyme Xba I (see section 2.2.2), to confirm the presence of the 
fragment in the pGEM-T vector. Upon electrophoretic analysis, an increase in size 
for the plasmid DNA was observed consistent with the incorporation of the insert 
fragment. Similarly, digestion of plasmid DNA using the restriction enzyme Bam HI 
resulted in two DNA bands on a 1% agarose gel consistent with the presence of the 
correct insert. A single Bam HI site is present in the insert fragment, located in the 
upstream sequence with a single Bam HI recognition site present also on the pGEM- 
T vector backbone (Promega UK). The cloned insert DNA was finally sequenced 
using the T7 forward and reverse primers ^hose target sequences are located 5’ (T7 
forward primer) and 3’ (T7 Reverse primer) o f the cloned insert in pGEM-T. 
Sequence analysis confirmed that the plasmid contained the correct l,419bp insert 
(Figure 5.4). The plasmid was designated pGEM-us34.
b) Cloning of the 34kDa putative serine protease ORF and upstream region into 
PÜS972
Cloning the 34kDa putative serine protease and upstream region into pGEM-T 
allowed the fragment to be excised using restriction sites located in the vector 
sequence, facilitating further cloning into a mycobacterial shuttle vector. The 
resultant shuttle vectors could then be introduced into M.smegmatis mc^l55 to 
determine whether or not the upstream sequence was transcriptionally active. The 
restriction sites Xba I and Spe I are located on either side o f the 34kDa putative 
serine protease and upstream region as shown in Figure 5.4. No recognition site for 
either enzyme is present in the 34kDa putative serine protease or the upstream 
sequence, as determined by sequence analysis using the Vector NTI software 
package. Plasmid pGEM-us34 was digested with both Xba I and Spe I in buffer 
conditions suitable for optimal activity of both enzymes. The restriction digest was 
resolved on a 1% LMP agarose gel and the l,440bp insert fragment purified from the 
gel as previously described.
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34kDa antigen coding sequence
34USF PCR Primer p c R  Primer
Spe I  ^ Bam HI Bam HI Xba I
T
Signal Peptide sequence
pGEM -T pGEM -T
Figure 5.4 Shown is the location of the entire 34kDa putative serine protease ORF 
and 346bp of upstream region in pGEM-T vector. The location of the single Xba  I 
and Spe I restriction and both Bam HI enzyme (one is located in the upstream 34kDa 
putative serine protease region with a second located down stream of the Spe I site in 
pGEM-T) recognition sites relative to the cloned insert are shown. Also shown is the 
location of the signal peptide of the 34kDa putative serine protease, and the location 
of the PCR primers used to generate the fragment (Forward primer 34usF and reverse 
primer 34Rev: the nucleotide sequences o f which are given in section 5.2.2). The 
Figure was generated by the Vector NTI Suite, using sequence data derived from 
sequencing pGEMus34 (Appendix 4).
148
The fragment was to be cloned into the mycobacterial shuttle vector pUS972 by 
blunt end ligation. Both of the restriction sites used to excise the fragment from 
pGEM-us34 generate 5’-overhangs that had to be removed prior to attempting the 
ligation reaction. To achieve this, the recovered fragment was treated with the 
Klenow Fragment of DNA polymerase I (see section 2.2.6) and gel purified from a 
1% LMP agarose gel (see section 2.2.4). pUS972 Vector DNA (200ng) was digested 
to completion with the restriction enzyme Sea I under appropriate buffer conditions 
(Promega Inc.) generating a linear plasmid with blunt ends. The linear 3.6kb vector 
was purified from a 1% LMP agarose gel. Linear pUS972 was treated with Shrimp 
Alkaline Phosphatase (SAP) to remove the 5’-phosphate (see section 2.2.5), 
preventing re-ligation of the plasmid without the fragment during ligation. The linear 
de-phosphorylated vector was again purified from 1% LMP agarose.
SAP treated linear vector and blunt ended insert DNA were ligated together with a 
3:1 (vector:insert) molar ratio. SAP treated and non-treated pUS972 were used as 
ligation controls. Competent E.coli JM109 cells were transformed with 5pi o f the 
ligation reactions and positive transformants were selected by growth on solid L-agar 
media supplemented with 50pg/ml kanamycin. It was noted that the transformation 
efficiency was low with only 8 colonies present on selective solid media.
Blunt end ligation results in the incorporation of the fragment in two orientations 
relative to the vector DNA backbone. The approach for confirming the presence and 
the orientation of the fragment in the plasmid backbone is out-lined in Figure 5.5. 
Briefly, a single Bam HI recognition site is located in the vector with two sites 
located in the fragment to be cloned (Figure 5.4). Digestion of plasmid DNA 
containing the cloned fragment with Bam HI would result in the removal of several 
fragments from the plasmid DNA of different sizes reflecting the different 
orientation of the insert relative to the backbone vector.
Digestion of plasmid DNA recovered from each of the 8 positive colonies with Bam 
HI resulted in a single DNA band on a 1% agarose gel with a molecular size 
corresponding to the vector alone without any insert being present. Other 
vector: insert ratios (5:1, 1:1, 1:3) were attempted resulting in the recovery o f re-
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pUS972 ^  34kDa antigen coding sequence
Bam HI
w—g
BamHl
I
pUS972
 h.
pMRIus341
Ha nb
BamHl
N
Bam HI BamHl
pMRIus34 II
Figure 5.5 The relative orientation of the cloned fragment containing the entire 
34kDa putative serine protease ORF (purple arrow) and the upstream region in the 
pUS972 vector (yellow arrows) can be determined using the Bam HI restriction 
enzyme. A single Bam HI site is located in the MCS of pUS972 with two recognition 
sites in the cloned 34kDa putative serine protease ORF and upstream region 
fragment. Introduction of the 34kDa putative serine protease fragment into the vector 
through blunt end ligation would result in the insert being in two orientations relative 
to the vector backbone. In orientation I, digestion o f the plasmid DNA by Bam HI 
results in the removal of 287 bp (product I) from the vector. Digestion of plasmid 
DNA in orientation II results in the removal o f approximately 1,496 Kb (product I la) 
and 287 bp (product Ilb) of DNA from the plasmid DNA.
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ligated vector DNA alone. This was in spite of the fact that all the usual controls 
were noted to be satisfactory; re-ligated Sea I cut pUS972 vector DNA that had not 
been treated with SAP consistently resulted in the recovery of -100 cfu/50ng DNA; 
indicating the efficacy of the T4 DNA ligase and the reaction buffer supplied by the 
manufacturer (Roche Ltd.); E.coli JM109 transformation with uncut circular pUS972 
resulted in approximately 5x10^ cfu/50 ng DNA. Treatment of the vector with SAP 
failed to completely prevent re-ligation of the vector as control ligation reactions 
successfully transformed E.coli JM109. This was consistently the case even when the 
concentration of SAP used in the reaction was increased to 2 U of SAP per reaction 
and the time allowed for completion of the reaction was also increased, to 90 min. 
The possibility existed that the failure to successfully ligate the insert into the vector 
backbone was due to the preferential reformation of the vector during the ligation 
reaction. This may have been due to the apparent inefficiency of the de­
phosphorylation reaction in removing the 5’-phosphate groups on either end of the 
linear DNA.
In an attempt to overcome these problems linear vector, digested with Sea I but 
which was not subsequently treated with SAP, was used in the subsequent ligation 
reaction. This would be expected to result in the reformation of the vector with a 
corresponding reformation of the Sea I restriction site. However, the ligation of the 
insert into the vector would not regenerate the Sea I site as determined by computer 
based sequence analysis of the expected vector-insert junctions. Digestion of the 
vector-insert ligation mix with the restriction enzyme Sea I would digest the re­
ligated vector DNA but not vector DNA containing the insert fragment. The ligation 
was attempted with non-SAP treated vector DNA and a 1:1 vector:insert ratio. lOpl 
of the resulting reaction was digested with the Sea I restriction enzyme and 5 pi of 
this reaction was used to transform chemically competent E.coli JM109 cells (see 
section 2.3.3. The transformation efficiency remained low with only 12 colonies 
observed on selective media. Plasmid DNA was recovered (see section 2.2.1) from 
10 positive colonies and digested with the Bam HI. Electrophoretic analysis of the 
resulting digested plasmid DNA revealed the presence of two or three DNA bands on 
a 1% agarose gel demonstrating successful integration of the insert DNA (Figure 
5.6).
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2.500 -
2.000  -
1.500 -
1,000  -  
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Figure 5.6 Agarose gel showing Bam HI digestion of plasmids pMRIus34I and 
pMRlus34II, confirming the orientation of the cloned fragment relative to the 
plasmid backbone, as described in the text. Lane 1 : digestion of pMRIus34I results in 
the presence of two DNA bands at -4,741bp and -287 bp; Lane 2: digestion of 
pMRlus34II results in the presence of tliree DNA bands of -3,600, -1,144 and -287 
bp. L corresponds to molecular weight markers (Hyperladder I, Bioline Ltd.).
152
As expected, the molecular size of the bands varied according to the orientation of 
the cloned fragment in the plasmid backbone (Figures 5.5 and 5.6).
The resultant vectors were designated pMRIus34-1 (orientation I, Figure 5.5) and 
pMRIus34-II (orientation II, Figure 5.5). Both vectors were then introduced by 
electroporation into electrocompetent mc^l55 cells (see sections 2.3.1b
and 2.3.2b) and positive transformants selected on 7H11S plates containing 
kanamycin at 50 pg/ml resulting in M.smegmatis mc^l55 clones M.smegmatis 
pMRIus34-I and M.smegmatis pMRIus34-II.
5.3.5 Expression of the 34kDa putative serine protease from the endogenous 
promoter in M.smegmatis mc^l55
Having successfully cloned the entire 34kDa putative serine protease ORF and the 
upstream region into a mycobacterial shuttle plasmid and introduced the plasmid into 
M.smegmatis mc^l55 (section 5.3.4), the potential expression of the 34kDa putative 
serine protease from the upstream promoter could be ascertained. M.smegmatis 
mc^l55 strains containing the following plasmids, pUS972, pMRIus34 I, pMRIus34 
II and pMRI34 (see Appendix 2) were grown in 7H9^-broth culture supplemented 
with 50 pg/ml kanamycin to an ODôoo of 0.6 and lysates prepared as described in 
section 2.6. The cell-free supernatants from all cultures were retained, passed 
through a 0.45pm filter to remove remaining mycobacteria and concentrated down to 
a final volume of 1ml in a Microcon spin column (Amicon-Millipore Ltd.) spun for 
20 min at 4,000 x g at 4°C. PMSF was added to the final concentrated sample to a 
final concentration of ImM. Mycobacterial bacterial lysates and concentrated culture 
supernatants derived from strains M.smegmatis pMRIus34-I, M.smegmatis 
pMRIus34-II, M.smegmatis pMRI34 and M.smegmatis pUS972 were analysed for 
the presence of the 34kDa putative serine protease by western immunoblotting as 
described in section 2.10 with the 34kDa putative serine protease specific 
monoclonal antibody as probe. A single band of approximately 34kDa was detected 
in the lysate and supernatant samples of M.smegmatis pMRI34, M.smegmatis 
pMRIus34-I, and pMRIus34-II, with no band detected in the control M.smegmatis 
pUS972 lysate (Figure 5.7). The same lysates and culture supernatants were also 
probed with the Hsp65 monoclonal antibody. As the Hsp65 is retained within intact
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Figure 5.7 Western blot showing mycobacterial cell lysates and the corresponding 
concentrated culture supernatants probed with anti-34kDa antigen monoclonal 
antibody. Lane 1, M.smegmatis pMRI34 lysate, Lane 2; M.smegmatis pUS972 lysate. 
Lane 3; M.smegmatis pMRIus34-I lysate. Lane 4; M.smegmatis pMRIus34-II lysate. 
Lane 5; M.smegmatis pMRI34 culture supernatant. Lane 6; M.smegmatis pUS972 
culture supernatant. Lane 7: M.smegmatis pMRIus34-I culture supernatant. Lane 8: 
M.smegmatis pMRIus34-II culture supernatant. A 34kDa band was detected in all 
experimental lysates and in the corresponding supernatants but not in the plasmid 
control lysate or supernatant.
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mycobacterial cells the absence of a 65kDa band in the culture supernatants would 
indicated that limited lysis of the bacterial culture has occurred. A 65kDa band was 
observed in all lysates tested with no protein detected in the corresponding 
supernatants (Figure 5.8), suggesting that the 34kDa putative serine protease 
expressed from the putative endogenous promoter is secreted by M.smegmatis 
pMRIus34-I and M.smegmatis pMRIus34-II and not present in the supernatant as a 
result of mycobacterial cell lysis during growth. These results suggested that a 
transcriptionally active promoter capable o f expressing the 34kDa putative serine 
protease in the upstream 346 bp region o f the gene. Expression of the 34kDa putative 
serine protease was seen when the cloned fragment was in both orientations relative 
to the plasmid backbone.
5.3.6 Investigation of the transcriptional activity of the 34kDa putative serine 
protease promoter
The identification of promoter activity is the first step in the determination of what 
environmental stimuli control the activity of a gene. Another aim of the upstream 
sequence analysis was to identify sequences homologous to known regulatory 
binding sites. An IdeR binding site has been identified previously in the upstream 
region of the M.tuberculosis Rv0983 gene. Rv0983 is annotated in the TUBERCULIST 
database (section 2.5) as being demonstrating homology to the HtrA family o f serine 
proteases. As such, the possibility existed that a similar regulatory element was 
located in the upstream region of the 34kDa putative serine protease. The consensus 
IdeR recognition site (IdeR box) of Manabe et al (1999) was aligned to the upstream 
sequence of the 34kDa putative serine protease using the ALIGN X component o f the 
Vector NTI suite. The analysis of the 346 bp of upstream sequence revealed a 
potential IdeR box approximately 250 bp from the start o f the coding sequence 
(Figure 5.9) demonstrating 58% identity to the IdeR/DtxR consensus sequence, while 
the sequence differed from that of Rv0983, the level of identity between both and the 
consensus sequence was the same. Experimental evidence was required to determine 
if this region was in fact a functional IdeR box, capable o f regulating the 
transcriptional activity of the 34kDa putative serine protease in response to IdeR and 
the concentration of iron.
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Figure 5.8 Western blot showing mycobacterial cell lysates and the corresponding 
concentrated culture supernatants probed with anti-Hsp65 monoclonal antibody. 
Lane 1, M.smegmatis pMRI34 lysate, Lane 2; M.smegmatis pUS972 lysate. Lane 3; 
M.smegmatis pMRIus34I lysate. Lane 4; M.smegmatis pMRIus34II lysate. Lane 5; 
M.smegmatis pMRI34 culture supernatant. Lane 6; M.smegmatis pUS972 culture 
supernatant. Lane 7: M.smegmatis pMRIus34-I culture supernatant. Lane 8: 
M.smegmatis pMRIus34-II culture supernatant. A ~65kDa band was detected in all 
mycobacterial lysates but not in the corresponding culture supernatants.
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3 4 k D a  u p s t r e a m  s e q  CGGGCTACCG AGGCCCGGCC GAACCTCGCC
Ironhox-Rv0983 ...................... AC AGGTGGTGCT CAACCACG. .
I r o n b o x - a d h B   GC AGGTGACCGT CAACCGAT. .
iTonhox-narG .......................GA AGGTCAACCA NAACAAGA. .
I r o n b o x - p h o P  .......................GA AGGTAACGTT CAACCAAT. .
Ironbox-19kDa . . . . . . .  .G C  AGGCCAGTGA NAACCTGT. .
I r o n b o x  c o n s e n s u s  .......................GT AGGTTAGGCT . A A C C T A T. .
Figure 5.9 Alignment of five IdeR binding sites in M.tuberculosis, a IdeR/DtxR 
consensus recognition sequence (“Ironbox”) and the upstream region of the 34kDa 
putative serine protease. M.tuberculosis binding sites and the ironbox consensus 
sequence were taken from Mananbe et al 1999. All five previously identified 
IdeR/DtxR binding sites have been shown to bind IdeR in gel shift experiments. 
Sequence depicted in bold represent conserved sites relative to the IdeR/DtxR 
consensus sequence (“Ironbox” consensus).
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5.3.7 Regulation of the 34kDa putative serine protease promoter by IdeR
In order to confirm a role for IdeR in the transcriptional regulation of the 34kDa 
putative serine protease, transcriptional fusions of the upstream putative promoter 
region and the reporter molecule p-gal were created. The integrative mycobacterial 
vector, pSml28 (Appendix 2), allows the transcriptional fusion o f a cloned putative 
promoter sequence upstream of a promoter less lacZ gene, followed by integration in 
single copy in to the attP site of M.smegmatis. The choice of integrative vectors for 
this particular work was necessary in order to have a single copy o f the promoter-p- 
gal fusion in each strain to accurately determine regulation. M.smegmatis strain SM3 
(Appendix 2) is an ideR isogenic mutant strain demonstrating no IdeR activity by 
western blotting (Dussurget et al, 1996). The SM3 strain has a slower doubling time, 
typically 6 hours, than the parent M.smegmatis mc^l55 strain (Benjamin Gold 
personal communication). Recent work carried out by Gold et al have demonstrated 
that the M.tuberculosis bfd promoter is regulated by IdeR and the cellular 
concentration of iron in M.smegmatis. Indeed the promoter demonstrated increased 
activity under iron starved growth conditions and also in the SM3 isogenic mutant 
strain (Gold et a l,  2001). Therefore, M.smegmatis mc^l55 harbouring an integrated 
vector, ^8mbfd  containing the bfd promoter fused to LacZ  (designated strain 8Mbfd) 
and M.smegmatis SM3 harbouring the same integrated vector construct (designated 
SMZibfd) were used as a positive control in the following experiments (Appendix 2).
a) Generation of 34kDa putative serine protease promoter-P-gal fusion vectors
The upstream sequence of the 34kDa putative serine protease was amplified by PCR 
from pGEM34P as described in section 5.2.1b. pSml28 vector DNA (Appendix 2) 
was digested to completion with the restriction enzyme Sea I and purified from LMP 
agarose (section 2.2.4). The 317 bp PCR fragment was ligated into the linearised 
pSml28 vector with a insert:vector molar ratio of 1:1 (see section 2.2.7). The blunt 
end ligation protocol was similar to that used to successfully clone the 34kDa 
putative serine protease and upstream region into the pUS972 vector (section 5.3.3). 
The ligation reaction was digested to completion with the Sea I restriction enzyme, 
digesting re-ligated pSml28 vector but not pSml28 containing the insert. Five pi of 
digested ligation reaction was then used to transform E.coli JM109 chemically
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competent cells (see section 2.3.3) with positive transformants selected on L-B agar 
media supplemented with 20 pg/ml streptomycin.
The resulting plasmid DNA, designated pSm34p, was sequenced in both directions 
with the same primers used to generate the cloned fragment (see section 5.2.2). The 
sequence confirmed the orientation of the promoter fragment relative to the 
downstream lacZ coding sequence. The cloned PCR fragment was present in the 
plasmid DNA in both orientations as shown in Figure 5.10. pSm34pI contains the 
fragment in an orientation capable of expressing lacZ, where as pSM34pII contains 
the fragment in the opposite orientation such that no expression o f lacZ is expected 
(Appendix 2).
b) Introduction of pSm34pl and pSm34pII into M.smegmatis strains
In order to determine if  the putative IdeR box located in the upstream region of the 
34kDa putative serine protease was capable of controlling gene expression through 
IdeR, both pSm34pI and pSm34pII were electroporated into M.smegmatis SM3 and 
M.smegmatis mc^I55 (section 2.3.1b and 2.3.2b) and positive transformants selected 
on 7H11S (Appendix 3) medium supplemented with 20pg/ml streptomycin. In the 
case of recombinant SM3 strains streptomycin resistant transformants were 
subsequently grown on 7H11S media supplemented with 30 pg/ml kanamycin, to 
confirm the presence of the inactive IdeR gene. M.smegmatis SM3 transformants 
harbouring the integrated pSm34pI and pSm34pII vectors were designated ^M 3l34pl 
and SM3l34pII respectively. Similarly M.smegmatis mc^l55 transformants 
harbouring integrated vector were designated SM34pI and ^M34pII. pSml28 vector 
was also electroporated into M.smegmatis mc^l55 and M.smegmatis SM3 generating 
the control strains SM725 and SM3/725 respectively.
c) Expression of p-gal from 34kDa putative serine protease promoter
In order to test transcriptional activity of the 34kDa putative serine protease 
promoter, recombinant M.smegmatis SM3 strains (SM 3/2^7, ^M3l34pII, SMZtbfd) 
and the M.smegmatis mc^l55 strains (SM54/?/, SM34pII, ^Mbfd) were assayed for p- 
gal activity using the X-gal substrate on solid media (see section 5.2.3). SM3/54p/ 
was shown to demonstrate positive expression of P-gal, as measured by the
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Figure 5.10 Upstream putative promoter region of the 34kDa putative serine 
protease was cloned into Sea I site o f the integrative pSml28 vector up stream from 
the promoter-less lacZ gene. The vector is a transcriptional fusion as the lacZ gene 
has a RBS allowing expression of the protein from the mRNA produced from any 
cloned promoter. The Figure shows the location of the promoter fragment in the 
pSml28 vector upstream from start o f lacZ ORF. Also shown are the locations of the 
PCR primers used to generate the fragment for cloning and similarly used to 
sequence the fragment in the pSml28 vector, the sequences of which can be found in 
section 5.2.1. The Figure was generated using the Vector NTI suite based on 
available sequence data (Appendix 4).
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appearance of blue colonies in the presence of X-gal. Similarly SM ibfd  colonies 
demonstrated positive expression of P-gal under similar growth conditions. However, 
SM34pI and SMbfd were also positive for P-gal expression in the presence of X-gal. 
Strains SM3/54/?//, SM34pII, SM128 and SM3/725 were all negative for expression 
of p-gal under the same conditions. The positive demonstration of p-gal activity for 
both ^M 34pl and SM3/54p7 was suggestive that the transcriptional activity of the 
upstream 34kDa putative serine protease promoter was not regulated by the presence 
of IdeR. However, it was also noted that SMbfd demonstrated p-gal activity, in spite 
of the presence of functional IdeR in these strains. This was unexpected, as the bfd 
promoter has been shown to demonstrate repression in the presence of IdeR and iron 
in the growth media (Gold et al, 2001). The residual activity of the bfd promoter in 
M.smegmatis mc^l55, grown in the presence o f iron, was attributed to the incomplete 
suppression of promoter activity by IdeR. A similar situation may have existed for 
the 34kDa putative serine protease promoter, with incomplete repression of the 
promoter in M.smegmatis mc^l55 under normal growth conditions. The use of a 
solid media based p-gal precluded an accurate measurement the P-gal activity for 
each strain as it relies on the appearance of blue colonies alone.
A second more sensitive p-gal assay was employed to demonstrate the potential 
regulation of the 34kDa putative serine protease promoter. The protocol utilises the 
ONPG substrate and allows the cells to be grown in liquid cultures, facilitating the 
manipulation of the growth conditions (section 5.2.4). Mycobacterial cell pellets 
were prepared for the all strains as described in 5.2.4, each lysate was tested for P-gal 
activity as described in section 5.2.5. As expected, bfd-lacZ fusions were repressed in 
the presence of iron in M.smegmatis mc^l55, as the p-gal levels obtained for strain 
^M bfd  under conditions of low iron were significantly higher than those obtained in 
iron replete conditions (Table 5.1). Expression of the bfd-lacZ fusion was 
independent of iron in the ideR mutant strain SM3, where levels were similar to those 
obtained with bfd-lacZ in M.smegmatis mc^l55 under low iron conditions. The low 
p-gal activity seen for the bfd-lacZ fusion in S M ^  under high iron conditions and in 
SMbfd may be sufficient to explain the appearance of positive p-gal colonies on solid 
media in section 5.2.5.
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Strain -DP +DP Activation*
S M ^ 14.8 (2.4) 348.2 (26.5) 23.6
SM 3Z^ 306.1 (23.5) 287.2 (7.0) 0.9
SM54p7 11.0 (2.4) 11.6(1.9) 1.1
SM3/34p7 3.2 (0.9) 4.7 (0.9) 1.5
SM128 0.5 (0.1) 1.0 (0.5) 2.0
SM3/72($ 0.9 (0.2) 0.3 (0.1) 0.3
Table 5.1 Shown is the p-gal activity (expressed as Miller Units) o f each strain, 
determined as described in section 5.2.5. The bfd promoter demonstrates increased 
expression under iron limiting conditions (+DP) and also constitutively high 
expression in M.smegmatis SM3 irrespective of iron concentration (SM 3/7/^ 
expression +DP/-DP indicates that the strains were grown in the presence or absence 
of the iron chelator Dipyridyl. * Activation is the ratio o f p-gal activity between the 
same strain grown in the presence or absence of Dipyridyl. For strain nomenclature 
see text. Standard deviations are shown in parenthesis.
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The 34kDa putative serine protease-lacZ fusion p-gal expression levels in SM34pI 
were similar in both high- and low-iron growth conditions (Table 5.1). Similar 
results were seen for the 34kDa putative serine protease-lacZ fusions in SM3 (Table 
5.1). The failure to show induction of the promoter under iron limiting conditions in 
mc^l55 and similarly the low level of expression found in the IdeR knockout SM3 
strain, suggest that the 34kDa putative serine protease promoter is not regulated by 
IdeR in M.smegmatis. The levels of p-gal observed for the 34kDa putative serine 
protease-lacZ ÎMsion in mc^l55 and SM3 were comparable, demonstrating 
constitutive expression in both M.smegmatis strains independent of the presence of 
IdeR or iron limiting conditions.
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5.4 Discussion
Mycobacterial genes that undergo specific up-regulation within the host cells may be 
important for the intracellular survival and virulence o f the bacterium. As such, 
determining the specific regulation of a gene offers an insight into whether the gene 
is constitutively expressed or expressed as a result o f exposure to a specific 
environmental stimuli encountered in the host cell. The work described in this 
chapter attempted to address two important points in the potential regulation of the 
34kDa putative serine protease, the presence of a promoter in the upstream region of 
the gene in M.a.paratuberculosis and the specific signals regulating the 
transcriptional activity of the promoter.
The continuing M.avium genome project allowed the identification of the 
M.a.paratuberculosis 34kDa putative serine protease homologue in M.avium. As 
expected, given that the MAC comprises a group of closely related organisms 
exhibiting up to 98% homology at the genomic level the sequence of the 34kDa 
putative serine protease was identical for both species. The available cosmid 
sequence data also facilitated the identification of the upstream region of the gene in 
M.avium. This region was shown to be identical to corresponding region in 
M.a.paratuberculosis. This suggests that the any transcriptional machinery and 
regulatory elements located in the upstream region are capable of expressing the 
gene in both species
Analysis of the upstream region of the 34kDa putative serine protease in 
M.a.paratuberculosis using a consensus promoter recognition site constructed from 
several, different mycobacterial promoters (MPI) failed to identify any 
mycobacterial promoter element. Similarly a search for sequences exhibiting identity 
to a M.a.paratuberculosis promoter consensus also failed to identify a promoter in 
the upstream region. A second promoter homology search using the promoter predict 
program created at the Centenary Institute in Australia located two potential 
promoter elements in the upstream region of the 34kDa putative serine protease. 
However, the level of identity observed for between both promoters and the 
consensus sequence was relatively low. The major difference in the promoter 
consensus sequences MPI and that used by the promoter predict program, that o f
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Mulder et al (Mulder et al, 1997), appears to reside in the -10  sequence, in particular 
the central two nucleotides of the hexamer. In M PI these nucleotides are GC where 
as in Mulder et al the corresponding nucleotides are TA, more closely resembling the 
E.coli a^^-like promoter consensus. The failure to identify a strong consensus 
promoter does not preclude the presence of a functional promoter in this region. 
Several reports have identified mycobacterial promoters that show weak or no 
homology to previously identified promoters (Bashyam et al, 1996; Jain et al, 1997; 
DasGupta et al, 1998), including a study demonstrating that a set of identified 
M.a.paratuberculosis promoters appear more similar to each other than to other 
mycobacterial promoters (Thomas et al, 1992). Similarly mycobacterial promoters 
with no recognisable -10  or -35 consensus sequences have been demonstrated to 
undergo specific up-regulation in response to environmental stress conditions.
Another possible reason for the failure to identify a promoter element was that the 
consensus sequence used for both the -35 and -10  regions and the methodology of 
aligning the small -35 and -10  regions to larger fragments may not have been 
sufficiently robust to detect a promoter element. The upstream region of the 
conserved mycobacterial p40 gene from several mycobacterial species was analysed 
for the presence of recognisable promoter elements using the same consensus -10  
and -35 consensus hexamers. A promoter was identified in the upstream region 
located 7bp to the start o f the gene. While the putative promoter has not been 
demonstrated to be transcriptionally active the finding of homologous -35 and -10  
consensus sequences in the upstream p40  region demonstrate that it was possible to 
identify promoter consensus elements using this approach (Inglis et al, 2001).
Finally the lack of a promoter homologue in the upstream region may have also be 
indicative of the gene being part of an operon, transcribed from a distal promoter. 
The full annotation of both the M.avium and M.a.paratuberculosis genomes are 
currently unavailable and therefor the intergenic distance between the 34kDa 
putative serine protease and the upstream gene was not known. In M.tuberculosis the 
distance between the 34kDa putative serine protease homologue pepA and the 
upstream gene Rv0124 is 155 bp, sufficient for the presence o f a promoter in that 
species. The 155 bp demonstrating little homology to the upstream region of the
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34kDa putative serine protease, which may suggest that, the transcription of pepA  in 
M.tuberculosis is different from the 34kDa putative serine protease in 
M.a.paratuberculosis. In essence to demonstrate the presence of a promoter in the 
upstream region, functional experimental evidence was required.
The 346 bp of 34kDa putative serine protease upstream sequence was demonstrated 
to be capable of expressing the protein in M.smegmatis mc^l55. This region 
therefore contains all the transcriptional signals necessary to express the gene in 
M.smegmatis mc^l55. Transcriptional activity was seen when the fragment was in 
both orientations relative to the plasmid. The backbone plasmid does not contain a 
transcriptional terminator in the immediate upstream region of the vector MCS used 
in the cloning procedure. As such the 34kDa putative serine protease detected by 
western blotting may have been the result o f transcriptional read through from the 
surrounding plasmid DNA. Demonstrating expression of the gene in both 
orientations argues against transcriptional read through as being the source o f the 
34kDa putative serine protease.
The relative level of 34kDa putative serine protease protein expressed from its own 
promoter as detected on western blots was less than that for the hsp60 promoter 
expressed 34kDa putative serine protease, despite the fact that approximately equal 
amounts of protein were added to each well. The reason for this may be reflected in 
the relative activity of the two promoters. Dellagostin et al demonstrated that in 
terms of p-gal activity the M.leprae 18kDa promoter was weak compared to the 
hsp60 promoter in culture but that a large increase was seen for the 18kDa promoter 
in vivo (Dellagostin et al, 1995). The authors also noted high constitutive expression 
for the hsp60 promoter. The level of transcriptional activity for 34kDa putative 
serine protease promoter appears to be low under normal growth conditions in 
comparison to hsp60 promoter expression. This finding raised an interesting question 
as to promoter regulation, namely is the promoter a constitutively expressed 
promoter under all conditions or does it exhibit specific up-regulation under stress 
conditions? Further work would be required to determine the exact transcriptional 
signals resulting in expression of the 34kDa putative serine protease. Similarly 
further work would be necessary to confirm that a similar pattern of gene expression
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from the 34kDa putative serine protease promoter was also seen in 
M.a.paratuberculosis.
Few transcriptional regulatory proteins have thus far been well characterised for 
mycobacteria. One exception is the iron dependant transcriptional repressor IdeR. In 
the presence of divalent metals, IdeR has been shown to bind to a number of so 
called “iron box” elements located upstream of several genes in mycobacteria 
(Manabe et al, 1999), including Rv0983, annotated in the TUBERCULIST genome 
database as a M.tuberculosis serine protease homologue and also independently 
identified by Skeiky et al as MT32B, a major secreted putative serine protease of 
M.tuberculosis (Skeiky Y A, 1999). The potential regulation of a mycobacterial 
serine protease by IdeR initiated an analysis of the upstream region o f the 34kDa 
putative serine protease for the presence o f an “Iron Box” element. A 65% 
homologous sequence was identified approximately 250 base pairs from the start of 
the gene. It was also possible to show the presence of a IdeR homologue in the 
M.a.paratuberculosis unfinished genome (data not shown). Fusions of the 34kDa 
putative serine protease upstream promoter region with lacZ failed to demonstrate a 
role for IdeR in the regulation of the 34kDa putative serine protease. Gold et al, have 
recently published a comprehensive computer based analysis of the M.tuberculosis 
genome searching for potential IdeR binding sites (Gold et al, 2001). In their studies 
they use a cut off point of 5 mismatches between the target site and the consensus 
sequence. In the case of the IdeR box identified in the upstream region, 8 mismatches 
were observed. Similarly, the Rv0983 Iron Box homologue was shown to bind IdeR 
in gel shift experiments only and no experimental determination of transcriptional 
repression by IdeR was presented. More recent evidence has argued that Rv0983 is 
potentially part of a regulon of contiguous genes (Rv0981, Rv0982, Rv0983 and 
Rv0984) up-regulated by following SDS treatment (Manganelli et al, 2001). As 
such the assignation of a regulatory function to a homologous sequence based solely 
on gel shift may represent an artefact of that technique and not a true biologically 
significant interaction, is also thought to regulate the expression of another HtrA 
homologue in M.tuberculosis, which has been annotated as HtrA in the 
TUBERCULIST database (Smith et a l, 1998). In E.coli degP QitrA) and degQ have 
been shown to be regulated in response to the accumulation of damaged or denatured
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proteins in the periplasm (Laskowska et a l, 1996). The third HtrA homologue, degS, 
demonstrates constitutive expression under all conditions (Alba et a l,  2001). The p- 
gal activity of the transcriptional fusion was constitutively low in M.smegmatis 
mc^l55 under both low- and high-iron conditions and comparable to the levels seen 
in Sm3. These results complemented the low level of expression observed for 
expression of the 34kDa putative serine protease from its own promoter, relative to 
expression from the hsp60 promoter. The potential therefore exists that the gene is 
expressed at a constitutively low level under all growth conditions. However, it may 
also be the case that the promoter undergoes up-regulation in the host cell, similarly 
only a subset of environmental stimuli have been examined as potential up-regulators 
of the 34kDa putative serine protease promoter. Further work is required to fully 
elucidate the exact transcriptional activity both in culture under various stress 
conditions and in vivo. It must also be noted that the results presented here, relate 
specifically to the expression of the promoter in M.smegmatis, the possibility exists 
that the gene may not be regulated in the same way in M.a.paratuberculosis.
In conclusion, the evidence presented in this chapter suggests that a functional 
mycobacterial promoter is located in the 317 bp of sequence immediately upstream 
of the 34kDa putative serine protease in M.a.paratuberculosis. The exact mechanism 
regulating the transcriptional activity remains to be defined. However, and despite 
the presence of a IdeR box homologue in the upstream region, the promoter is not 
regulated by IdeR or iron concentration as no increase in expression was observed in 
iron depleted media or in an isogenic M.smegmatis mutant strain lacking IdeR. The 
identification of a promoter element suggests that the gene is not part of an operon, 
whose gene expression is controlled by a remote promoter. However, the exact 
location o f promoter has not heen determined.
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CHAPTER 6 
GENERAL DISCUSSION
The central aim of the work presented in this thesis was to characterise further the 
M.a.paratuberculosis 34kDa putative serine protease, with particular focus on the 
role that the protein plays in the virulence of M.a.paratuberculosis. The 34kDa 
putative serine protease ORF was cloned into a mycobacterial shuttle vector under 
the transcriptional control of the hsp60 promoter. The expression and subsequent 
secretion of the recombinant protein by M.smegmatis mc^l55 was shown. This was 
o f critical importance, as it appeared likely that secretion o f the protein into the 
extracellular milieu may be required for any virulence-associated function. This 
observation was based on the antigenic properties o f the protein in sheep naturally 
infected with M.a.paratuberculosis. A robust and reproducible intracellular survival 
assay was developed using OA-macrophages. The choice o f OA-macrophages 
reflected a desire to develop an assay that approximated as closely as possible the 
type of host cells encountered by M.a.paratuberculosis during the course o f natural 
infection. M.smegmatis mc^l55 expressing the 34kDa putative serine protease 
demonstrated increased survival in OA-macrophages over the initial 24 hours of 
infection in comparison to M.smegmatis expressing GFP and wild-type M.smegmatis 
mc^l55. The presence of the gene did not increase the ability of M.smegmatis to 
enter macrophages as no significant differences were observed between the 
experimental and control groups following phagocytosis. The overall increase in 
survival observed was low with the presence of the protein having no affect on the 
long-term intracellular survival of M.smegmatis mc^l55.
Transcriptional activity capable of expressing the gene in M.smegmatis mc^l55 was 
observed in the region immediately upstream of the 34kDa putative serine protease 
ORF. A similar level of increased intracellular survival was observed when the 
34kDa putative serine protease was expressed in M.smegmatis mc^l55 from the 
endogenous promoter as observed when the 34kDa putative serine protease was 
expressed from the hsp60 promoter. An examination of the sequence upstream of the
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34kDa putative serine protease revealed the presence of a putative IdeR regulatory 
sequence, an IdeR ‘box’. However, further studies failed to confirm a role for IdeR in 
the regulation of the transcriptional activity of the 34kDa putative serine protease in 
M.smegmatis mc^l55. Transcriptional start point mapping is required before the 
exact location of the promoter can be determined in the upstream region. Similarly, 
the regulatory mechanisms determining the expression of the 34kDa putative serine 
protease remain to be determined. The transcriptional activity and regulation of the 
promoter must be confirmed in M.a.paratuberculosis, as differences may exist in 
promoter recognition and activity between M.a.paratuberculosis and M.smegmatis.
6.1 The 34kDa Putative Serine Protease and Pathogenesis
The inability of the 34kDa putative serine protease to prevent bacterial killing over 
72 hours suggests that the presence of the protein is unable to prevent the 
acidification of the phagosome containing ingested mycobacterial and its entry into 
the late endosomal pathway. The protective function of the 34kDa putative serine 
protease in M.smegmatis mc^l55 was associated with the initial stages o f infection 
following ingestion by macrophages. Phagocytic cells, including macrophages, are 
known to produce toxic oxygen metabolites following the ingestion of 
microorganisms (Krause, 2000). Superoxide can not only cause bacterial damage on 
its own but also participates in a chemical reaction with hydrogen peroxide and iron 
(the Fenton mechanism) that can produce an even more toxic hydroxyl radical 
(Miller and Britigan, 1997). Indeed, the function of HtrA in the pathogenesis of other 
intracellular pathogens has been postulated to be associated with the degradation of 
oxidatively damaged proteins in the periplasmic space, preventing their accumulation 
to toxic levels (Fallen and Wren, 1997). It is tempting to speculate that the presence 
of the 34kDa putative serine protease affords protection against such oxidative 
metabolites resulting in the observed increase in survival mM.smegmatis mc^l55.
There are currently two postulated mechanisms by which pathogenic mycobacteria 
protect themselves from toxic oxygen metabolites. Firstly, pathogenic mycobacteria 
are thought to enter mononuclear phagocytes via complement receptors and 
component C3, a mechanism that prevents the activation of an oxidative burst and its 
associated toxic consequences (Bermudez et a l, 1999; El Etr and Cirillo, 2001).
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Secondly, pathogenic mycobacteria including M.avium have been shown to export an 
iron-dependant superoxide dismutase (SOD) that is almost exclusively associated 
with the cytosol or cell membrane of the non-pathogenic M.smegmatis and M.phlei 
(Harth and Horwitz, 1999; El Etr and Cirillo, 2001). However, no signal peptide 
element was observed at the N-terminal region of the protein. M.smegmatis was 
shown to be capable of exporting the M.avium SOD, suggesting that the nucleotide 
sequence of the recombinant protein contained all the requirements to direct the 
export of the protein (Escuyer et a l, 1996). The secretion of SOD by pathogenic 
strains may afford protection against oxygen metabolites in two ways. Firstly, by 
neutralising such toxic radicals before they can interact with the mycobacterial cell 
wall, and secondly, by limiting the availability of iron in the host cell for 
participation in the Fenton mechanism. The unique structure and composition o f the 
mycobacterial cell envelope has been implicated as an important constitutive 
component of the virulence of mycobacterial species. Interestingly, a capsule has 
been observed to surround virulent mycobacteria growing intracellularly (Daffe and 
Etienne, 1999). The significance of such a structure in pathogenesis remains to be 
determined. However, it may prove pivotal in controlling the bacterial-host 
interaction and possibly also retain exported proteins crucial in the survival o f the 
bacillus in the host mononuclear phagocyte.
The secretion of the 34kDa putative serine protease may facilitate the degradation of 
oxidatively damaged or denatured proteins associated with the mycobacterial outer 
cell wall or possibly the proposed protective capsule. Such damaged proteins could 
be inaccessible to degradation by membrane associated or cytosolic proteases. Under 
this hypothesis the 34kDa putative serine protease is acting to prevent the 
accumulation of damaged proteins, maintaining the integrity of the cell wall or 
capsule. The secreted protein would therefore be expected to be associated with the 
bacillus in the phagosome of the infected phagocytic cell. The immunological 
detection of the 34kDa putative serine protease in infected macrophages was 
attempted but was unsuccessful. Further work using polyclonal antibodies against the 
34kDa putative serine protease is required to demonstrate the presence o f the 
recombinant protein in infected macrophages and also to indicate the cellular fate of 
the secreted protein. It remains possible that the 34kDa putative serine protease is not
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associated with the mycobacterial cell in the phagosome, implying a direct 
interaction between the protein and components of the host cell. Similarly, further 
studies of the intracellular survival of M.smegmatis mc^l55 expressing a 34kDa 
putative serine protease derivative lacking the signal peptide would ascertain if  the 
secretion of the protein were critical in the function of the 34kDa putative serine 
protease.
Other extracellular proteins exported by M.tuberculosis have been implicated in 
pathogenesis, including the mycolyl transferases of the Antigen 85 complex, 
glutamine synthetase, and the macrophage cell entry protein (Andersen et a l,  1992; 
Arruda et a l, 1993; Harth et a l,  1994; Belisle et a l,  1997). Indeed, M.smegmatis 
expressing the M.tuberculosis glutamine synthase {glnA) gene exhibited increased 
survival in THP-1 macrophage-like cell line (Miller and Shinnick, 2000). A recent 
comparison of pathogenic and non-pathogenic mycobacterial species revealed eight 
differences in the extracellular location, secreted or surface exposed, of 
enzymatically active proteins in M.tuberculosis and M.avium that are predominantly 
associated with the cytosol or located deeper in the cell envelope in the non- 
pathogenic strains M.smegmatis and M.phlei (Raynaud et a l,  1998). The export of 
proteins by pathogenic mycobacteria into the extracellular environment therefore 
represents a significant difference between pathogenic and non-pathogenic 
mycobacterial species with important implications for host-pathogen interaction.
6.2 HtrA-like Proteins in Mycobacteria
There are three HtrA-like genes in the annotated genome of M.tuberculosis H37Rv, 
namely htrA,pepA  and Rv0983, for which limited functional information is available 
in the literature (Wu et a l, 1997; Skeiky et a l,  1999; Miller and Shinnick, 2000; 
Manganelli et a l,  2001). M.tuberculosis HtrA has been shown to be located 
downstream from and co-transcribed with the alternative sigma factor, (W u  et al, 
1997). Interestingly, expression of the M.tuberculosis HtrA gene in M.smegmatis did 
not increase the intracellular survival of the bacillus in mononuclear phagocytes, 
questioning the role of the protein in the pathogenesis of M.tuberculosis (Miller and 
Shinnick, 2000). However, this does not preclude the involvement o f HtrA in 
pathogenesis as the protein may function differently in M.tuberculosis.
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M.tuberculosis HtrA (549 amino acids) homologues were identified in the genomes 
of M.leprae, M.bovis, M.avium and M.smegmatis (Table 6.1).
Rv0983 (MTB32B) was shown to be present in the CF of M.tuberculosis, although 
no recognisable signal peptidase cleavage site was found (Skeiky et al, 1999). This 
suggests that the protein may be surface exposed or is exported via an alternative 
mechanism as has been proposed for both the M.tuberculosis SOD and glutamine 
synthase proteins (Harth and Horwitz, 1999). Highly conserved homologues of 
Rv0983 were found in the genomes o îM.leprae, M.bovis, M.avium m d  M.smegmatis 
(Table 6.2). Recently, Rv0983 has been postulated to be part o f a regulon of four 
genes in M.tuberculosis regulated by in response to SDS-stress (Manganelli et al, 
2001). The presence of highly conserved orthologues o f both Rv0983 and HtrA in 
both pathogenic and non-pathogenic mycobacteria and their regulation by a stress 
associated alternative sigma factor suggests that they represent a conserved feature of 
the mycobacterial stress response.
M.tuberculosis PepA was also shown to be an important component of the 
M.tuberculosis CF demonstrating significant homology to M.a.paratuberculosis 
34kDa putative serine protease (Table 6.3). The proteins also share several 
phenotypic similarities including the extracellular location of the protein and 
associated antigenic properties (Cameron et a l, 1994; Skeiky et al, 1999). Therefore, 
it appears likely that PepA is the functional homologue o f the 34kDa putative serine 
protease in M.tuberculosis. The 34kDa putative serine protease is highly conserved 
in the genomes of M.bovis and M.leprae but not in the genome of the non-pathogenic 
M.smegmatis strain (Table 6.3). Although it should be noted that confirmation o f the 
absence of a conserved 34kDa putative serine protease homologue in the genome of 
M.smegmatis is required upon completion of the genome sequence. However, given 
the high level of sequence identity observed and the evidence provided in this thesis 
the possibility remains that such proteins may represent an important conserved 
feature of mycobacterial pathogenesis. However, this remains speculative as no role 
in pathogenesis for either PepA or ML2659 has been reported in the literature.
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Mycobacterial 
Species (ORF)
Identity Probability
Score
Source
M.avium
(Unassigned**)
74% identity in 
506 amino acid 
overlap
1.9e-194 TIGR M.avium genome sequencing 
project
http://tigrblast.tigr.org/ufmg/
M.leprae
(HtrA)
81.8% identity in 
533 amino acid 
overlap
0 Pasteur Institute LEPROMA 
database
http://genolist.pasteur.fr/Leproma/
M.bovis
(Unassigned**)
87% identity in 
540 amino acid 
overlap
2.2e-239 Welcome Sanger Centre M.bovis 
genome sequencing project 
http://www.sanger.ac.uk/Projects/ 
M_bovis/blast_server.shtmI
M.smegmatis
(Unassigned**)
68% identity 
over 508 amino 
acids
l.le-176 TIGR M.smegmatis genome 
sequencing project 
http://tigrblast.tigr.org/ufmg/
Table 6.1 Homologues of the M.tuberculosis HtrA in the genomes o f other 
mycobacterial species. For the unfinished genomes of M.avium, M.bovis and 
M.smegmatis the entire 542 amino acids of HtrA were used to search the unfinished 
genome using the TBLASTN facility provided by the corresponding database server. 
Unassigned**; no genomic annotation available. M.tuberculosis HtrA was also 
detected in the genomes of M.tuberculosis CDC1551 (annotated as MT0133) and 
M.tuberculosis 210.
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M ycobacterial 
Species (ORF)
Identity Probability
Score
Source
M.avium
(Unassigned**)
74% identity in 
458 amino acid 
overlap
3.6e-106 TIGR M.avium genome 
sequencing project 
http://tigrblast.tigr.org/ufmg/
M.leprae
(ML0176)
74.5% identity 
in 467 amino 
acid overlap
e-134 Pasteur Institute LEPROMA 
database
http://genoIist.pasteur.fr/Leproma/
M.bovis
(Unassigned**)
78% identity in 
464 amino acid 
overlap
6.7e-179 Welcome Sanger Centre M.bovis 
genome sequencing project 
http://www.sanger.ac.uk/Projects/ 
M_bovis/blast_server.shtml
M.smegmatis
(Unassigned**)
67% identity in 
458 amino acid 
overlap
3.5e-147 TIGR M.smegmatis genome 
sequencing project 
http://tigrblast.tigr.org/ufmg/
Table 6.2 Homologues of the M.tuberculosis Rv0983 in the genomes of other 
mycobacterial species. For the unfinished genomes of M.avium, M.bovis and 
M.smegmatis the entire 464 amino acids o f Rv0983 were used to search the 
unfinished genome using the TBLASTN facility provided by the corresponding 
database server. Unassigned** no genomic annotation available. M.tuberculosis 
Rv0983 was also detected in the genomes of M.tuberculosis CDC1551 genome 
(annotated as M T lO ll) m d M.tuberculosis 210.
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Mycobacterial
Species
Identity Probability
Score
Source
M.tuberculosis
(PepA*)
70.7% identity 
in 362 amino 
acid overlap
e-143 Pasteur Institute TUBERCULIST 
database
http://genoIist.pasteur.fr/TubercuLis1
M.leprae
(ML2659)
71.4% identity 
in 364 amino 
acid overlap
e-145 Pasteur Institute LEPROMA 
database
http://genolist.pasteur.fr/Leproma/
M.bovis
(Unassigned**)
71% identity in 
316 amino acid 
overlap
8.9e-119 Welcome Sanger Centre M.bovis 
genome sequencing project 
http://www.sanger.ac.uk/Projects/ 
M bovis/blastserver.shtml
M.smegmatis
(Unassigned**)
46% identity in 
309 amino acid 
overlap
1.5e-66 TIGR M.smegmatis genome 
sequencing project 
http://tigrblast.tigr.org/ufmg/
Table 6.3 Homologues of the 34kDa putative serine protease in the genomes o f other 
mycobacterial species. For the unfinished genomes o f M.bovis and M.smegmatis the 
entire 361 amino acids of 34kDa putative serine protease were used to search the 
unfinished genome using the TBLASTN faeility provided by the corresponding 
database server. Unassigned**; no annotation available. PepA* has also been shown 
to be present in the genomes of M.tuberculosis strain 210 and M.tuberculosis strain 
CDC1551 (annotated as MT0133).
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The sequencing of the attenuated vaccine strain M.bovis BCG Pasteur is ongoing 
(http://www.pasteur.fr/recherche/unites/Lgmb/mycogenomics.html), with no BLAST 
facility available yet to confirm the presence or absence of any mycobacterial HtrA 
like genes in this species. Numerous genome deletions and tandem duplications have 
been reported in M.bovis BCG relative to M.tuberculosis H37Rv (Behr et a l, 1999). 
However, the deleted regions identified do not correspond to the genomic regions 
encoding htrA, Rv0983 orpepA  in the M.tuberculosis H37Rv genome 
(http://www.pasteur.fr/recherche/unites/Lgmb/Deletion.html).
All three HtrA-like proteins in M.tuberculosis (PepA, Rv0983 and HtrA) 
demonstrate greater sequence identity to each other than to other HtrA like proteins 
from other bacterial families. However, they still retain the conserved features of a 
trypsin like serine protease (see Figure 1.1) and as such they represent an 
orthologous group of proteins. Each HtrA demonstrates greater homology to the 
corresponding paralogue in other mycobacterial species. The high level o f sequence 
conservation observed suggests that these proteins fulfil conserved roles in 
mycobacteria. The presence of homologues of Rv0983 and HtrA in the non- 
pathogenic M.smegmatis suggest that these genes and the corresponding proteins 
may be components of a general stress response common to mycobacteria in general. 
However the apparent lack of a 34kDa putative serine protease homologous gene in 
M.smegmatis suggests that this particular paralogous group may have a conserved 
role in pathogenesis possibly associated with increased survival in the intracellular 
environment of the host cell. Under this hypothesis all three HtrA like proteins in 
mycobacteria function as serine proteases protecting the bacilli during stress, with 
the 34kDa putative serine protease and its orthologues affording protection in the 
intracellular environment.
The sequencing of the attenuated vaccine strain M.bovis BCG Pasteur is ongoing 
(http://www.pasteur.fr/recherche/unites/Lgmb/mycogenomics.html), with no BLAST 
facility available yet to confirm the presence or absence o f any mycobacterial HtrA 
like genes in this species. Numerous genome deletions and tandem duplications have 
been reported in M.bovis BCG relative to M.tuberculosis H37Rv (Behr e/ a l,  1999).
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However, the deleted regions identified do not correspond to the genomic regions 
encoding htrA, Rv0983 o rpepA in the M.tuberculosis H37Rv genome 
(http://www.pastenr.ff/recherche/nnites/Lgmh/Deletion.html).
Mycobacterial pathogenesis is a complicated and dynamic process requiring 
numerous protein products co-ordinately expressed by the bacillus in response to the 
changing environment of the host mononuclear phagocyte. The precise mechanisms 
that permit the bacillus to survive and replicate intracellularly remain to be fully 
determined. The continuing development of techniques to examine the mycobacterial 
transcriptome and proteome coupled to the complete genome sequence of the 
bacillus will greatly enhance our understanding o f the underlying molecular 
mechanisms of mycobacterial pathogenesis. The evidence presented here indicates 
that the 34kDa putative serine protease may protect M.a.paratuberculosis from 
oxidative damage in host macrophages, and possibly represents a conserved 
protective mechanism shared among all pathogenic mycobacteria.
6.3 Future Work
The exact function that the 34kDa putative serine protease plays in the virulence of 
M.a.paratuberculosis remains to be determined. Several observations from the work 
presented here merit further investigation. The extracellular location o f the protein is 
considered a crucial component in the observed increase in intracellular survival for 
M.smegmatis expressing the 34kDa putative serine protease. Information regarding 
the cellular fate of the secreted protein would indicate whether or not the protein is 
associated with the ingested bacillus, supporting the hypothesis that the 34kDa 
putative serine protease affords protection against the effects o f host oxidative 
metabolites. Similarly, expressing the 34kDa putative serine protease without the 
signal peptide in M.smegmatis would also confirm the requirement of the gene in the 
extracellular milieu for its protective function.
While it appears likely that a promoter is located in the upstream region of the gene 
in M.a.paratuberculosis, the exact location o f such a promoter element and the 
environmental conditions controlling its transcriptional activity remain to be 
determined. Characterisation of the presence of a 34kDa putative serine protease
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homologue in the genomes o f other non-pathogenic mycobacteria may help to 
establish if the presence of a homologous protein is associated exclusively with the 
pathogenic members o f the genus. Finally, of critical importance in confirming a role 
in M.a.paratuberculosis virulence for the 34kDa putative serine protease is the 
determination of the phenotypic characterisation o f a M.a.paratuberculosis null 
mutant in OA-macrophages and ultimately in animal models. Techniques allowing 
the selective replacement of gene sequences with inactivated copies have been 
developed for mycobacteria. Attempts have already been made to apply such 
techniques in the generation of null mutants in M.a.paratuberculosis at the 
University of Surrey. The successful application o f reverse genetic techniques to 
M.a.paratuberculosis remains a priority in determining the role that the 34kDa 
putative serine protease and possibly other M.a.paratuberculosis gene sequences 
play in pathogenesis.
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Bacterial Strains and Vectors
Mycobacterium
Species/Strain
M. a.paratuberculosis :
F13
JDl
F162
51/91
R7
R186
JD88/107
Source/Details
SAC Perth, Scotland, UK: 
SAC Perth, Scotland, UK: 
SAC Perth, Scotland, UK: 
MRI, ovine isolate 
SAC Perth, Scotland, UK: 
SAC Perth, Scotland, UK: 
SAC Perth, Scotland, UK:
bovine isolate 
bovine isolate 
ovine isolate
leporine isolate 
leporine isolate 
cervine isolate
M. a. avium 
JD88/118 MRI, cervine isolate (type A/I)
M.smegmatis
mc^l55*
SM3
High transformation efficiency mutant o f M.smegmatis 
ATCC607 (Snapper et a l,  1990)
Isogenic IdeR mutant strain of M.smegmatis mc^l55 
(Dussurget et a l, 1996)
(* A gift from Dr. John T Belisle, Dept, of Microbiology, Colorado State University, 
Ft. Collins, CO 80523, USA)
(** A gift from Issar Smith, TB Centre, Public Health Research Institute 
455 1st Avenue, New York, NY 10016, USA)
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Eschericha coli
Strain Genotype
DH5a (BD Biosciences Clontech UK) F' ([)80d/flcZAM15 recAl endAl gyrA96
thil h sd R ll  (rC nik^) 5wpE44 relA l deoK 
E{lacZYA-argF)\] 169
JM109 (Promega UK) E14'(McrA') recAl endAl gyrA96 thi-l
hsdR ll (rk’ mk^) supEAA relAl E{lac- 
proAB) [F’ traD36 proAB /ac/ZAMlS]
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PLASMID REFERENCE GUIDE
Plasmid
pUS972*
pUS1780*
pUS1803*
pUS1870*
pUS1878*
pUS1883*
pGEM-T
pGEM34
pGEMus34
pGEM34P
pMRI34
pMRIus34 I
Relevant Characteristic/Use 
Mycobacterial shuttle plasmid, Kan^ 
Mycobacterial shuttle plasmid, Kan^ 
Mycobacterial shuttle plasmid, M .bovis 
mpb70 promoter GFP ORF, Kan^ 
Mycobacterial shuttle plasmid, GFP 
ORF, Kan^
Mycobacterial shuttle plasmid, 
M .tuberculosis hsp60  promoter, GFP 
ORF, Kan^
Mycobacterial shuttle plasmid, M .leprae  
ISkDa  Promoter, GFP ORF, Kan^ 
E.coli plasmid, PGR cloning vector 
^Amp^
E.coli plasmid, pGEM-T vector 
containing 34kDa putative serine  
protease  ORF 
E.coli plasmid, pGEM-T vector 
containing 34kDa pu tative serine  
protease  ORF and upstream region, 
Amp'^
E.coli plasmid, pGEM-T vector 
containing 34kDa putative serine  
protease  promoter, Amp^ 
Mycobacterial shuttle plasmid, hsp60 
promoter, 34kDa pu tative serine 
protease  ORF, Kan^ 
Mycobacterial shuttle plasmid, 34kDa 
putative serine pro tease  and upstream 
region, Kan^, Orientation I
Source/Reference 
Uni. Surrey 
Uni. Surrey 
Uni. Surrey
Uni. Surrey
Uni. Surrey
Uni. Surrey
Promega UK.
This Thesis 
(Chapter 3)
This Thesis 
(Chapter 5)
This Thesis 
(Chapter 5)
This Thesis 
(Chapter 3)
This Thesis 
(Chapter 5)
ccxvii
pMRIus34 II
pSml28**
pSmbfd^^
Mycobacterial shuttle plasmid, 34kDa 
putative serine pro tease  and upstream 
region, Kan^, Orientation II 
Integrative vector , lacZ  ORF, ^Strep^
Integrative vector, lacZ  ORF, bfd 
promoter, Strep^
This Thesis 
(Chapter 5)
(Dussurget et a l ,  
1999)
(Gold et a l ,  2001)
pSm34P I Integrative vector, lacZ  ORF, 34kDa This work
antigen promoter, Strep^ (Chapter 5)
pSm34P II Integrative vector, lacZ  CDS, 34kDa This work
antigen promoter (opposite orientation), (Chapter 5)
Streps.
(* Kindly provided by members of the Molecular Biology Group, Dept, of 
Microbiology, University o f Surrey, Guildford, Surrey, GU2 5XH, UK.)
(** A gift from Dr. Benjamin Gold (Laboratory of Dr. Issar Smith), TB Centre, 
Public Health Research Institute, 455 1st Avenue, New York, NY 10016, USA.)
1. Kan^: Kanamycin resistance; Tn903 aph gene.
2. Amp^: Ampicillin resistance; p-lactamase coding sequence.
3. Strep'll Streptomycin resistance; Omega cassette harbouring a 
Streptomycin/Spectinomycin resistance gene.
CCXVlll
APPENDIX 3.
Laboratory Media
Luria-Bertani (L-B) broth
1% ('^ Vv) Bacto®-Tryptone, 0.5% (^Vy) Bacto®-yeast extract, 10 mM NaCl, pH 7.5. 
Sterilised at 12HC for 15 min.
L-B agar
1% ('^ Vv) Bacto®-tryptone, 0.5% C'^ Vy) Bacto®-yeast extract, 10 mM NaCl, pH 7.5, 
1.5% Bacto®-agar. Sterilised at 121°C for 15 min.
SOC broth
1% ('^ Vy) Bacto®-Tryptone, 0.5% ('^ Vy) Bacto®-yeast extract, 10 mM NaCl, 2.5 MM 
KCl, 5 MM MgClz.ôHzO, 5 mM MgS0 4 .7 H2 0 , pH 7.0. Sterilised at 121"C for 15 
min and supplemented with sterile glucose to 0.36% (% ).
7H11 medium
2.1% ('^/y) 7H11 agar (BD Biosciences UK), 0.5% (%) glycerol, pH 7.0. Sterilised at 
12UC for 15 min and supplemented as follows using sterile stock reagents; 10% (%) 
Middlebrook OADC enrichment (BD Biosciences UK), pH 7.0, Selectatabs, Code 
MS 24 (Mast Laboratories). Note: each Selecetatab contains the following antibiotics 
100,000 U Polymyxin B, 50 mg Carbenicillin, 5 mg Amphotericin B and 5 mg 
Trimethoprim, one Selectatab was used per 500 ml of media.
7H11+ medium
2.1 % ('% ) 7H11 agar (BD Biosciences UK), 2.3 mM L.asparagine, 2.5% (%) 
glycerol, 2 pg/ml mycobactin J (Allied Monitor), Ph 7.0. Sterilised at 121°C for 15 
min and supplemented as follows using sterile stock reagents; 10% (%) 
Middlebrook OADC enrichment (BD Biosciences UK), 20% (%) heat-inactivated 
new bom calf semm (Invitrogen life sciences), Selectatabs, Code MS 24 (Mast 
Laboratories).
ccxix
7H11-E medium
2.1 % ('^ Vv) 7H11 agar (Becton Dickinson UK Ltd), 2.3 mM L.asparagine, 2.5% (%) 
glycerol, 2 pg/ml mycobactin J (Allied Monitor), Ph 7.0. Sterilised at 121°C for 15 
min and supplemented as follows using sterile stock reagents; 10% (%) Middlebrook 
OADC enrichment (Becton Dickinson UK Ltd), pH 7.0, 20% (%) heat-inactivated 
new bom calf semm (Invitrogen life sciences).
(“E” corresponds to post-Elecroporation medium).
7H11-S medium
2.1 % ('% ) 7H11 agar (Becton Dickinson UK Ltd), 0.5% (%) glycerol, pH 7.0. 
Sterilised at 121°C for 15 min.
(“S” corresponds to use of the medium in culturing M.smegmatis strains only) 
7H10-SU
1.9% ('^ Vv) Middlebrook 7H10 medium (BD Biosciences UK), 1 pg/ml mycobactin J 
(Allied Monitor), pH 5.9. Sterilised at 121°C for 15 min and supplemented as follows 
using sterile stock reagents: 5% (7y) Middlebrook OADC (BD Biosciences UK), pH 
7.0, 0.6% (Vv) glucose and 0.41% ('^ Vy) sodium pymvate.
(“Su” corresponds to media used by the University of Surrey in culturing post­
electroporation M. a.paratuberculosis)
7H9^ broth
0.47% ('^ Vy) 7H9 medium (BD Biosciences UK), 1% (7y) Tween 80, 2 pg/ml 
mycobactin J (Allied Monitor), pH 5.9. Sterilised at 121°C for 15 min and 
supplemented as follows using sterile stock reagents; 10% ('^/y) Middlebrook ADC 
(BD Biosciences UK), pH 7.0 and 0.6% (7y) glucose.
(“^” corresponds to the use of glucose as opposed to glycerol in the medium)
7H9^^ broth
0.47% ('^ Vy) 7H9 medium (BD Biosciences UK), 0.05% (7y) Tween 80, 1 pg/ml 
mycobactin J (Allied Monitor), pH 5.9. Sterilised at 121°C for 15 min and 
supplemented as follows using sterile stock reagents: 5% (7y) Middlebrook ADC 
(BD Biosciences UK), pH 7.0, 0.6% (7y) glucose and 0.41% (^/y) sodium pyruvate.
ccxx
corresponds to media used by the University of Surrey in culturing post­
electroporation M. a.paratuberculosis)
7H9^ broth
0.47% ('^/y) 7H9 medium (BD Biosciences UK), 0.05% (7y) Tween 80, pH 5.9. 
Sterilised at 12UC for 15 min.
(“^” corresponds to use of the broth in culturing M.smegmatis strains only)
7H9^ broth
0.47% ('^ Vy) 7H9 broth (BD Biosciences UK), 10% (7y) Tween 80, 2 pg/ml 
Mycobactin J (Allied Monitor), 2.5% (7y) glycerol, pH 5.9. Sterilised at 121°C for 15 
min and supplemented as follows using sterile stock reagents; 10% (7y) Middlebrook 
ADC (BD Biosciences UK), pH 7.0.
(“^” corresponds to the increased Tween content of the medium)
ccxxi
APPENDIX 4.
Amino Acid and Nucleotide Sequences
> 34kDa putative serine protease protein sequence (Figure 1.2)
Amino acid positions Feature
1-38 Signal Peptide
86-246 Trypsin Catalyic Domain
102, 133 and 215 His, Asp and Ser respectively
267-344 PDZ Domain
1 MSKSHHHRSV WWSWLVGVLT WGLGLGLGS GVGLAPASAA PSGLALDRFA DRPLAPIDPS AMVGQVGPQV
71 VNIDTKFGYN NAVGAGTGIV IDPNGW LTN NHVISGATEI SAFDVGNGQT YAVDWGYDR TQDIAVLQLR
1 4 1  GAAGLPTATI GGEATVGEPI VALGNVGGQG GTPNAVAGKV VALNQSVSAT DTLTGAQENL GGLIQADAPI
2 1 1  KPGDSGGPMV NSAGQVIGVD TAATDSYKMS GGQGFAIPIG RAMAVANQIR SGAGSNTVHI GPTAFLGLGV
2 81  TDNNGNGARV QRWNTGPAA AAGIAPGDVI TGVDTVPING ATSMTEVLVP HHPGDTIAVH FRSVDGGERT
3 5 1  ANITLAEGPP A
CCXXll
> DNA sequence of pUS1878 (Figure 3.4)
Nucleotide positions Feature
50-372 pAL5000 derived ori
392-773 hsp60 Promoter
842-1092 GFP ORF
1 NGGCAAGAAA NANGTCGCAA AACAGAAACG GCCAAAAGGC CNCAAAAAAC CGACAATCCN CCGNTGTTTT
NCCGTTCTTT NTNCAGCGTT TTGTCTTTGC CGGTTTTCCG GNGTTTTTTG GCTGTTAGGN GGCNACAAAA
71 AACNCAATTG GGAACGGGTG TCGCGGGGGT TCCGTGGGGG TTCCGTTGCA ACGGGTCGGA CAAGGTAAAA
TTGNGTTAAC CCTTGCCCAC AGCGCCCCCA AGGCACCGCG AAGGCAACGT TGCCCAGCCT GTTCCATTTT
1 4 1 GTCTTGGTAG ACGCTAGTTT TCTGGTTTGG CCCATGCCTG TCTCGTTGCG TGTTTCGTTG CGCCCGTTTT
CAGAACCATC TGCGATCAAA AGACCAAACC GGGTACGGAC AGAGCAACGC ACAAAGCAAC GCGGGCAAAA
2 1 1 GAATACCAGC CAGACGAGAC GGGGTTCTAC GAATCTTGGT CGATACCAAG CCATTTCCGC TGAATATCGG
CTTATGGTCG GTCTGCTCTG CCCCAAGATG CTTAGAACCA GCTATGGTTC GGTAAAGGCG ACTTATAGCC
2 8 1 GGAGCTCACC GCCAGAATCG GTGGTTGTGG TGATGTACGT GCGAACTCCG TTGTAGTGCC TGTGGTGGCA
CCTCGAGTGG CGGTCTTAGC CACCAACACC ACTACATGCA CGCTTGAGGC AACATCACGG ACACCACCGT
Not I
Kpn I Xha I
3 5 1 TCCGTGGCGC GGCCGCGGTA CCAGATCTTT AAATCTAGAT CGACCACAAC GACGCGCCCG CTTTGATCGG
AGGCACCGCG CCGGCGCCAT GGTCTAGAAA TTTAGATCTA GCTGGTGTTG CTGCGCGGGC GAAACTAGCC
4 2 1 GGACGTCTGC GGCCGACCAT TTACGGGTCT TGTTGTCGTT GGCGGTCATG GGCCGAACAT ACTCACCCGG
CCTGCAGACG CCGGCTGGTA AATGCCCAGA ACAACAGCAA CCGCCAGTAC CCGGCTTGTA TGAGTGGGCC
4 9 1 ATCGGAGGGC CGAGGACAAG GTCGAACGAG GGGCATGACC CGGTGCGGGG CTTCTTGCAC TCGGCATAGG
TAGCCTCCCG GCTCCTGTTC CAGCTTGCTC CCCGTACTGG GCCACGCCCC GAAGAACGTG AGCCGTATCC
5 6 1 CGAGTGCTAA GAATAACGTT GGCACTCGCA ACCGGTGAGT GCTAGGTCGG GACGGTGAGG CCAGGCCCGT
GCTCACGATT CTTATTGCAA CCGTGAGCGT TGGCCACTCA CGATCCAGCC CTGCCACTCC GGTCCGGGCA
6 3 1 CGTCGCAGCG AGTGGCAGCG AGGACAACTT GAGCCGTCCG TCGCGGGCAC TGCGCCCGGC CAGCGTAAGT
GCAGCGTCGC TCACCGTCGC TCCTGTTGAA CTCGGCAGGC AGCGCCCGTG ACGCGGGCCG GTCGCATTCA
B s t  E l i
7 0 1 AGCGGGGTTG CCGTCACCCG GTGACCCCCG TTTCATCCCC GATCCGGAGG AATCACTTCG CAATGGCCAA
TCGCCCCAAC GGCAGTGGGC CACTGGGGGC AAAGTAGGGG CTAGGCCTCC TTAGTGAAGC GTTACCGGTT
Pst I
Bam  HI ECO RI Hind I I I Kpn :I
7 7 1 GACGTCCATG GATCCAGCTG CAGAATTCGA AAGCTAAAGC TTAGGCGAGG AGCTTGGTAC CGGTAGAAAA
CTGCAGGTAC CTAGGTCGAC GTCTTAAGCT TTCGATTTCG AATCCGCTCC TCGAACCATG GCCATCTTTT
8 4 1 AATGAGTAAA GGAGAAGAAC TTTTCACTGG AGTTGTCCCA ATTCTTGTTG AATTAGATGG TGATGTTAAT
TTACTCATTT CCTCTTCTTG AAAAGTGACC TCAACAGGGT TAAGAACAAC TTAATCTACC ACTACAATTA
9 1 1 GGGCACAAAT TTTCTGTCAG TGGAGAGGGT GAAGGTGATG CAACATACGG AAAACTTACC CTTAAATTTA
CCCGTGTTTA AAAGACAGTC ACCTCTCCCA CTTCCACTAC GTTGTATGCC TTTTGAATGG GAATTTAAAT
9 8 1 TTTGCACTAC TGGAAAACTA CCTGTTCCAT GGCCAACACT TGTCACTACT TTCTCTTATG GTGTCAATGC
AAACGTGATG ACCTTTTGAT GGACAAGGTA CCGGTTGTGA ACAGTGATGA AAGAGAATAC CACAGTTACG
1 0 5 1 TTTTCAAGAT ACCCAGATCA TATGAAACGG CATGACTTTT TTNAGAAATG CCNTTCCCNA ANGGNTTTTC
AAAAGTTCTA TGGGTCTAGT ATACTTTGCC GTACTGAAAA AANTCTTTAC GGNAAGGGNT TNCCNAAAAG
1 1 2 1 AAGAAAAAAA CCTTTTTTTT AAAAAACAAC GGGGACTTNC AANACCCNNN TGAANTCAAG TTTGAAGGGG
TTCTTTTTTT GGAAAAAAAA TTTTTTGTTG CCCCTGAANG TTNTGGGNNN ACTTNAGTTC AAACTTCCCC
1 1 9 1 ATNCCCTTTT TAATAAAATC CN
TANGGGAAAA ATTATTTTAG GN
ccxxm
> DNA sequence of pUS1883 (Figure 3.4)
Nucleotide positions Feature
69-397 pALSOOO derived ori
442-813 ISkDa Promoter
849-1151 GFP ORF
1 CNTNTGANCC CCGTNAANGA NTCGGCTTTN GGGNCAAGAA AAAGCGTGCG GCCAAACAGA AACGGCCTAA
71 AAGGCCCNCA ANGAAAGCCG ACATCCCNCG GNTGTTCTAA CGCAATGGGG AGCGGGTGTC GCGGGGGGTC
1 4 1  CGTGGGGGGT TCCGTTGCAA CGGGTCGGAC AGGTAAAAGT CCTGGTAGAC GCTAGTTTTC TGGTTTGGGC
2 1 1  CATGCCTGTC TCGTTGCGTG TTTCGTTGCG CCCGTTTTGA ATACCAGCCA GACGAGACGG GGTTCTACGA
2 8 1  ATCTTGGTCG ATACCAAGCC ATTTCCGCTG AATATCGGGG AGCTCACCGC CAGAATCGGT GGTTGTGGTG
Not  I
Kpn I
3 51  ATGTACGTGG CGAACTCCGT TGTAGTGCCT GTGGTGGCAT CCGTGGCGCG GCCGCGGTAC CAGATCTTTA
Xha I
Eco  RV
4 2 1  AATCTAGATA TCCATGGCCA TCCGCAGCGA CGGCACCGGG AACGCCGGAA AGTTCGGCCG CTACCGATGA
4 91 TGTCGTATAC GCTGCGTTGC AGTGCCGACG TACCCGTGCC GGCACTACAA TCGGTCATGA GCAATCTCCT
5 6 1  CAGCTGTTCA GACAGAAAAC TTGTCTATCA CAACTTGCAT CAATATATCG ACCAGTGCTA TATCAAATCT
Bst  E l i
6 3 1  ATGTAGTCAG GAACAGCTAT ATAGTTATAG TTTGTCACAA CAGATTGGAG TGCGAGGTGA CCACACATGC
7 0 1  TGATGCGTAC TGACCCGTTC CGTGAACTGG ACCGCTTCGC CGAGCAAGTG TTAGGTACGT CTGCCCGCCC
Hind III
Eco RI Kpn I
7 7 1  AGCAGTAATG CCCATGGACA CTTGGCGTGA GGGCGAAGAA TTCAAGCTTA GGCGAGGAGC TTGGTACCGG
8 4 1  TAGAAAAAAT GAGTAAAGGA GAAGAACTTT TCACTGGAGT TGTCCCAATT CTTGTTGAAT TAGATGGTGA
9 1 1  TGTTAATGGG CACAAATTTT CTGTCAGTGG AGAGGGTGAA GGTGATGCAA CATACGGAAA ACTTACCCTT
9 8 1  AAATTTATTT GCACTACTGG AAAACTACCT GTTCCATGGC CAACACTTGT CACTACTTTC TCTTATGGTG
1 0  51  TTCAATGCTT TTCAAGATAC CCAGATCATA TGAAACGGCA TGACTTTTTC AAGAGTGCCA TGCCCGAAGG
1 1 2 1  GTATGTACAG GAAAAAACTA TTTTTTTCAA ANACNNCCGG GAACNCCAAN AACCNGCCTG AAANCAAGTT
1 1 9 1  GGAAGGGGAT NCCTTGTTAA TAAAATCNNN TAAAANGGNT TTGGNTTTTA AAAAAAA
CCXXIV
> DNA sequence of pUS1803 (Figure 3.4)
Nucleotide positions Feature
69-397 pAL5000 derived ori
442-813 mpbJO Promoter
849-1151 GFP ORF
1 AANAGGTCGG CAANACAAGA ANCGGCTCAA AAGGCCCCCA AGAAACCGCC AATCCCCCGC TGTTCTAACG
71 CAATTGGGAA CGGTGTCCCG GGGGTTCCGT GGGGGGTTCC GTTGCAACGG GTCGGACAGG TAAAAGTCCT
1 4 1 GGTAGACGCT AGTTTTCTGG TTTGGGCCAT GCCTGTCTCG TTGCGTGTTT CGTTGCGCCC GTTTTGAATA
2 1 1 CCAGCCAGAC GAGACGGGGT TCTACGAATC TTGGTCGATA CCAAGCCATT TCCGCTGAAT ATCGGGGAGC
2 8 1 TCACCGCCAG AATCGGTGGT TGTGGTGATG TACGTGGCGA ACTCCGTTGT AGTGCCTGTG GTGGCATCCG
No tl
Kpnl Xbal
3 5 1 TGGCGCGGCC GCGGTACCAG ATCTTTAAAT CTAGAGCAGC CAACAGCTTT GCACTGCGCG GCCGGTGGGC
4 2 1 GCTGGACTAT CAGGGTGCCA CGTCCGACGG CAACGACGCC GCTATCAAAT TGAATTACCA CGCCAAAGAC
4 9 1 GTCTACATCG TTGTCGGTGG CACCGGCACC CTCACGGTCG TGAGGGACGG AAAGCCAGCC ACACTACCGA
5G1 TCAGCGGGCC GCCGACCACC CATCAGGTGG TCGCCGGCGA TCGGCTGGCG TCCGAAACAC TTGAGGTGCG
6 3 1 GCCCAGCAAG GGGCTACAGG TTTTTTCCTT CACCTACGGA TGAATATCCA TCCAAGACCC GGACGGCTCC
7 0 1 GAAGAAATCA TGTCGGGGGT AGCGAGACGG CACAAGCCGC CGTCTCCGGC AGCCGAAGGA GTGAACGGCG
Ps tl Kpnl
BamRl B co R I Hindlll
7 7 1 GGATCCAGCT GCAGAATTCG AAGCTTGGTA CCGGTAGAAA AAATGAGTAA AGGAGAAGAA CTTTTCACTG
8 4 1 GAGTTGTCCC AATTCTTGTT GAATTAGATG GTGATGTTAA TGGGCACAAA TTTTCTGTCA GTGGAGAGGG
9 1 1 TGAAGGTGAT GCAACATACG GAAAACTTAC CCTTAAATTT ATTTGCACTA CTGGAAAACT ACCTGTTCCA
9 8 1 TGGCCAACAC TTGTCACTAC TTTCTCTTAT GGTGTTCAAT GCTTTTCAAG ATACTCCAGA TCATATGAAA
1 0 5 1 CGGCATGACN TTTTNAAAG
ccxxv
> DNA sequence of pGEM34 (Figure 3.11)
Nucleotide positions Feature
1 -86 pGEM-T
97-114 34F PGR primer
106-112 RBS
119-1204 34kDaORF
143-265 Signal peptide sequence
1204-1185 34R primer
1208-1263 PGEM-T
GTTGANNTCC GNTTGCATCC AACGCGTTGG GAGCTCTCCA TATGGTCGAC CTGCAGGCGG CCGCACTAGT 
Bst E l i
71 GATTCGGGAT CCCGCCGTGG GTTACCCCGC GACGCAGGAG GGTGACGGAT GAGCAAATCG CACCACCACC
1 4 1 GCTCGGTCTG GTGGTCATGG TTGGTCGGTG TGCTGACCGT GGTCGGGCTG GGCCTCGGGC TGGGGTCCGG
2 1 1 CGTGGGGCTG GCGCCGGCGT CCGCGGCACC GTCGGGCCTG GCGCTGGACC GGTTCGCCGA TCGCCCCCTG
2 8 1 GCGCCGATCG ACCCGTCGGC CATGGTCGGT CAGGTGGGGC CGCAAGTGGT CAACATCGAC ACCAAGTTCG
3 5 1 GCTACAACAA CGCGGTGGGC GCCGGTACCG GCATCGTGAT CGACCCGAAC GGCGTGGTGC TCACCAACAA
4 2 1 CCACGTCATC TCGGGCGCCA CCGAAATCAG CGCGTTCGAC GTCGGCAACG GGCAGACCTA CGGCGTCGAC
4 9 1 GTGGTCGGCT ATGACCGCAC CCAGGACATC GCCGTGCTGC AGCTGCGCGG CGCGGCCGGC CTGCCCACCG
56 1 CCACCATCGG CGGCGAGGCC ACGGTGGGCG AGCCCATCGT CGCGCTTGGC AACGTCGGCG GCCAGGGCGG
6 3 1 CACCCCCAAC GCGGTGGCCG GCAAGGTCGT CGCGCTCAAC CAGAGCGTCT CGGCGACCGA CACGCTGACC
7 0 1 GGCGCGCAGG AGAACCTCGG CGGCCTGATC CAGGCCGACG CGCCGATCAA GCCGGGCGAC TCCGGTGGCC
77 1 CGATGGTGAA CAGCGCCGGG CAGGTGATCG GCGTGGACAC CGCCGCCACC GACAGCTACA AGATGTCCGG
8 4 1 CGGGCAGGGC TTCGCCATCC CGATCGGCCG CGCCATGGCC GTCGGCAACG AGATCCGCTC CGGCGCCGGC
9 1 1 TCCAACACCG TGCACATCGG GCCCACCGCA TTCCTCGGGC TGGGCGTGAC GGAGAAGAAC GGCAACGGCG
9 8 1 CGCGGGTGCA GCGGGTGGTC AACACCGGCC CGGCCGCGGC CGCGGGCATC GCGCCCGGCG ACGTCATCAC
1 0 5 1 CGGCGTCGAC ACCGTCCCGA TCAACGGGGC GACGTCGATG ACCGAGGTGC TCGTCCCGCA CCACCCCGGT
1 1 2 1 GACACCATCG CGGTGCACTT
Xha
CCGGTCCGTC
I
GACGGCGGCG AGCGCACCGC GAACATCACC CTGGCGGAGG
1 1 9 1 GGCCGCCGGC CTGAGCTCTA GAGCAATCCC GCGGCCATGG CGGCCGGGAG CATGCGACGT CGGGNACCGA
1 2 6 1  TCN
CCXXVl
> DNA sequence of pGEMus34 (Figure 5.4)
Nucleotide positions Feature
1-84 pGEM-T
82-101 34usF PGR primer
201-214 RBS
415-1500 34kDa ORF
439-561 Signal peptide sequence
1500-1481 34R primer
1504-1559 pGEM-T
Spe I
1 GTTGANNTCC GNTTGCATCC AACGCGTTGG GAGCTCTCCA TATGGTCGAC CTGCAGGCGG CCGCACTAGT
CAACTNNAGG CNAACGTAGG TTGCGCAACC CTCGAGAGGT ATACCAGCTG GACGTCCGCC GGCGTGATCA 
7 1  GATTCGATCC CGCCGTGTAC ACCACGTCCG GGTCGGCGTC ATGGTCCGCG TCGGGGCCTT GCGCGAGGGC
CTAAGCTAGG GCGGCACATG TGGTGCAGGC CCAGCCGCAG TACCAGGCGC AGCCCCGGAA CGCGCTCCCG 
1 4 1  GAAGACGACC GGCACCAGGT GTGGCTGCCC GCCCGGGGAG ACGGTGGCCA ACCGGGCTAC CGAGGCCCGG
CTTCTGCTGG CCGTGGTCCA CACCGACGGG CGGGCCCCTC TGCCACCGGT TGGCCCGATG GCTCCGGGCC 
2 1 1  CCGAACCTCG CCCTGGCGTC GAATTCGCCC ACCAGATCAG GGTAGGGCGC GCGGCAGCAA ACGGCGGTAA
GGCTTGGAGC GGGACCGCAG CTTAAGCGGG TGGTCTAGTC CCATCCCGCG CGCCGTCGTT TGCCGCCATT
2 81 GCCTATGAGC CGGCTGAGAA CCTGGCACAT GCCGTGCATA GCTACCTGCA TTACGGTTAT ATACACAAAA
CGGATACTCG GCCGACTCTT GGACCGTGTA CGGCACGTAT CGATGGACGT AATGCCAATA TATGTGTTTT 
BamHI
3 51 TTGTGCCGCC AGGATCCTCA GGCCGGGACA GTTTGGTGTT TACCGCGACG CAGGAGGGTG ACGGATGAGC
AACACGGCGG TCCTAGGAGT CCGGCCCTGT CAAACCACAA ATGGCGCTGC GTCCTCCCAC TGCCTACTCG
4 2 1  AAATCGCACC ACCACCGCTC GGTCTGGTGG TCATGGTTGG TCGGTGTGCT GACCGTGGTC GGGCTGGGCC
TTTAGCGTGG TGGTGGCGAG CCAGACCACC AGTACCAACC AGCCACACGA CTGGCACCAG CCCGACCCGG 
4 9 1  TCGGGCTGGG GTCCGGCGTG GGGCTGGCGC CGGCGTCCGC GGCACCGTCG GGCCTGGCGC TGGACCGGTT
AGCCCGACCC CAGGCCGCAC CCCGACCGCG GCCGCAGGCG CCGTGGCAGC CCGGACCGCG ACCTGGCCAA 
5 6 1  CGCCGATCGC GGCCTGGCGC CGATCGACCC GTCGGCCATG GTCGGTCAGG TGGGGCCGCA AGTGGTCAAC
GCGGCTAGCG GGGGACCGCG GCTAGCTGGG CAGCCGGTAC CAGCCAGTCC ACCCCGGCGT TCACCAGTTG 
6 3 1  ATCGACACCA AGTTCGGCTA CAACAACGCG GTGGGCGCCG GTACCGGCAT CGTGATCGAC CCGAACGGCG
TAGCTGTGGT TCAAGCCGAT GTTGTTGCGC CACCCGCGGC CATGGCCGTA GCACTAGCTG GGCTTGCCGC 
7 0 1  TGGTGCTCAC CAACAACCAC GTCATCTCGG GCGCCACCGA AATCAGCGCG TTCGACGTCG GCAACGGGCA
ACCACGAGTG GTTGTTGGTG CAGTAGAGCC CGCGGTGGCT TTAGTCGCGC AAGCTGCAGC CGTTGCCCGT 
7 7 1  GACCTACGCC GTCGACGTGG TCGGCTATGA CCGCACCCAG GACATCGCCG TGCTGCAGCT GCGCGGCGCG
CTGGATGCGG CAGCTGCACC AGCCGATACT GGCGTGGGTC CTGTAGCGGC ACGACGTCGA CGCGCCGCGC 
8 4 1  GCCGGCCTGC CCACCGCCAC CATCGGCGGC GAGGCCACGG TGGGCGAGCC CATCGTCGCG CTTGGCAACG
CGGCCGGACG GGTGGCGGTG GTAGCCGCCG CTCCGGTGCC ACCCGCTCGG GTAGCAGCGC GAACCGTTGC 
9 1 1  TCGGCGGCCA GGGCGGCACC CCCAACGCGG TGGCCGGCAA GGTCGTCGCG CTCAACCAGA GCGTCTCGGC
AGCCGCCGGT CCCGCCGTGG GGGTTGCGCC ACCGGCCGTT CCAGCAGCGC GAGTTGGTCT CGCAGAGCCG 
9 8 1  GACCGACACG CTGACCGGCG CGCAGGAGAA CCTCGGCGGC CTGATCCAGG CCGACGCGCC GATCAAGCCG
CTGGCTGTGC GACTGGCCGC GCGTCCTCTT GGAGCCGCCG GACTAGGTCC GGCTGCGCGG CTAGTTCGGC 
10  5 1  GGCGACTCCG GTGGCCCGAT GGTGAACAGC GCCGGGCAGG TGATCGGCGT GGACACCGCC GCCACCGACA
CCGCTGAGGC CACCGGGCTA CCACTTGTCG CGGCCCGTCC ACTAGCCGCA CCTGTGGCGG CGGTGGCTGT 
1 1 2 1  GCTACAAGAT GTCCGGCGGG CAGGGCTTCG CCATCCCGAT CGGCCGCGGC ATGGCCGTCG CCAACCAGAT
CGATGTTCTA CAGGCCGCCC GTCCCGAAGC GGTAGGGCTA GCCGGCGCGG TACCGGCAGC GGTTGGTCTA 
1 1 9 1  CCGCTCCGGC GCCGGCTCCA ACACCGTGCA CATCGGGCCC ACCGCATTCC TCGGGCTGGG CGTGACGGAC
GGCGAGGCCG CGGCCGAGGT TGTGGCACGT GTAGCCCGGG TGGCGTAAGG AGCCCGACCC GCACTGCCTG 
1 2 6 1  AACAACGGCA ACGGCGCGCG GGTGCAGCGG GTGGTCAACA CCGGCCCGGC CGCGGCCGCG GGCATCGCGC
TTGTTGCCGT TGCCGCGCGC CCACGTCGCC CACCAGTTGT GGCCGGGCCG GCGCCGGCGC CCGTAGCGCG
13 3 1  CCGGCGACGT CATCACCGGC GTCGACACCG TCCCGATCAA CGGGGCGACG TCGATGACCG AGGTGCTCGT
GGCCGCTGCA GTAGTGGCCG CAGCTGTGGC AGGGCTAGTT GCCCCGCTGC AGCTACTGGC TCCACGAGCA
14 0 1  CCCGCACCAC CCCGGTGACA CCATCGCGGT GCACTTCCGG TCCGTCGACG GCGGCGAGCG CACCGCGAAC
GGGCGTGGTG GGGCCACTGT GGTAGCGCCA CGTGAAGGCC AGGCAGCTGC CGCCGCTCGC GTGGCGCTTG
Xbal
14 7 1  ATCACCCTGG CGGAGGGGCC GCCGGCCTGA GCTCTAGAGC AATCCCGCGG CCATGGCGGC CGGGAGCATG
TAGTGGGACC GCCTCCCCGG CGGCCGGACT CGAGATCTCG TTAGGGCGCC GGTACCGCCG GCCCTCGTAC 
1 5 4 1  CGACGTCGGG NACCGATCN
GCTGCAGCCC NTGGCTAGN
CCXXVll
> DNA sequence of pSm34pI (Figure 5.10)
Nucleotide positions Feature
480-796 34kDa antigen upstream region
480-499 34usForward PCR primer
796-744 34us-Reverse PCR primer
925-1269 /acZ
1 TATCCGGGTA AAMGCGGCAA GGGTCGRAAA CAAGGAAGAG CGCACRAGGR AGCTTTCCAA GGGGNAAAAC
71  GCCTGGTATC TTTTATAGTC CTGTCGGGTT TCGCCACCTC TTGAACTTGA GCGTCGATTT TTGTRATGCT
1 4 1  CGTCAAGGGG GGGCGGAGCC TATGRAAAAA CGCCAGCAAC GCGGCCTTTT TACGGTTCCT GGCCTTTTGC
2 1 1  TGGCCTTTTG CTCACATGTT CTTTCCTGCG TTATCCCMTR ATTCTGTGGA TAACYGTATT ACNCGCCTTT
2 8 1  GAGTGAGCAT GATACCGCTC GCCGCAAGCC GAACRACCRA GCGCAACGCG TSCGGCCGCG GTACCAGATC
3 51 TTTGTGRATG ACCTTTTATA GATTATATTA CTAATTAATT GGGGACCCTA GAGGTCCCCT TTTTTATTTT
4 2 1  AAAAATTTTT TCACAAWACG GTTTACAAGC ATAAAGMTAG TGKCCSCGGK AATTCGATTC GGGGCCTTGC
4 91  GCGAGGGCGA AKTTGAMGMC CGGCTTNCNG MMCCAGGTSG GGGCTGCCCG CCCGGGGAGA CGCTGGCCAA
5 6 1  CCGGGCTACC GAGGCCCGGC CGAACCTCGC CCTGGCGTCG AATTCGCCCA CCAGATCAGG GTAGGGCGCG
6 3 1  CGGCAGCAAA CGGCGGTAAG CCTATGAGCC GGCTGAGAAC CTGGCACATG CCGTGCATAG CTACCTGCAT
BamHI
7 0 1  TACGGTTATA TACACAAAAT TGTGCCGCCA GGATCCTCAG GCCGGGACAG TTTGGTGTTT ACCRMRACGC
BamHI
7 71 RGKAGGGTGA CGGATGAGCA AATCGCAATC ACTAGTGAAT TCGCGGGCAC TGGGCCCGCG GATCCGCATG
H i n d i I I
8 4 1  CGGTACCAAG CTTGATCCGA TAACACAGGA ACAGATCTAT GGTTCGTGCA AACAAACGCA ACGAGGCTCT
H i n d i I I
9 1 1  ACGAATCGGA AGCTTCGATC CCGTCGTTTT ACAACGTTCG TGACTGGGAA AACCCTGGCG TTACCCAACT
9 8 1  TAATCGCCTT GCAGCACATC CCCCTTTYGC CAGCTGGCCG TAATAGCGAA AGAGGCCCGC ACCGATCGCC
1 0 5 1  CTTYCCAACA AGWTTGCGCA GCCTGAATGG YGAAATGGCG CTTTGCCTGG TTTTCCGGCA ACCAAGAAGC
1 1 2 1  GGTGCCGGGA AAAGCTGGCT TGGAAGGTGC GAATCTTTTC CTGAGGCCCG ATTACCTGTC CGTYGGTCCC
1 1 9 1  CTTCAAACTG GCANGAATGC ACCGGTTACC GATGCGGCCC CATTCTTACA CCCAACGGNG ACCTTATNCC
1 2 6 1  AATTTACCGG
CCXXVlll
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Expression of a gene encoding a novel protein antigen of 40 kDa (p40) was 
detected in IS907+ strains of Mycobacterium avium, but not in any other 
species or subspecies of Mycobacterium  tested, including IS901~ M. avium  and 
the other members of the M. avium  complex. Although Southern hybridization 
revealed that the p40 gene is widely distributed within the genus, expression 
of the antigen could not be detected on Western blots of mycobacterial cell 
lysates. Nucleotide sequence analysis of the cloned p40 gene, and a database 
search, revealed high levels of sequence identity with a homologous gene in 
lS90t“ M. avium. M. avium  subsp. paratuberculosis, Mycobacterium bovis, 
Mycobacterium leprae, Mycobacterium smegmatis and Mycobacterium  
tuberculosis. Further analysis of upstream sequences identified a putative 
promoter region. The p40 gene is the first example of a gene that is widely 
distributed within the genus Mycobacterium  but expressed only in association 
with the presence of a genomic insertion element, in this case IS901, in strains 
of M. avium isolated from birds and domestic livestock.
Keywords : M AC, genomic insertion element, p40 gene, differential expression, gene 
conservation
INTRODUCTION
The genus M ycobacterium  contains a number of im­
portant pathogens of both medical and veterinary 
importance. Consequently, there have been extensive 
efforts to identify reagents, particularly antigens, that 
are specific for each of these pathogenic species. H ow ­
ever, such searches generally have been unsuccessful and 
very few specific proteins have been identified.
Recently, we described a 40 kDa protein in IS90H  
strains of M ycobacterium  avium  (isolated from birds 
and domestic livestock) that is absent in IS901~ strains 
(Nyange, 1990; Ingiis et al., 1994). This tight link 
between expression of the 40 kDa protein and the 
presence of 1S901 was confirmed in a larger study of M. 
avium  complex (MAC) isolates; only M. avium  strains 
that were IS90H expressed the 40 kDa protein (Ahrens 
et al., 1995).
Experiments in mice and sheep have indicated that this 
protein may have an important role in vivo. Burrells et
The GenBank accession number for the p40 gene, together with 542 bp 
upstream sequence, is AF247653.
al. (1995) provided clear evidence for in vivo  expression 
of the 40 kDa protein by demonstrating that sheep, 
infected experimentally with IS90H M . avium, de­
veloped specific T-cell immune responses to the 40 kDa 
protein. N o responses to the 40 kDa protein were 
detected in uninfected animals or in sheep infected with 
the closely related M. avium  subsp. paratuberculosis, 
which is IS900"'' but IS901“. Furthermore, experiments in 
mice have suggested that IS901 may enhance the 
pathogenicity of M. avium. In experimentally inoculated 
mice, IS90H M . avium  strains grew more rapidly than 
an 18901“ strain and induced splenomegaly (Kunze et 
a/., 1991).
Because of the apparently absolute association between 
IS901 and expression of the 40 kDa protein, and because 
of their implication in increased pathogenicity, we 
initiated a study to characterize the 40 kDa gene and to 
determine its distribution and expression in other 
mycobacteria.
METHODS
Bacterial cultures. All cultures used in this study are listed in 
Table 1. M . avium  (JD88/118) and M . avium  subsp. para-
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Table 1. M ycobacterium  species used in this study, and results o f  PCR (presence o f  IS907), W estern im m unoblotting  
(p40 expression) and nucleic acid hybridization (presence o f  a p40 g e n e  h om ologu e)
M ycobacteriu m  species Identification no. IS901 PCR p40 expression p40 gene homologue
M. a v iu m  (porcine) NCTC 8551 + + +
M. a v iu m  (bovine) NCTC 8552 4- + +
M. a v iu m  (ovine) NCTC 8553 + + +
M. a v iu m  (avian) NCTC 8559 + + +
M. a v iu m  (avian) NCTC 8562 + + +
M. a v iu m  (cervine)”' JD88/118 + +
M. a v iu m  (human HIV patient) T133 - - +
M. a v iu m  subsp. p a ra tu b ercu lo sis  
(cervine)”'
JD88/107 +
M. a v iu m  subsp. p a ra tu b ercu lo sis ATCC 19698 - - +
M. in tracellu lare NCTC 10425 — — +
M. scro fu laceu m NCTC 10803 - - +
M. sm e g m a tis NCTC 8159 - - +
M. p h le i NCTC 8151 — — +
M. tu b ercu lo sis  H37Rv NCTC 7416 — — +
M. tu b ercu lo sis  H37Ra NCTC 7417 — — +
M. b o v is NCTC 10772 — — +
M. b o v is  BCG NCTC 5692 — — +
M. m ic ro ti NCTC 8710 — — +
M. terrae NCTC 10856 — — +
M. kan sasii NCTC 10268 -- — ■ +
M. x e n o p i NCTC 10042 - -
M. m a lm o en se NCTC 11298 — — +
M. g o rd o n a e NCTC 10267 - — +
M. szu lg a i NCTC 10831 - — +
M. f lavescens NCTC 10271 - - +
M. m arin u m NCTC 2275 — — +
M. ch elon ae  subsp. chelon ae NCTC 946 — — i
M. ch elon ae  subsp. a bscessu s NCTC 10882 — — i
M. fo r tu itu m NCTC 10394 - - i
M. p eregrin u m NCTC 10264 - - +
M. h a em o p h ilu m NCTC 11185 - - +
M. leprae NA — — ; +
NA, N ot a p p lic a b le ;  i, in c o n c lu s iv e .
“'M . avium JD88/118 and M. avium subsp. paratuberculosis JD88/107 were isolated from commercially farmed red deer {Cervus 
elaphus) by Dr J. F. C. Nyange at the Moredun Research Institute.
tuberculosis (JD88/107) were propagated at 37 °C on 
M iddlebrook 7H11 agar medium supplemented with 20%  
(v/v) heat-inactivated newborn-calf serum, 2-5% (v/v)
glycerol, 2 mM  asparagine, Selectatabs (code MS 24; MAST  
Laboratories), 10% (v/v) M iddlebrook oleic acid-album in- 
dextrose-catalase (OADC) enrichment medium (Becton 
Dickinson) and 2 pg mycobactin J ml“  ^ (Allied M onitor) for 
4 -6  w eeks and 8-10 weeks, respectively. M . avium (T133) was 
subcultured and maintained subsequently on unsupplemented 
M iddlebrook 7H11 agar medium. Cultures were incubated at 
37 °C for 6 -8  weeks.
All other Mycobacterium  species were propagated in 
M iddlebrook 7H 9 liquid medium, with the exception of 
M ycobacterium bovis (NCTC 10772) and M . bovis BCG 
(N C T C  5692), which were grown in M iddlebrook 7H9^ 
w ithout glycerol and supplemented with sodium pyruvate at 
0-4% (w /v ). Mycobacterium haemophilum  (NCTC 11185)
was propagated in M iddlebrook 7H9 medium supplemented 
with ferric ammonium citrate at 0-25% (w /v). All species 
were incubated for 4 -6  weeks at 37 °C, with the follow ing  
exceptions : Mycobacterium chelonae subsp. chelonae (NCTC  
946) and M. chelonae subsp. abscessus (NCTC 10882) were 
grown at 25 °C, M . haemophilum  (NCTC 11185) and 
Mycobacterium marinum (NCTC 2275) were grown at 30 °C, 
and Mycobacterium xenopi (NCTC 10042) was grown at 
45 °C.
Disruption o f mycobacterial cells. M . avium (JD88/118) cells 
were harvested and washed three times in fresh PBS (0437 M  
NaCl, 0-003 M  KCl, 0 008 M  Na^HPO^, 0 015 M  KH^PO^, 
pH  6 9). Approximately 1 g washed mycobacterial cells was 
resuspended in 10 ml PBS containing PMSF at a final 
concentration o f 1 mM. The cell suspension was transferred 
to the upper compartment o f a pre-chilled ( —70°C ) Eaton 
pressure chamber (Eaton, 1962), allowed to freeze for 3 -4  min.
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and then forced through the aperture at 10000 p.s.i. ( =  
69 MPa) in a hydraulic press. After thawing, high-M^ genomic 
D N A  was sheared by 2 x  15 s rounds of sonication at 50 % 
amplitude in a Vibra-cell model VCX 600 sonicator (Sonics &  
Materials), allowing 1 min cooling on ice between each 
sonication.
All other mycobacteria were disrupted by shaking with  
zirconium beads (Biospec Products). Approximately 100 mg 
washed mycobacterial cells was resuspended in 0 4 ml PBS 
containing PMSF at a final concentration o f 1 mM . The cells 
were transferred to a screw-cap microfuge tube containing 
1 ml washed 0 1  mm zirconium /silica beads. Cells were 
disrupted by bead-beating in a M ini Bead-Beater (BioSpec 
Products) (Challans et al., 1994). Five beating cycles of 1 min 
each were separated by 1 min cooling intervals on ice to avoid 
overheating and possible dénaturation o f the antigen prep­
aration.
Protein purification and characterization. Soluble protein 
concentrations in cell lysates were determined using the Micro 
BCA Protein Assay Reagent (Pierce-Warriner) in accordance 
with the manufacturer’s recommendations. p40 was purified 
from M . avium (JD88/118) cell lysates by HPLC (Burrells et 
al., 1995; Ingiis, 1997). The purity was confirmed by SDS- 
PAGF, using a discontinuous buffer system (Laemmli, 1970), 
and by visualization of proteins by silver-staining (Morrisey, 
1981).
To determine the amino-terminal amino acid sequence of 
HPLC-purified p40, protein was transferred from an SDS- 
PAGF gel onto a PVDF membrane in 50 mM boric acid 
(pH 8-0), 20% (v/v) methanol, 3 mM 2-yff-mercaptoethanol at 
100 V /1'0  A (constant voltage) for 60 min. Membrane-bound 
protein was visualized by staining with Coomassie brilliant 
blue and the bands were excised. The amino-terminal amino 
acid sequence was determined by sequential Fdman degra­
dation at the M icrochemical Facility, Institute o f Animal 
Physiology and Genetics Research, Babraham, Cambridge, 
UK.
Protein expression was investigated by Western transfer and 
immunoblotting. Electrophoretic transfer o f proteins from  
SDS-PAGE gels to nitrocellulose membranes (Schleicher &  
Schuell) was carried out in accordance with the method of 
Herring 6c Sharp (1984). M ono-specific polyclonal antibodies 
were affinity-purified from rabbit sera as described by Beall &  
M itchell (1986).
Confirmation o f species identity by PCR. Cultured myco­
bacterial cells were mechanically disrupted by bead-beating. 
Lysates were centrifuged at 13 000 g  for 5 min to remove 
cell debris, and 5 pi clarified lysate was subjected to PCR 
analysis. The identity of M. avium subsp. paratuberculosis 
was confirmed by the detection of IS900 amplified using 
primers P90 (5 -GTTCGGGGCCGTCGCTTAGG-3') and 
P91 (5'-CCCACGTGACCTCGCCTCCA-3'), as described by 
Sanderson et al. (1992). The identity o f M . avium was 
confirmed by the detection o f IS901 amplified using primers 
P102 (5'-CTGATTGAGATCTGACGC-3') and P103 (5'- 
TTAGCAATCCGGCGCCCT-3'). PCR conditions were as 
described for amplification o f IS900, and amplification of a 
single band o f 252 bp confirmed the species identity as IS90U  
M. avium.
Cloning and sequencing o f the p40 gen e. The entire p40 ORF 
was amplified by PCR from M. avium JD 88/118 as follows. 
M. avium genomic D N A  (125 ng) was added to pre-prepared 
reaction mixtures (100 pi final volume) comprising ( x 1) 
reaction buffer at 1-5 mM  MgCl^ (Qiagen), 1 25 mM  each of
dATP, dCTP, dGTP and dTTP, 20 pmol each of the forward 
and reverse primers (forward primer: 5'-CTGCCAGCAT- 
GTG G CG TTG TG -3', positions —18 to + 3 ;  reverse primer, 
5'-TCAGAACTGCAGCGCGTCGAACCGC-3', positions 
1023-998) and 1 U HotStar Taq polymerase (Qiagen). H ot- 
start PCR conditions consisted o f an initial dénaturation step 
of 15 min at 96 °C, follow ed by 35 cycles of 90 s dénaturation 
at 96 °C, 1 min annealing at 65 °C and 90 s extension at 72 °C. 
The final cycle included an extension at 72 °C for 8 min. The 
1041 bp amplification product was excised from a 0 8 % (w /v) 
low-m elting-point agarose gel, recovered using AgarAce 
(Promega) in accordance w ith the manufacturer’s instructions 
and then cloned into pGEM -T (Promega) using standard 
laboratory procedures (Sambrook et al., 1989). Competent 
Escherichia coli JM109 cells (Promega) were transformed in 
accordance with the manufacturer’s instructions. The identi­
fication o f recombinants o f interest was achieved by preparing 
colony arrays o f 100 transformants per grid (Buluwela et al., 
1989) and screening by D N A  hybridization, as described 
below. Small-scale preparations (‘minipreps’) o f plasmid D N A  
were prepared from E. coli host cells by using the QIAprep 
Spin Plasmid Miniprep Kit (Qiagen) in accordance with the 
manufacturer’s recommendations. Cloned D N A  fragments 
were sequenced bidirectionally by the dideoxy chain-ter- 
mination method (Sanger et al., 1977). All nucleotide 
sequencing was performed by O swel D N A  Service, 
Southampton, UK.
Sequence analysis. Database searches were performed using 
the BLAST (version 2.0) program from the N ational Centre 
for Biotechnology Information internet site covering the 
GenBank, EMBL, DDBJ and PDB databases, the w u - b l a s t  
(version 2.0) program from The Institute for Genome Research 
(TIGR) BLAST Search Engine for Unfinished M icrobial 
Genomes, the Sanger Centre M . bovis b l a s t  server, and the 
University of M innesota microbial genom e project b l a s t  
server. Preliminary sequence data for M . avium were obtained 
from the TIGR website at http : / / w w w .tigr.org.
Amplification o f the 5' flanking sequence. The upstream  
sequence o f the IS90U M . avium p40 gene was isolated by a 
PCR-based gene-walking technique described by Britton et al.
(1999). Briefly, initial low-stringency amplification was per­
formed using a random primer (5'-GCTCATAG CTGTGT- 
A TG TTCTG -3') in conjunction with a p40-gene-derived 
antisense primer (5'-GTGCGCGTGTAGAGGGAATCA-3') 
complementary to bases 4-341 to + 3 2 1  relative to the p40 
GTG translational start codon. Reaction mixtures contained  
500 ng IS90U M. avium genomic D N A , ( x 1) reaction buffer 
at 1 5  mM  MgCl^ (Promega), L25 mM  each of dATP, dCTP, 
dGTP and dTTP, 20 pmol each of the forward and reverse 
primers and 1 \]  Taq polymerase (Promega) in 50 gl reaction 
volum es. PCR conditions consisted o f an initial dénaturation 
step o f 5 min at 94 °C, follow ed by 30 cycles o f dénaturation  
at 94 °C for 1 min, annealing at 30 °C for 1 min and extension  
at 72 °C for 3 min. The final cycle included an extension at 
72 °C for 7 min. The amplification product o f this low - 
stringency PCR was then used as template in a second round 
of high-stringency amplification, using the same random  
primer as above, and a nested p40-gene-derived antisense 
primer (5'-CCAGGCCGCGATAGAACAGAT-3') com ple­
mentary to bases +  295 to +  275 relative to the translational 
start codon. PCR conditions were as described above, except 
that the annealing temperature was increased from 30 °C to 
57-9 °C. Second-round amplification products were separated 
on a 1% (w /v) agarose gel. Southern-blotted and probed at 
high stringency using a fluorescein-labelled (Gene Images; 
Amersham) p40 gene fragment corresponding to positions
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+  22 to + 2 9 5 . Hybridizing bands were excised from the gel 
and recovered by AgarAce digestion in accordance with the 
manufacturer’s recommendations.
Preparation of a 528 bp p40-specific DNA probe. M. avium 
genomic D N A  (125 ng) was added to pre-prepared reaction 
mixtures (100 gl final volume) comprising ( x 1) reaction buffer 
at 1-5 mM MgCL (Qiagen), T25 mM each of dATP, dCTP, 
dGTP and dTTP, 20 pmol each of the forward and reverse 
primers (forward primer, 5'-CAGCGGGTCAAGGCCAAT- 
GTGTTGTA-3% positions 256-281; reverse primer, 5'-CG- 
GGAGGGGGAATCCGATGGTGTGCC-3', positions 7 8 4 -  
759), and I U HotStar Taq polymerase (Qiagen). Hot-start 
PGR conditions consisted of an initial dénaturation step of 
15 mill at 96 °C, followed by 35 cycles of 1 min dénaturation 
at 96 °G, I min annealing at 65 °C and 90 s extension at 72 °C, 
and a final extension step o f 8 min at 72 °C. The PCR product 
was excised from a 0 8 % (w /v) low-m elting-point agarose gel, 
extracted with AgarAce and then labelled as described below.
Labelling and Southern hybridization of probe DNA. High- 
molecular-mass genomic D N A  was prepared from heat-killed 
organisms and digested with restriction endonuclease BamHl 
in accordance with a protocol described for PFGE (Hughes et 
al., 2001). Samples were electrophoresed in 1 % (w /v) agarose 
gels and the DNA transferred to Hybond N +  nylon mem­
brane (Amersham) as described by Sambrook et al. (1989). 
Probe DNA was labelled using the Gene Images random prime 
labelling module (Amersham) in accordance with the manu­
facturer’s recommendations. Hybridization was performed at 
55 °C over 15-16 h. The final probe concentration was 3 ng 
liquid block ml”  ^ (Amersham). Initial stringency washes 
(3 X 15 min) were carried out in 1 x  SSC/OT % (w /v) SDS at 
42 °C. Higher-stringency washes (3 x 15 min) were performed 
in 0 1 X SSC /0 1 % SDS at 55 °C. Hybridized probe D N A  was 
detected using the Gene Images CDP-Star detection module 
(Amersham) in accordance with the manufacturer’s recom­
mendations. Autoradiography was performed using Kodak X- 
O M A T AR scientific imaging film. Typical exposure times 
varied between 5 and 15 min at room temperature.
RESULTS
p40 is expressed only in \S901* M. avium
Previous studies investigating the expression of p40 in 
A4, avium  complex isolates suggested that the expression 
of this protein was restricted to IS90F  A4, avium  (Ingiis 
et at., 1994; Ahrens et al., 1995). The present study, 
therefore, investigated expression of p40 in a wider 
range of M ycobacterium  species by Western immuno­
blotting, using mono-specific polyclonal antibodies to 
p 4 0 .
p40 was purified from Eaton-pressed lysates of A4. 
avium  JD88/118 by ammonium sulphate precipitation 
followed by sequential size exclusion, anion exchange 
and hydrophobic interaction HPLC. This procedure 
yielded highly purified p40, as visualized on silver- 
stained SDS-PAGE gels (Fig. 1). Approximately 500- 
600 pg purified p40 could be obtained from 1 g (wet wt) 
A4, avium  cells. Purified p40 was used to raise polyclonal 
antibodies to p40 in rabbits, and mono-specific poly­
clonal antibodies were affinity-purified from the rabbit 
antisera.
Thirty-two different M ycobacterium  species, subspecies 
and strains were screened for expression of the p40
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Fig. 1. Silver-stained SDS-PAGE gel sflowing highly purified p40 
resulting from sequential size exclusion, anion exchange and 
hydrophobic interaction HPLC. Labels 26-29 above the lanes 
correspond to elution times (min) from the hydrophobic 
interaction column. Lane M contains standard protein markers 
(shown in kDa). Artefactual bands of ~  55-67 kDa are visible in 
all lanes and originate from the 2-y5-mercaptoethanol used in 
the sample denaturing buffer (Tasheva & Dessev, 1983).
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Fig. 2. Western blot of mycobacterial cell lysates probed with 
affinity-purified anti-p40 polyclonal antibody. Lanes; 1, IS907+ 
M. avium (JD88/118); 2, 15907“ M. avium (T133); 3, M. avium 
subsp. paratuberculosis (JD88/107); 4, M. tuberculosis (NCTC 
7416); 5, M. leprae. Lane M contains standard protein markers 
(shown in kDa).
antigen: without exception, only those strains of A4. 
avium  isolated from birds or domestic livestock were 
observed to express the p40 antigen (Table 1 and Fig. 2).
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M.avium {1S901+) 
M. avium (IS901-)  
M .a .p tb  
M. tu b e r c u lo s i s  
M .bovis  
M. le p ra e  
M. smegmatis  
C onsensus -10 
C onsensus -35
-40 -30  -20  -10  -1
GATTGACCCT C6ATTCTACA GCCTGCTAGC ATGTGGCGTT 
GATTGACCCT CGATTYCACA GCCTGCCAGC ATGTGGCGTT 
GATTGACCCT CGATTCCACA GCCTACCAGC ATGTGGCGTT 
TATTGACCCC CTGTCCGATA GCCTGCCAGC ATGTGGCGTT 
TATTGACCCC CTGTCCGATA GCCTGCCAGA ATGTGGCGTT 
GATTGATCCC G . GATCGACA ATCTGCCAGC ATGTGGCGTT
GGCTGCCACC G  CGGAGG CGTGAATAGC ATGTGAAGCC
..................................................................................TAGC A T ......................
. .TTG A C A .....................................................................................................
+ 1 +10 
GTGACCAGTG 
GTGACCAGTG 
GTGACCAGTG 
GTGGCTAGCG 
GTGGCTAGCG 
GTGACTGCTA 
GTGACTGCAC
Fig. 3. Alignment of sequences upstream of the p40 gene homologues in IS907+ M avium, 15907“ M. avium, M. avium 
subsp. paratuberculosis {M.a.ptb), M. bovis, M. leprae, M. smegmatis and M. tuberculosis. Numbering (—40 to +10) 
refers to the 15907+ M. avium  sequence. The first 10 bp of the p40 ORFs are shown underlined, beginning with +1 at the 
GTG translational start codon. Consensus —10 and —35 regions mark the position of a putative promoter. A TGN motif 
immediately precedes the —10 region in all species except M. avium subsp. paratuberculosis. In the case of M. smegmatis, 
a single nucleotide (A) separates the TGN motif and the start of the —10 hexamer.
Furthermore, in support of our previous observations, 
expression of the p40 antigen was detected only in 
IS90F  organisms. N one of the other species of M yco­
bacterium, including an IS901~ human isolate of M. 
avium  (strain T133), could be shown to harbour IS901 
or express p40, and neither IS901 nor p40 was detected 
alone in any isolate.
p40 gene homologues are present in \S901~ M. 
avium, M. avium subsp. paratuberculosis, M. bovis,
M. leprae, M. tuberculosis and M. smegmatis
A search of the currently available M ycobacterium  
genome databases with the 20 N-terminal amino acid 
residues of p40 (data not shown) revealed p40 hom o­
logues in several M ycobacterium  species. Sequence 
identity (50-100% ) was shown with p40 homologues in 
M ycobacterium  tuberculosis (65%) (EMBL accession 
number Z92669), M ycobacterium  leprae (70%) (EMBL 
accession no. Z95398), M. avium  and M ycobacterium  
smegmatis (100 and 50% , respectively) (TIGR un­
finished genome sequences), M. avium  subsp. para­
tuberculosis (95 % ) (University of M innesota unfinished 
genome sequence) and M. bovis (65 % ) (Sanger Centre 
unfinished genome sequence).
Cloning and sequencing of the gene encoding p40 in 
IS901* M. avium
To characterize the p40 gene in IS90U M. avium  in more 
detail, the entire p40 ORF was amplified by PCR from 
M. avium  JD88/118 genomic D N A , using primer 
sequences determined from the TICR unfinished M. 
avium  genome sequence. This human isolate of M. 
avium  (strain 104) is IS901“. A product of 1041 bp, 
including 18 bp genomic sequence upstream of the 
putative initiation codon (CTC), was amplified and 
sequenced. The complete nucleotide sequence of the p40 
gene, together with 542 bp upstream sequence, is avail­
able from CenBank (accession no. AF247653). Com­
parative alignment of the p40 genes of IS90U and IS901“ 
M. avium  revealed only four nucleotide substitutions at 
positions 4-291, 4-321, -F336 and 4-493 (99 6 % ident­
ity) (data not shown). Only one of these substitutions 
(position 493) translated to an amino acid substitution
at residue 164, where proline, in 15901“ M. avium, is 
replaced with alanine in IS901''" M . avium  (data not 
shown).
Characterization of the upstream sequences of the 
p40 gene from IS907'*' M. avium
To determine whether any features of the genomic 
sequences immediately upstream of the p40 genes in 
IS90U and 15901“ strains of M. avium  might be 
associated with the differential expression of p40, the 
upstream region of I590U  M. avium  strain JD88/118  
was obtained by a PCR-based gene-walking technique. 
A total o f 814 bp was obtained, comprising 272 bp of the 
5' end of the p40 gene sequence and 542 bp upstream  
sequence (accession no. AF247653). A b l a s t  search of 
the TICR unfinished M . avium  genome sequence 
revealed 99% identity with a hom ologous region on 
fragment 187. Further searches of the TICR, CenBank, 
University of M innesota and 5anger Centre databases 
identified the corresponding p40 upstream sequences of 
M. avium  subsp. paratuberculosis, M . bovis, M . leprae, 
M . smegmatis and M. tuberculosis. Comparison of the 
p40 upstream regions of both I590U  and 15901“ M. 
avium  revealed two single base pair substitutions at 
positions —14 and —24, relative to the C TC  initiation 
codon, with a possible third substitution at position
— 25, where Y, in the 15901“ M. avium  sequence, 
denotes either C or T  (Fig. 3). N o copy of the 15901 
insertion element was observed within the 542 bp 
upstream region.
To identify potential promoters in the upstream regions, 
a consensus mycobacterial promoter sequence was 
compiled (Bashyam et al., 1996; Mulder et al., 1997) by 
aligning the —10 and —35 regions of known myco­
bacterial promoters (data not shown). The resulting
— 10 and —35 consensus sequences were aligned with  
the sequences lying upstream of the p40 gene hom o­
logues of I590U  M. avium, 15901“ M. avium , M . avium  
subsp. paratuberculosis, M . bovis, M . leprae, M . sm eg­
matis and M. tuberculosis. 5equence alignments were 
performed using the a l i g n  x  program in the Vector N TI 
Suite (Informax). This analysis highlighted a putative 
promoter region (Fig. 3).
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Fig. 4. Southern blot of mycobacterial 
genomic DMAs probed with a 528 bp 
fragm ent of the M. avium (strain JD88/118) 
p40 gene. Lanes; 1, IS907+ M. avium (strain 
JD88/118); 2, 15907“ M. avium (1133); 3, M. 
avium subsp. paratuberculosis (JD88/107); 
4, M. intracellulare (NCTC 10425); 5, M. 
tuberculosis H37Rv (7416); 5, M. bovis 
(10772); 7, M. malmoense (11298); 8, M. 
haemophilum (11185); 9, M. xenopi (10042); 
10, M. fortuitum (10394); 11, M. kansasii 
(10268); 12, M. marinum (2275); 13, M. 
leprae. Lane M contains molecular size 
markers (shown in kb).
p 4 0  g e n e  h o m o lo g u e s  are w id e ly  d is tr ib u ted  w ith in  
th e  g e n u s  Mycobacterium
T o  d eterm ine the d istr ib u tion  o f  the p40 gene w ith in  the  
gen u s M ycobacteriu m , Southern  b lo ts o f  g en o m ic  D N A s  
o f  23 M ycobacteriu m  sp ecies (T ab le 1) w ere probed  
w ith  a 528 bp fragm ent o f  the p40 gen e o f  M . avium  
(strain J D 8 8 /1 1 8 ). G en es h o m o lo g o u s  to  the p 40 gene in 
IS901~  ^ M . avium  w ere d etected  in  all o f  th e  species  
tested , w ith  e igh t ex cep tio n s (T ab le 1 and Fig. 4). Seven  
o f  th ese  (M . chelonae  su bsp . chelonae  and subsp. 
abscessus, M ycobacteriu m  fortu itu m , M ycobacteriu m  
kansasii, M . m arinum , M ycobacteriu m  ph lei and M y c o ­
bacterium  terrae) w ere checked  by PGR usin g  p40  
co n sen su s prim ers. A p40-specific  prod u ct w as am plified  
from  M . kansasii, M . m arinum , M . ph lei and M . terrae 
but n o t from  M . fortu itu m , M . chelonae  su b sp . chelonae  
or subsp . abscessus. T h e  M . leprae  p 40 gen e h o m o lo g u e  
is currently  ava ilab le  in the E M BL  d atab ase and w as n ot  
tested  by PGR.
DISCUSSION
T h is stud y has confirm ed  earlier reports o f  the e x ­
p ress ion  o f  p 40  in IS90T^ M . avium  (Inglis e t al., 
1994; A hrens et al., 1995 ; Inglis, 1997) and h as ex ten d ed  
th is o b serva tion  to  sh o w  th at p40 is n o t exp ressed  in a 
w id e  range o f  m ycob acteria l species. D esp ite  the absence  
o f  p 40  ex p ress io n , it w as d em on stra ted  clearly  th at p40  
gen e h o m o lo g u es  are w id e ly  d istributed  w ith in  the genus  
M ycobacteriu m . T h e  con currence o f  IS901 and p40, 
therefore , represents a un ique exam p le  o f  con stitu tive  
ex p ress io n  o f  a h igh ly  con served  m ycob acteria l gene in  
a sso c ia tio n  w ith  a g en o m ic  in sertion  elem en t. T h ese  
ob serv a tio n s raise fu n d am en ta l q u estion s as to  w h y  the  
p40 gen e h o m o lo g u es  apparen tly  are n o t expressed  in 
oth er  sp ecies o f  M ycobacteriu m , and a lso  w h y  e x ­
p ress io n  o f  the p 40  gen e is confined  to  strains o f  M . 
avium  th at h arbour the in sertion  e lem en t IS901.
D a ta b a se  searches identified  co m p le te  p 40  O R F s in M . 
bovis, M . leprae, M . sm egm atis, M . tuberculosis  and, in 
particu lar , IS901“ M . avium  and M . avium  subsp. 
paratu bercu losis, w h o se  respective p40 gene h o m o ­
lo g u es  share 99 6 and 98 9 % id en tity  w ith  th at o f  IS901^ 
M . avium . H o w ev er , because a lm o st all o f  the m y co ­
bacteria  in clud ed  in th is stu dy w ere p rop agated  in vitro , 
ou r ob serva tion s ca n n o t ex c lu d e  in v ivo  exp ression  o f  
p40. N everth e less , the absence o f  p40 exp ression  in M . 
leprae, togeth er  w ith  the ob servation  o f  specific T -cell 
im m une resp on ses to  the p40 antigen  in sheep  e x ­
perim en ta lly  in fected  w ith  IS 9 0 H  M . avium  but n o t in 
sheep  in fected  w ith  M . avium  subsp . paratuberculosis  
(Burrells et al., 1995), su p p ort the ab sen ce o f  in vivo  
exp ress ion  in other m ycob acteria  and in d ica te  that 
differences in gene regu lation  m ay accou n t for the  
unusu al exp ress ion .
T o  ascertain  w h eth er  species-specific  exp ression  o f  p40  
m igh t be attributab le to  d ifferences in n u c leo tid e  se ­
quence at p rom oter  level, the upstream  region s o f  p40  
gen e h o m o lo g u es  from  all seven  o f  the ab ove M y co ­
bacterium  species w ere a ligned  and com p ared . Pre­
lim in ary  an alysis o f  these upstream  seq u en ces revealed  
— 10 and —35 h exam ers o f  a pu ta tive  prom oter  region . 
N o ta b ly , IS 9 0 H  M . avium  and M . sm egm atis  w ere  
observed  to  differ from  the oth er sp ecies at the — 14 
p o sitio n , w here T  rep laces C at the first p o sitio n  o f  the  
p u tative  — 10 reg ion . In ad d ition , T G N  m otifs , w h ich  
have been  reported  to  enhan ce the transcrip tional 
activ ity  o f  som e m ycob acteria l p rom oters (B ashyam  &  
T y a g i, 1998), w ere n oted  to  im m ed iate ly  precede the  
— 10 h exam er in all cases ex cep t M . sm egm atis, in w h ich  
a sing le  n u cleo tid e  (A) separated  the T G N  m o tif  and the  
first base o f  the — 10 reg ion . S ingle base pair m u tation s  
in — 10 reg ions or their T G N  ex ten s io n s  have been  
reported  to  exert m arked  effects on the efficiency o f  gene  
transcrip tion  in m ycob acteria  and enterobacteria  
(B ashyam  &  T y a g i, 1998; T im m  et al., 1994; Y ouderian  
e t al., 1982). H o w ev er , in the ab sen ce o f  lab oratory  
con firm ation , n o  firm co n c lu s io n s can be draw n  from  
currently ava ilab le  data . Further w ork  is under w ay  to  
estab lish  w h eth er  exp ression  o f  the p40 gene in IS 9 0 H  
M . avium  is the result o f  o n ly  a single  base pair  
su b stitu tion  in the — 10 reg ion  o f  the p u ta tive  p rom oter.
D ifferences in the p rom oter  reg ion , as d iscu ssed  ab ove, 
do  n o t exp la in  the ab so lu te  con cord an ce  b etw een  
exp ression  o f  p40 and IS901. T h e  in sertion  sequ en ce  
itse lf d oes n o t con ta in  an O R F  for a p 40  h o m o lo g u e , nor  
d oes it p ossess  o u tw ard -fac in g  prom oters that are 
cap ab le o f  sw itch in g  on  exp ression  o f  adjacent genes, as
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described for ISlO /TnlO  (Dale, 1995). It seems unlikely, 
therefore, that IS901 is acting in cis to upregulate p40; 
this is supported by our failure to amplify a product 
using primers derived from the 3' end of IS9Ô1 and the 5' 
end of the p40 gene (unpublished).
An alternative mechanism that could possibly account 
for constitutive expression of p40 only in IS90H  
M. avium  would be if expression o f the p40 gene were 
normally tightly regulated and under the control of a 
repressor mechanism in M ycobacterium  species that 
lack IS901. Such regulatory mechanisms have been 
reported for a number of mycobacterial genes 
(Dhandayuthapani et al., 1997; Durbach et al., 1997; 
Dussurget et al., 1996, 1999; Manabe et al., 1999; 
Movahedzadeh et al., 1997 ; Schmitt et al., 1995 ; Sun et 
al., 1998). If a similar repressor protein is responsible for 
regulating expression of the p40 gene, constitutive 
expression of p40 would be a direct consequence of 
integration of IS901 within either the repressor gene 
itself or the p40 gene repressor binding site. Such 
unregulated expression of p40 could be manifested as a 
phenotypic change or altered pathogenicity of IS90H M. 
avium. It has been demonstrated that IS90H M. avium  
(type A /I) is more virulent than IS901“ M. avium  (type 
A) in experimentally inoculated BALB/c mice (Kunze et 
al., 1991; Pedrosa et al., 1994). Although the increased 
virulence was attributed to the presence of IS901 in M. 
avium  type A /I strains, it is conceivable that unrepressed 
expression of p40 might be involved. Whatever the 
nature of the association between IS901 and expression 
of the p40 gene, it is clear that the presence of multiple 
copies of IS901 appears to divide M. avium  into two 
distinct subtypes with differing host ranges and patho­
genicity. It should be emphasized, however, that in the 
absence of a clearly defined molecular mechanism, there 
is currently no firm evidence upon which a direct link 
between these differences and the presence of IS901 can 
be based. Nevertheless, it is intriguing that the presence 
of the closely related insertion element IS900 in M. 
avium  subsp. paratuberculosis (Green et al., 1989) also 
supports differences in host range and pathogenicity 
relative to strains of M. avium  that possess neither IS901 
nor IS900. With the implications for comparative 
functional genomics in mind, it would clearly be of great 
interest to identify and characterize the genes affected by 
the insertion of IS901 and IS900 in M. avium  and M. 
avium  subsp. paratuberculosis, respectively. The charac­
terization of most of the IS900 loci in M. avium  subsp. 
paratuberculosis was reported recently (Bull et al., 
2000). Furthermore, completion of the ongoing M. 
avium  and M. avium  subsp. paratuberculosis genome 
sequencing projects should facilitate our understanding 
of how the acquisition and chromosomal integration of 
genomic insertion elements might affect the biology of 
these organisms.
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